<?xml version="1.0" encoding="utf-8"?>
<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd"><eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511"><eadid>FA1103A.xml</eadid><filedesc><titlestmt><titleproper type="filing">Rockefeller University collection of The Medical Letter publication, 1996-2004</titleproper><titleproper>A Guide to the Rockefeller University collection of The Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper></titlestmt><publicationstmt><publisher>Rockefeller Archive Center</publisher><address><addressline>15 Dayton Avenue</addressline><addressline>Sleepy Hollow 10591</addressline><addressline>archive@rockarch.org</addressline><addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline></address></publicationstmt></filedesc><profiledesc><creation>This finding aid was produced using ArchivesSpace on <date>2019-10-29 00:36:45 -0400</date>.</creation><descrules>Describing Archives: A Content Standard</descrules></profiledesc></eadheader><archdesc level="collection">
  <did>
    <langmaterial>
      <language langcode="eng">English</language>
    </langmaterial>
    <repository>
      <corpname>Rockefeller Archive Center</corpname>
    </repository>
    <unittitle>Rockefeller University collection of The Medical Letter publication</unittitle>
    <origination label="Creator">
      <corpname role="aut" source="naf">Rockefeller University</corpname>
    </origination>
    <origination label="Creator">
      <corpname role="aut" source="naf">Medical Letter, Inc</corpname>
    </origination>
    <unitid>FA1103A</unitid>
    <physdesc altrender="whole">
      <extent altrender="materialtype spaceoccupied">131.21 Cubic Feet</extent>
    </physdesc>
    <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
  </did>
  <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
    <head>Processing Information</head>
<p>Minimal processing</p>  </processinfo>
  <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
    <head>Preferred Citation</head>
<p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>  </prefercite>
  <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
    <head>Conditions Governing Access</head>
<p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>  </accessrestrict>
  <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
    <head>File Plan</head>
<p>Former Classification: I 891-U</p>  </fileplan>
  <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
    <head>Other Finding Aids</head>
<p>For additional Medical Letter materials open for research see:</p><p>FA241 Rockefeller University collection of the Medical Lettter publication</p>  </otherfindaid>
  <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
    <head>Scope and Contents</head>
<p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>  </scopecontent>
  <bioghist id="6c159867ba2a2151b8b7399752c3890b">
    <head>Biographical / Historical</head>
<p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>  </bioghist>
  <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
    <head>Conditions Governing Use</head>
<p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>  </userestrict>
  <dsc><c id="722d135ab2e6b9a0415068e6118db069" level="file"><did><unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="64f2186f29650f8d6afffd927ebcd3cb" label="mixed materials [A0000000075844]" type="box">1</container><container id="caf5e6dbdabc76b92a4c198ca268d0d5" parent="64f2186f29650f8d6afffd927ebcd3cb" type="folder">1-4</container></did><accessrestrict id="6413d819e0f61297a55139d343bc6b2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e0dd5900ff39bfca71872aabc11f428" level="file"><did><unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="af58fa2ea33d577abd6a7479bba3a887" label="mixed materials [A0000000075844]" type="box">1</container><container id="ca4bfb17c5b769232a8643a2ed70d400" parent="af58fa2ea33d577abd6a7479bba3a887" type="folder">5-7</container></did><accessrestrict id="656f8049cade326890b44a882a172390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file"><did><unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="884513a0c571afec9b848a880d6328b0" label="mixed materials [A0000000075844]" type="box">1</container><container id="1e796dab60352033e73149f582720640" parent="884513a0c571afec9b848a880d6328b0" type="folder">8-12</container></did><accessrestrict id="ca3616172a78ef218806617937be4ae3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="299c68349552c9c16b93a8a4762f739e" level="file"><did><unittitle>TML, 38-35 - New drugs for HIV</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="2d0b9eff8c36aa91a0c15288b8da44bd" label="mixed materials [A0000000075844]" type="box">1</container><container id="b175db167662ffdafc7e737a9a5d289b" parent="2d0b9eff8c36aa91a0c15288b8da44bd" type="folder">13-17</container></did><accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="fadeb32a6aeec4a2e528f9bbc04e8b0a" label="mixed materials [A0000000075844]" type="box">1</container><container id="2c0429c0d2974d75538095c0d5f3ba1c" parent="fadeb32a6aeec4a2e528f9bbc04e8b0a" type="folder">18</container></did><accessrestrict id="6490910db6cb9773d516babe0e3ba2c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="25c672276d8de231f00bfa483bb42cb2" level="file"><did><unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="57eafa3200732ec718801ae4a4d82dd8" label="mixed materials [A0000000075845]" type="box">2</container><container id="f6d52db3dd52f281eaf3d540468bf385" parent="57eafa3200732ec718801ae4a4d82dd8" type="folder">1-3</container></did><accessrestrict id="2d841e9b213eca4386b5020a0f960ab2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="520cba0819f4d1a661ffbae9d84a72d2" level="file"><did><unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="47cdd54ffde55fff98ed19a65661ecb7" label="mixed materials [A0000000075845]" type="box">2</container><container id="d2881175207b78b5e7bd40f498e708fe" parent="47cdd54ffde55fff98ed19a65661ecb7" type="folder">4-6</container></did><accessrestrict id="391e7265783eb309c372f58724caf420"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b466c2ae20545eb902a029aabfadd4a2" level="file"><did><unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle><unitdate type="inclusive">1996 March 29</unitdate><container altrender="Record Storage Box (Paige)" id="7376093fad5c0e21bfd52e166ad95a1c" label="mixed materials [A0000000075845]" type="box">2</container><container id="468edd8728e23ee07a95ffc3837f531d" parent="7376093fad5c0e21bfd52e166ad95a1c" type="folder">7-9</container></did><accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ef71891079fc8afb056a13746e052f75" level="file"><did><unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle><unitdate type="inclusive">1996 August 30</unitdate><container altrender="Record Storage Box (Paige)" id="758af4f2986fce08f3ee56e34c14d79c" label="mixed materials [A0000000075845]" type="box">2</container><container id="ee6433515e398376324298bc1696dddb" parent="758af4f2986fce08f3ee56e34c14d79c" type="folder">10-16</container></did><accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="630284f8fa9310d4604f35f82942ec99" level="file"><did><unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="6d9249667825807eb661f9140b3fdd4b" label="mixed materials [A0000000075845]" type="box">2</container><container id="c83e78383282a1ef9fe123c2c1d8efcf" parent="6d9249667825807eb661f9140b3fdd4b" type="folder">17-18</container></did><accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="55a866931bef718a2ca01e1c584458f9" label="mixed materials [A0000000075845]" type="box">2</container><container id="aadd00f344d0bbd1765c4934b7e4f69a" parent="55a866931bef718a2ca01e1c584458f9" type="folder">19-20</container></did><accessrestrict id="c9d5e1a415d2921805aa74b729504b02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file"><did><unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="7f3ff04abeb17d2bbd48e885ce33f594" label="mixed materials [A0000000075846]" type="box">3</container><container id="0a10fb72a61a67ad71f9bd6b532c807f" parent="7f3ff04abeb17d2bbd48e885ce33f594" type="folder">1</container></did><accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8e8440ccfa5de303b70df4a8556b7da1" level="file"><did><unittitle>TML, 38-103 - Bone Density Testing</unittitle><unitdate type="inclusive">1996 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="450700a616ef02ea44d4668047169a3e" label="mixed materials [A0000000075846]" type="box">3</container><container id="95965683f0c57adc9ae1336193e92d50" parent="450700a616ef02ea44d4668047169a3e" type="folder">2-3</container></did><accessrestrict id="9371d9820f979006c113e8341494696d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2bc3e056d1f8fa2492e7303d95310131" level="file"><did><unittitle>TML, 37-109 - Dirithromycin</unittitle><unitdate type="inclusive">1995 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="275893db5ddd09fb57b1933a4bd3770d" label="mixed materials [A0000000075846]" type="box">3</container><container id="5efedabae099c95e5401330b7bbf40a4" parent="275893db5ddd09fb57b1933a4bd3770d" type="folder">4-7</container></did><accessrestrict id="70e63df474c05d465a52ed6834a63c2e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="404e68490aeea4bc03276bd2e1972297" level="file"><did><unittitle>TML, 38-108 - Calcium Supplements</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="e363c2db1b5ecde556f447ca36d8b91a" label="mixed materials [A0000000075846]" type="box">3</container><container id="ff4c7672740bbc9aec4527042f058a46" parent="e363c2db1b5ecde556f447ca36d8b91a" type="folder">8-12</container></did><accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="787f855d64193a39aa5fa640c29b09f9" level="file"><did><unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="205ffd7c8dbfe52dc0bfc7106e0decb4" label="mixed materials [A0000000075846]" type="box">3</container><container id="32986fe41769dd58ec887b88e62de6b4" parent="205ffd7c8dbfe52dc0bfc7106e0decb4" type="folder">13-16</container></did><accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="6ee9fed32bd765fba31910157fc457da" level="file"><did><unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="609e53de19e77b2a31090646af511e81" label="mixed materials [A0000000075846]" type="box">3</container><container id="797dfde6f6c3fa5329b6d1969bc5f021" parent="609e53de19e77b2a31090646af511e81" type="folder">17-19</container></did><accessrestrict id="fe428baa314a27bf86569a7a685bf75c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file"><did><unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="0d7317eb7e5bda4017544747737fa531" label="mixed materials [A0000000075847]" type="box">4</container><container id="67775430c51fff479c81cf9d2651a1b2" parent="0d7317eb7e5bda4017544747737fa531" type="folder">1-4</container></did><accessrestrict id="cd47248ae2cfc55d2fb4424654263054"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file"><did><unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle><unitdate type="inclusive">1996 May 10</unitdate><container altrender="Record Storage Box (Paige)" id="bce6427820b6e14a92b109eb6befa310" label="mixed materials [A0000000075847]" type="box">4</container><container id="7981a7a0ebf45aced975dd453f4cbe69" parent="bce6427820b6e14a92b109eb6befa310" type="folder">5</container></did><accessrestrict id="2fb3ed462271aeec0fb14801053de435"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9050bc8c28970ad791e377582e9c079c" level="file"><did><unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle><unitdate type="inclusive">1996 August 2</unitdate><container altrender="Record Storage Box (Paige)" id="75db56f511d64ad941032334b3fa31f3" label="mixed materials [A0000000075847]" type="box">4</container><container id="a96ab628242c7ff105a09bca2981d47a" parent="75db56f511d64ad941032334b3fa31f3" type="folder">6-13</container></did><accessrestrict id="88da501863cd117b47bcae321e4b3b00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="5c5e7299af1de05e46453f0fea0e1720" level="file"><did><unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="d8a1c4727fe8f23cddccff460c1fda47" label="mixed materials [A0000000075847]" type="box">4</container><container id="a727cb72d938784d611f7e73eb92f805" parent="d8a1c4727fe8f23cddccff460c1fda47" type="folder">14-18</container></did><accessrestrict id="0f7c6d142759503d2196573bb0b89f9a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0f91362447d7a3cdff68d7ebac520b38" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="bf7dc72fb37fef52c554e55f26e64d19" label="mixed materials [A0000000075847]" type="box">4</container><container id="7dc039f29012143443378f88d9ee23e2" parent="bf7dc72fb37fef52c554e55f26e64d19" type="folder">19-20</container></did><accessrestrict id="4e5c9545497b1cea799d01d6d8e16965"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c714362a04b8f852b521155e586e0af2" level="file"><did><unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="3213f77dc6fc896502024520b39726bb" label="mixed materials [A0000000075848]" type="box">5</container><container id="4823abf75faa1d2cccae3b495179cbd6" parent="3213f77dc6fc896502024520b39726bb" type="folder">1</container></did><accessrestrict id="a545b57ddc41b86449988949e310c707"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="484f5bda82347b92c1fd763adae1bf8a" level="file"><did><unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="2a438e79bcf94abf330c9405a7d7f06d" label="mixed materials [A0000000075848]" type="box">5</container><container id="b10ff47ff3fde72aa530bdb2abb37ed8" parent="2a438e79bcf94abf330c9405a7d7f06d" type="folder">2-5</container></did><accessrestrict id="0ae4223f8a683f538d4cd77c366f1250"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="8d0423127d33593f9f53a6262dc9f97c" level="file"><did><unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="5b1fe5e23e768d518db67c706c014583" label="mixed materials [A0000000075848]" type="box">5</container><container id="16f14c64be14833f7e1d66f71758c987" parent="5b1fe5e23e768d518db67c706c014583" type="folder">6-8</container></did><accessrestrict id="ed7cc80f5cac6080418667469e63fcc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="a348057f4e83121c70f8e63e18862273" level="file"><did><unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="72c0217ca5245e243158507310d85b4b" label="mixed materials [A0000000075848]" type="box">5</container><container id="988bba36d3159d56a17a903e20f016c1" parent="72c0217ca5245e243158507310d85b4b" type="folder">9-10</container></did><accessrestrict id="9060f4c1941e62cde507283711c42123"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4fb37dc500fa2658eede9f802e9df8f8" level="file"><did><unittitle>TML, 38-95 - Fexofenadine</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="61e54c4f4c9549c121cc7e96b5c9d556" label="mixed materials [A0000000075848]" type="box">5</container><container id="741a3ffbc3cbc96b2e3c2c958f4c1eb3" parent="61e54c4f4c9549c121cc7e96b5c9d556" type="folder">11-12</container></did><accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="64be8e3eb6b9a7f019087998bc44abd8" level="file"><did><unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle><unitdate type="inclusive">1995 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="8de2d0a8482f23bc217a1a6c6093bbeb" label="mixed materials [A0000000075848]" type="box">5</container><container id="ca7c46ec84fa92d9bc616ce9a491f229" parent="8de2d0a8482f23bc217a1a6c6093bbeb" type="folder">13-16</container></did><accessrestrict id="695bcbd1bf632b907b932d7960966f9f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="5af585e03fa4ad89ca3751c353279c4c" label="mixed materials [A0000000075848]" type="box">5</container><container id="e15c5ce2e105bde9117987aef387b916" parent="5af585e03fa4ad89ca3751c353279c4c" type="folder">17-21</container></did><accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="35c106caf84841f600db741ede502382" level="file"><did><unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="1fc6e357eace8d18c4e6c6dace085576" label="mixed materials [A0000000075849]" type="box">6</container><container id="b9d409dbfc593e2b842cf24b30be4cf9" parent="1fc6e357eace8d18c4e6c6dace085576" type="folder">1</container></did><accessrestrict id="f54d8351e9c7683733c760ddc9c6386f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9c02c90545e46d220940cf2a507e0a28" level="file"><did><unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle><unitdate type="inclusive">1996 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="9ae61f0127eb2bb93b0a5d7358b6e7a8" label="mixed materials [A0000000075849]" type="box">6</container><container id="2beb526837793d3c8f172f409dabf23d" parent="9ae61f0127eb2bb93b0a5d7358b6e7a8" type="folder">2-3</container></did><accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file"><did><unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="9c3796977e2125f597b1a79d201f4ebf" label="mixed materials [A0000000075849]" type="box">6</container><container id="d9426e7ee790e4b524f1a4101388194f" parent="9c3796977e2125f597b1a79d201f4ebf" type="folder">4-6</container></did><accessrestrict id="7105d2dd194378e7c1b806e1786142c0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="237f462175824d3b36e04281c83344ac" level="file"><did><unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="426e50025541f2991aa57653ee341ce7" label="mixed materials [A0000000075849]" type="box">6</container><container id="7ca2a1e6a2509295ffbb17e48d6c7b7f" parent="426e50025541f2991aa57653ee341ce7" type="folder">7-8</container></did><accessrestrict id="d0c68415f609b87b8e322217b54f482b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file"><did><unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="fd83bc66f79717449699c20e991c63ca" label="mixed materials [A0000000075849]" type="box">6</container><container id="cc8a1785fadb505fc4655cdc2eafb39c" parent="fd83bc66f79717449699c20e991c63ca" type="folder">9-13</container></did><accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="df185de80953b9ba72734fc53563026f" level="file"><did><unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle><unitdate type="inclusive">1995 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="1e2332efd423baf711a6f7da7533615d" label="mixed materials [A0000000075849]" type="box">6</container><container id="8730379340398034710441a864191527" parent="1e2332efd423baf711a6f7da7533615d" type="folder">14-16</container></did><accessrestrict id="ee2185b1e98265927be53db9e0fa2dda"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9ea393808d7941a34a9237ff7d3e21d0" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="87ed739933c3ebff3b6387480497f6e0" label="mixed materials [A0000000075849]" type="box">6</container><container id="d1d156a9d1383390f12b7c60d9a0481d" parent="87ed739933c3ebff3b6387480497f6e0" type="folder">17-20</container></did><accessrestrict id="052ebcc34a91845237e97c0df53775e3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b5728f730c61991eb3d049832355c05c" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="bdff74d4e3c50a5532c29999d553bede" label="mixed materials [A0000000075850]" type="box">7</container><container id="f128aac85a61c8e307688449d09174bb" parent="bdff74d4e3c50a5532c29999d553bede" type="folder">1-2</container></did><accessrestrict id="8725ceb0317248c73c37ce2386f5e01b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="34fded3e81407289cef7298c43db888c" level="file"><did><unittitle>TML - Drugs of Choice - Pain</unittitle><unitdate type="inclusive">1995</unitdate><container altrender="Record Storage Box (Paige)" id="ed087c045b0d58709dc940f99365a736" label="mixed materials [A0000000075850]" type="box">7</container><container id="1b09a0a36b8f16ccc95fe5157a912d47" parent="ed087c045b0d58709dc940f99365a736" type="folder">3-7</container></did><accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="73f114dc6e630afb990634a443031d95" level="file"><did><unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle><unitdate type="inclusive">1995 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="a9f51961b1ae0471c4fef9beb011f73f" label="mixed materials [A0000000075850]" type="box">7</container><container id="439605ef22583a33de57d3f36f2f765a" parent="a9f51961b1ae0471c4fef9beb011f73f" type="folder">8-10</container></did><accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3ff759a8063b390ff0175205e40649d" level="file"><did><unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="a48186316c372ce564bd82c7d1bc232f" label="mixed materials [A0000000075850]" type="box">7</container><container id="07c04557bfebe4768b46029b1427f489" parent="a48186316c372ce564bd82c7d1bc232f" type="folder">11-13</container></did><accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file"><did><unittitle>TML, 38-17 - Advice for Travelers</unittitle><unitdate type="inclusive">1996 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="b33880ca168a260a0f095506d5fd2c2b" label="mixed materials [A0000000075850]" type="box">7</container><container id="b40e4540ecc5f0e3917bbaf4cd38b032" parent="b33880ca168a260a0f095506d5fd2c2b" type="folder">14-16</container></did><accessrestrict id="c3bea7a676bd5b9981068ccf42242297"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="314ebfe0a12d0bad31002df2bbabf782" level="file"><did><unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle><unitdate type="inclusive">1995 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="cfe492feddbef8fa7c970c7a9ca3c248" label="mixed materials [A0000000075850]" type="box">7</container><container id="7ea49e6e4299665ba3bb780a158b959c" parent="cfe492feddbef8fa7c970c7a9ca3c248" type="folder">17</container></did><accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="fa30b8e25d30bd60ee7b9207731748dd" level="file"><did><unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle><unitdate type="inclusive">1996 September 13</unitdate><container altrender="Record Storage Box (Paige)" id="7dadb1502e25ef8e0cb28c239a6ca306" label="mixed materials [A0000000075850]" type="box">7</container><container id="0e1fff6e1235a06f44b8f6ba4a5469db" parent="7dadb1502e25ef8e0cb28c239a6ca306" type="folder">18</container></did><accessrestrict id="5726a4d76a933c3152d68d2618f96f58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="76dcb6a56a7b5f83636afb906304e3de" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="cd9fb0169e1e402c2336be0349efc80b" label="mixed materials [A0000000075850]" type="box">7</container><container id="ecd29aaa89b242bbd2afd0cae71ec8bd" parent="cd9fb0169e1e402c2336be0349efc80b" type="folder">19</container></did><accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file"><did><unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle><unitdate type="inclusive">1996 July 5</unitdate><container altrender="Record Storage Box (Paige)" id="0c22f6bc35a9be99e90888062d7fdf11" label="mixed materials [A0000000075851]" type="box">8</container><container id="52bd8c2a415e1aeddbd3c20070f67298" parent="0c22f6bc35a9be99e90888062d7fdf11" type="folder">1-4</container></did><accessrestrict id="5afb2bc4dd74607653137719b41bcbd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file"><did><unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="998dd3ccfdfce119fb5d3a58700e3e42" label="mixed materials [A0000000075851]" type="box">8</container><container id="e12924391b0e4506366b26362fabfa41" parent="998dd3ccfdfce119fb5d3a58700e3e42" type="folder">5-6</container></did><accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c90350a57c09afa4b1edf8990faf82c4" level="file"><did><unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle><unitdate type="inclusive">1996 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="589c5125230fdb0bb1e2805cf87e969a" label="mixed materials [A0000000075851]" type="box">8</container><container id="5b8db90a92aa9b4c6cb69bd51eb22b21" parent="589c5125230fdb0bb1e2805cf87e969a" type="folder">7-10</container></did><accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="838bd206e5b57f1350c9a04ae42f2583" level="file"><did><unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle><unitdate type="inclusive">1996 November 8</unitdate><container altrender="Record Storage Box (Paige)" id="9ae09bd0b51ffdfb58f0ae24a59f3722" label="mixed materials [A0000000075851]" type="box">8</container><container id="9925776b11f771b8416a4eb2653de448" parent="9ae09bd0b51ffdfb58f0ae24a59f3722" type="folder">11-14</container></did><accessrestrict id="2e48e9ac6a735700c373ee378f599caa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="45a205e5a189cb71c6708535b75c4937" level="file"><did><unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="87556b9663d01b7680ca14531ae051ba" label="mixed materials [A0000000075851]" type="box">8</container><container id="172f2088b6e58a8f284f28b12035e62f" parent="87556b9663d01b7680ca14531ae051ba" type="folder">15-16</container></did><accessrestrict id="0c7d5401af543b0c0983defbe212a6e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2cbe2967f283fa20d7d713e0125238d8" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="39420c0b889b24788c8b8da65e8cc737" label="mixed materials [A0000000075851]" type="box">8</container><container id="4f354225700272a56856902053d4e6e1" parent="39420c0b889b24788c8b8da65e8cc737" type="folder">17-18</container></did><accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="f7093bc2141bbd10998f3dc5ff41875b" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="b14635db911806b600af868c0235b6af" label="mixed materials [A0000000075852]" type="box">9</container><container id="d84c6c255d6be281eca2e37b55e55f3a" parent="b14635db911806b600af868c0235b6af" type="folder">1-3</container></did><accessrestrict id="5de98fca91cbe16591ff580840223c8c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file"><did><unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="a75a549a42d84e2bf104e6d546305822" label="mixed materials [A0000000075852]" type="box">9</container><container id="4ebf365efa45e8d876cb02adb2047a7c" parent="a75a549a42d84e2bf104e6d546305822" type="folder">4-7</container></did><accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0ab086d0742f0a6f31a054d358cbefcf" level="file"><did><unittitle>TML, 35-62 - Nedocromil for asthma</unittitle><unitdate type="inclusive">1993 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="19d58c54a6f45dca12e1ee8d70cdd347" label="mixed materials [A0000000075852]" type="box">9</container><container id="d2640fbc186ea07d99458ba89046d3f7" parent="19d58c54a6f45dca12e1ee8d70cdd347" type="folder">8-12</container></did><accessrestrict id="d876b6e0e035d2d97ee9711f878a831c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="9f3042b173404cf6a3ccd9df900d20c0" level="file"><did><unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="9b18febb7cb99119a9ccb6cd660c9340" label="mixed materials [A0000000075852]" type="box">9</container><container id="59de35bb4739bbf7f6bc89de964e1b12" parent="9b18febb7cb99119a9ccb6cd660c9340" type="folder">13-18</container></did><accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file"><did><unittitle>TML, 38-53 - Prostatron</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="43511a5e17870d71faf726dec576f92b" label="mixed materials [A0000000075852]" type="box">9</container><container id="e5cd7956b19447647815788ff1765593" parent="43511a5e17870d71faf726dec576f92b" type="folder">19-20</container></did><accessrestrict id="fa8555c81ed0ff184e52c7e939db327c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file"><did><unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle><unitdate type="inclusive">1996 December 6</unitdate><container altrender="Record Storage Box (Paige)" id="54d5f32dd7d3ad7f662bd173ac3b9685" label="mixed materials [A0000000075853]" type="box">10</container><container id="0b6e281e737f316c31a3ac5a596efecf" parent="54d5f32dd7d3ad7f662bd173ac3b9685" type="folder">1-3</container></did><accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c1416d4fc58c7899cbc27ca73d15c172" level="file"><did><unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle><unitdate type="inclusive">1996 June 21</unitdate><container altrender="Record Storage Box (Paige)" id="a790c197e2ded6ce3dff6eaf566e3106" label="mixed materials [A0000000075853]" type="box">10</container><container id="0f8cc9ee10d455b477741c09124d814e" parent="a790c197e2ded6ce3dff6eaf566e3106" type="folder">4-5</container></did><accessrestrict id="76d78aedee8d1ddf219a07affe27bb10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="26af25957e59124a08f91eba499fc700" level="file"><did><unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="b0b8dee72f22e7c58fad17772736ccfd" label="mixed materials [A0000000075853]" type="box">10</container><container id="ef877a9570216121e22df854d123969a" parent="b0b8dee72f22e7c58fad17772736ccfd" type="folder">6-7</container></did><accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="4273a72d699f99aeabfcab12d5bde513" level="file"><did><unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="2d1c5dbe8f9eb1e43e2dfb622092a857" label="mixed materials [A0000000075853]" type="box">10</container><container id="87e3a8c8e66d95b0484dab888fe4b6e1" parent="2d1c5dbe8f9eb1e43e2dfb622092a857" type="folder">8-11</container></did><accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="afa8fcead3849c57e46148fac07fdf16" level="file"><did><unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle><unitdate type="inclusive">1996 May 24</unitdate><container altrender="Record Storage Box (Paige)" id="55727723877242cc5ec3204b070046c3" label="mixed materials [A0000000075853]" type="box">10</container><container id="0261b25a333692cf8bedf62ce527614b" parent="55727723877242cc5ec3204b070046c3" type="folder">12-15</container></did><accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e83fc33c009862fb85873ce44225451e" level="file"><did><unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle><unitdate type="inclusive">1996 October 25</unitdate><container altrender="Record Storage Box (Paige)" id="d06f44a15f444353b6b48fb00b461023" label="mixed materials [A0000000075853]" type="box">10</container><container id="12c05c7573e6a822b23f32894a708ba2" parent="d06f44a15f444353b6b48fb00b461023" type="folder">16-18</container></did><accessrestrict id="f4f4ca0b76dee28258679841660c3e53"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="1d1e2499f47a2c5a2498c508251c060e" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="3a0f9489ea8e7bdae3ba0a4b3aa275c6" label="mixed materials [A0000000075853]" type="box">10</container><container id="7e8a3602fd453d961ce1688cb9a56fd0" parent="3a0f9489ea8e7bdae3ba0a4b3aa275c6" type="folder">19</container></did><accessrestrict id="5e026f0f926c42121383574e48a743ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="e3cd99c272218799e02c72a5e28f33c9" level="file"><did><unittitle>TML, 38-3 - Valacyclovir</unittitle><unitdate type="inclusive">1996 January 5</unitdate><container altrender="Record Storage Box (Paige)" id="8d62fe6c7c6cc70e19b266f5700da0c8" label="mixed materials [A0000000075946]" type="box">11</container><container id="1192bda1173e4242db6319dc2cf3928a" parent="8d62fe6c7c6cc70e19b266f5700da0c8" type="folder">1-2</container></did><accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="2146f075bfb01adf0c99fddbe6268b26" level="file"><did><unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle><unitdate type="inclusive">1996 November 22</unitdate><container altrender="Record Storage Box (Paige)" id="b1af2665ffc9667a9075e8fe9d2f5617" label="mixed materials [A0000000075946]" type="box">11</container><container id="8a7cb36db0577aad5bb7beafaec82a5b" parent="b1af2665ffc9667a9075e8fe9d2f5617" type="folder">3-5</container></did><accessrestrict id="a1dd4aa7256167e609397b035b7478d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="7a2f268994b16b4876604d64167ade0b" level="file"><did><unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle><unitdate type="inclusive">1996 August 16</unitdate><container altrender="Record Storage Box (Paige)" id="3f113e95efffb65e7bcff2874c202b50" label="mixed materials [A0000000075946]" type="box">11</container><container id="b50337aaf0326869476c423fa20d8e3e" parent="3f113e95efffb65e7bcff2874c202b50" type="folder">6-8</container></did><accessrestrict id="c284795ebfbae6dd142f49e2c3d64449"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file"><did><unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle><unitdate type="inclusive">1996 June 7</unitdate><container altrender="Record Storage Box (Paige)" id="82e954dfbe785a852fd1ab6b7d670c94" label="mixed materials [A0000000075946]" type="box">11</container><container id="578ed8ea0bd07fc7d0498b0d80fa6095" parent="82e954dfbe785a852fd1ab6b7d670c94" type="folder">9-11</container></did><accessrestrict id="d93e4e485f03621de43519409ecd0ebb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d2847f832cf8b7dfa8bae10d4079561b" level="file"><did><unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle><unitdate type="inclusive">1996 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="183945ef55ba9ff9acf5950d2d6bc6b0" label="mixed materials [A0000000075946]" type="box">11</container><container id="dd93511df28b28641db7022afbc7cb92" parent="183945ef55ba9ff9acf5950d2d6bc6b0" type="folder">12-14</container></did><accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="07f911d357717fedb196ba2a95b08c6f" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="d1b872c8ecd3653274f288812fe95867" label="mixed materials [A0000000075946]" type="box">11</container><container id="81dbe68868036202af05e769b7ee147f" parent="d1b872c8ecd3653274f288812fe95867" type="folder">15-19</container></did><accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file"><did><unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle><unitdate type="inclusive">1996</unitdate><container altrender="Record Storage Box (Paige)" id="7c863f51306f7e870190057403c9b544" label="mixed materials [A0000000075854]" type="box">12</container><container id="6996e393eec6f57661bb84128a7061fd" parent="7c863f51306f7e870190057403c9b544" type="folder">1-2</container></did><accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file"><did><unittitle>TML, 38-65 - Drugs past their expiration date</unittitle><unitdate type="inclusive">1996 July 19</unitdate><container altrender="Record Storage Box (Paige)" id="00ac6613359e442b202e814615bac096" label="mixed materials [A0000000075854]" type="box">12</container><container id="347c6feae71d2fd32b651de31be62f6c" parent="00ac6613359e442b202e814615bac096" type="folder">3-4</container></did><accessrestrict id="861175c1c60e1d08ff94909fca12e380"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file"><did><unittitle>TML, 38-38 - Ibutilide</unittitle><unitdate type="inclusive">1996 April 12</unitdate><container altrender="Record Storage Box (Paige)" id="352fc1fe35a9da13d71da83231fc07e0" label="mixed materials [A0000000075854]" type="box">12</container><container id="3039429846e006ae91f09fbb57ad4363" parent="352fc1fe35a9da13d71da83231fc07e0" type="folder">5-6</container></did><accessrestrict id="d854aa1bc446941f011a8970567a2b37"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="93c5ceb8486269a6440d4a1164bd8a19" level="file"><did><unittitle>TML, 38-91 - DHEA</unittitle><unitdate type="inclusive">1996 October 11</unitdate><container altrender="Record Storage Box (Paige)" id="dd19100411e0c2cef20b6c93c47ee826" label="mixed materials [A0000000075854]" type="box">12</container><container id="1a09904e4aca130212e2a4ef369e2364" parent="dd19100411e0c2cef20b6c93c47ee826" type="folder">7-9</container></did><accessrestrict id="0b753cb331038a0a1193ae254361f43e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="489aaa51c24f7c3822366d6381860b83" level="file"><did><unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle><unitdate type="inclusive">1996 September 27</unitdate><container altrender="Record Storage Box (Paige)" id="4969c6fb2423ef2294eb7012dd1d18f0" label="mixed materials [A0000000075854]" type="box">12</container><container id="c2aec834925d8baa6e101301cd895a56" parent="4969c6fb2423ef2294eb7012dd1d18f0" type="folder">10-14</container></did><accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="3a54f51aec4a83bee985f1670be2aff6" level="file"><did><unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle><unitdate type="inclusive">1996 April 26</unitdate><container altrender="Record Storage Box (Paige)" id="803bc3ac310b4a1048d3291be0d6e37d" label="mixed materials [A0000000075854]" type="box">12</container><container id="09c5d60a644904815e0dc43e50ec0c3f" parent="803bc3ac310b4a1048d3291be0d6e37d" type="folder">15</container></did><accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="43193a32312eb0204d12fd64fa6b6993" level="file"><did><unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="2e86801523b670168415618352df85f0" label="mixed materials [A0000000075854]" type="box">12</container><container id="e6b28d7059f81a9296acb1c5efb474a3" parent="2e86801523b670168415618352df85f0" type="folder">16-18</container></did><accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="49b7007dcadc3c636c88f299dc526e0d" level="file"><did><unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="8fb6af5017d316e878131dc8827e6fb1" label="mixed materials [A0000000075855]" type="box">13</container><container id="066b3324ac7b42c7439325d3eb518bce" parent="8fb6af5017d316e878131dc8827e6fb1" type="folder">1-3</container></did><accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="61b0c640e3f013a34c64133724020fa2" level="file"><did><unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle><unitdate type="inclusive">1997 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="88cabd5521b89bc7e5e74da912a4d131" label="mixed materials [A0000000075855]" type="box">13</container><container id="1c1e960c0c92b5488c7197a97520e162" parent="88cabd5521b89bc7e5e74da912a4d131" type="folder">4-12</container></did><accessrestrict id="84c4988675afd57f7b095139aa7bfdfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="133977107f40fa3272c401b7abcc89de" level="file"><did><unittitle>TML, 39-18 - Zileuton for asthma</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="1a18b85c345c9b2da763cbe96017991b" label="mixed materials [A0000000075855]" type="box">13</container><container id="dc767750bbdd3bf465458874e43c7c57" parent="1a18b85c345c9b2da763cbe96017991b" type="folder">13-14</container></did><accessrestrict id="4717fa288dd120e806e05499350ddf6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be46a606b805462c6cc03b6ec8b2c39e" level="file"><did><unittitle>TML, 39-9 - Zinc for the common cold</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="455848f0cb0011cd9f9ba6bb3d5fa413" label="mixed materials [A0000000075855]" type="box">13</container><container id="0bfd4d594f56b136e67b15d60d39234e" parent="455848f0cb0011cd9f9ba6bb3d5fa413" type="folder">15-17</container></did><accessrestrict id="ad1088be46d6652eb0405e32258a0bf9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="c4e3fe1d2b091420ef4ea86c8dde7a31" label="mixed materials [A0000000075855]" type="box">13</container><container id="e97bc801ce6ba0672fa1390ef76c1b53" parent="c4e3fe1d2b091420ef4ea86c8dde7a31" type="folder">18-20</container></did><accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c3fee2e8cf6e2d58695098807e086dab" level="file"><did><unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="96171c9aae2c543bc01e336f3d5fb676" label="mixed materials [A0000000075856]" type="box">14</container><container id="106dfb621720b47a214293ab35eceeb8" parent="96171c9aae2c543bc01e336f3d5fb676" type="folder">1</container></did><accessrestrict id="898d939f278bc6e6c335eb092f07c5a8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="393de6e6b75d4f4817695af30349dd68" level="file"><did><unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="43548ad2eb8a87f1becc9ce19e175f22" label="mixed materials [A0000000075856]" type="box">14</container><container id="610785cc115938f7e5a612e1e9d59e7a" parent="43548ad2eb8a87f1becc9ce19e175f22" type="folder">2-4</container></did><accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="4be741eb1bacb7f18527f5b2df647302" level="file"><did><unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="0b79aae67c09e7333ea53b57c2833cf3" label="mixed materials [A0000000075856]" type="box">14</container><container id="c7e3ba525452cf9895b55c468fb5044a" parent="0b79aae67c09e7333ea53b57c2833cf3" type="folder">5-10</container></did><accessrestrict id="7550d2d00d3b056285daa384c568544b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b81fc7aadd5fecc407e846095655da0e" level="file"><did><unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="99602463815568d17d3d3e966d13d723" label="mixed materials [A0000000075856]" type="box">14</container><container id="e12cca3e9d9e17f53954c00c4bc60433" parent="99602463815568d17d3d3e966d13d723" type="folder">11-15</container></did><accessrestrict id="0f1f31dc544a7820b6b3740572840e2c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d6a872b6263ad2beca76d2809d741c78" level="file"><did><unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="dd5b9965c17eef18ba7e8b67b2f0880d" label="mixed materials [A0000000075856]" type="box">14</container><container id="8ff2bab478812925f616640adb30befd" parent="dd5b9965c17eef18ba7e8b67b2f0880d" type="folder">16</container></did><accessrestrict id="37b13c54d0d04ba5299304f96256cfc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="62572ae54e7b47c32783a5b7f9f92261" level="file"><did><unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="45c3e8e173aa9f4c6b010a33b4ac928e" label="mixed materials [A0000000075856]" type="box">14</container><container id="e341519d0d83253558da142c71177314" parent="45c3e8e173aa9f4c6b010a33b4ac928e" type="folder">17-19</container></did><accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bbfc9de7adb6df0701f6173947f38bd2" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="5147d6086a7fde7ccde98a6683a01b59" label="mixed materials [A0000000075856]" type="box">14</container><container id="59032c897ee28acac8956da7f763f16d" parent="5147d6086a7fde7ccde98a6683a01b59" type="folder">20</container></did><accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6b378b12b2f16c81d85d36343d81a41b" level="file"><did><unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="68577592df48674f68c8906ccc56a822" label="mixed materials [A0000000075857]" type="box">15</container><container id="612f5b5706d8c458ee5db0ce08ad0ce5" parent="68577592df48674f68c8906ccc56a822" type="folder">1-2</container></did><accessrestrict id="62290c3388efd25a1b03329c60a4c2c5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="bf256a51de793456a4c7d083f141288c" level="file"><did><unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="551cd41ac4f99fd7ea24b1c6c77d383b" label="mixed materials [A0000000075857]" type="box">15</container><container id="a0b4a2fdedee834712ffbcb0f0a57c54" parent="551cd41ac4f99fd7ea24b1c6c77d383b" type="folder">3-5</container></did><accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e50c791d98c44790d8141d27cd4cfcab" level="file"><did><unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="e5f801c951d2a13ebe74f72312d9a7f9" label="mixed materials [A0000000075857]" type="box">15</container><container id="79f5d12ded89b0737ceafe6ae9aaef68" parent="e5f801c951d2a13ebe74f72312d9a7f9" type="folder">6-8</container></did><accessrestrict id="264d6479c0b4544b7007e8c452a7cee5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12444cf584e83734f66bfc290040544a" level="file"><did><unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle><unitdate type="inclusive">1997 May 23</unitdate><container altrender="Record Storage Box (Paige)" id="7a82ff56ef5ad9dbab5c029b06a1da1d" label="mixed materials [A0000000075857]" type="box">15</container><container id="eb8a06583b25deea7f3f9eaa6b4302c9" parent="7a82ff56ef5ad9dbab5c029b06a1da1d" type="folder">9-11</container></did><accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="64f0edfa5bd3b5159911a74e751d912b" level="file"><did><unittitle>TML, 39-43 - Valsartan for hypertension</unittitle><unitdate type="inclusive">1997 April 25</unitdate><container altrender="Record Storage Box (Paige)" id="5d8b230e44d519318dbdfb05a4a17ae4" label="mixed materials [A0000000075857]" type="box">15</container><container id="9ee35e426832e6fe6a95d8af6e984316" parent="5d8b230e44d519318dbdfb05a4a17ae4" type="folder">12-14</container></did><accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eb014687998353d0fb60326357526127" level="file"><did><unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle><unitdate type="inclusive">1997 January 3</unitdate><container altrender="Record Storage Box (Paige)" id="7041a72e6fde35fa4b5b8eb00cd4907d" label="mixed materials [A0000000075857]" type="box">15</container><container id="d998c80565440fb056a086cf328d15a1" parent="7041a72e6fde35fa4b5b8eb00cd4907d" type="folder">15-20</container></did><accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3436a17eac9c6f31692eb5d354b51a44" level="file"><did><unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="13bc09e78ba02a220a60fc1d9751ff5d" label="mixed materials [A0000000075858]" type="box">16</container><container id="50ff4a6f3cfafce1cc95da5aef130c30" parent="13bc09e78ba02a220a60fc1d9751ff5d" type="folder">1-4</container></did><accessrestrict id="9f23fe9c137d23133c2b5049c5b64530"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file"><did><unittitle>TML, 39-105 - New drugs for psoriasis</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="dcc39b2b9ea7ee6e36a72c9773125fa2" label="mixed materials [A0000000075858]" type="box">16</container><container id="595ee8c9269c1469c1c6ef6946143066" parent="dcc39b2b9ea7ee6e36a72c9773125fa2" type="folder">5-8</container></did><accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file"><did><unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle><unitdate type="inclusive">1997 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="38d8de2730de68782bd8387e4535198c" label="mixed materials [A0000000075858]" type="box">16</container><container id="3ec5785bc968c9ec5fd79638dda75435" parent="38d8de2730de68782bd8387e4535198c" type="folder">9-15</container></did><accessrestrict id="dbaf4673299ed575f189876448054a58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="123a71748e8ade20af228276bab2d8b6" level="file"><did><unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="0c0e0c2c535c83a2a3f62d4fa60e053d" label="mixed materials [A0000000075858]" type="box">16</container><container id="471520a390ca9bf91b790fb45a6e93d3" parent="0c0e0c2c535c83a2a3f62d4fa60e053d" type="folder">16-18</container></did><accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="498df0f2d9dce92679b2aa347629be3f" level="file"><did><unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="e0d2209980e13029a3e2845b97b1ad46" label="mixed materials [A0000000075859]" type="box">17</container><container id="5cda44059a02d8622c2f22e4a5a41ed8" parent="e0d2209980e13029a3e2845b97b1ad46" type="folder">1-2</container></did><accessrestrict id="b2dca34162d6868414a816046edfdff2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file"><did><unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="94e574b729d78fca6f18dc04e91bbef1" label="mixed materials [A0000000075859]" type="box">17</container><container id="70e8373e817c4dc58f4fb131e0995e2f" parent="94e574b729d78fca6f18dc04e91bbef1" type="folder">3-5</container></did><accessrestrict id="6532d645696e8a65297e0563e103f695"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file"><did><unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle><unitdate type="inclusive">1997 August 29</unitdate><container altrender="Record Storage Box (Paige)" id="5ae420005f5e5c1f0cd5baa6a93effce" label="mixed materials [A0000000075859]" type="box">17</container><container id="fd2f46d21943231d3eb0921a9d6514b3" parent="5ae420005f5e5c1f0cd5baa6a93effce" type="folder">6-10</container></did><accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fdd2b028e08760f46ba2467c4b638924" level="file"><did><unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle><unitdate type="inclusive">1997 March 14</unitdate><container altrender="Record Storage Box (Paige)" id="aab02c40f58a76f6cd289d8e934ff2d0" label="mixed materials [A0000000075859]" type="box">17</container><container id="e93ca131e9448013117ca4db57d97757" parent="aab02c40f58a76f6cd289d8e934ff2d0" type="folder">11-16</container></did><accessrestrict id="28f03f207bd6c378f505103883232f68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="42935bf2b5b11b084838a1252d3b3db8" level="file"><did><unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle><unitdate type="inclusive">1997 August 15</unitdate><container altrender="Record Storage Box (Paige)" id="efe993b0b7b130718e9f3b9406a5e634" label="mixed materials [A0000000075859]" type="box">17</container><container id="e53b5b29d392189cd43fae5a4e1f51a2" parent="efe993b0b7b130718e9f3b9406a5e634" type="folder">17</container></did><accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file"><did><unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="42da85ef79402b00bd676ba1b712a6ac" label="mixed materials [A0000000075860]" type="box">18</container><container id="d8e3094bbb1bd3507b4407abc89d0a9d" parent="42da85ef79402b00bd676ba1b712a6ac" type="folder">1-2</container></did><accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="856acb144bbba7a94b1cb63f73185f43" level="file"><did><unittitle>TML, 39-56 - Pentosan</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="58de69570f0a5e24ec3d123d014b82b9" label="mixed materials [A0000000075860]" type="box">18</container><container id="736feb026360c572318dd6a3500e8877" parent="58de69570f0a5e24ec3d123d014b82b9" type="folder">3-4</container></did><accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="afd34d20934d1be77bfc49f4d1241183" level="file"><did><unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle><unitdate type="inclusive">1997 November 7</unitdate><container altrender="Record Storage Box (Paige)" id="a0b88b36940788a7853757f45d3fdf98" label="mixed materials [A0000000075860]" type="box">18</container><container id="5a65a6a08cd0f21a38acc40398ea808e" parent="a0b88b36940788a7853757f45d3fdf98" type="folder">5-8</container></did><accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="de42e2f43ebae331da9c0b8180abb87c" level="file"><did><unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="23fea5bcd59f065155e89091d1f40f5c" label="mixed materials [A0000000075860]" type="box">18</container><container id="e21866f26f8f9943dddce2b8bf83a636" parent="23fea5bcd59f065155e89091d1f40f5c" type="folder">9-11</container></did><accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="96ceef3812b648bc28698beed66c5d75" level="file"><did><unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="27d60f939e580aee8cceba993ed0e45a" label="mixed materials [A0000000075860]" type="box">18</container><container id="64492c848a6b628cdc929005e3945ee3" parent="27d60f939e580aee8cceba993ed0e45a" type="folder">12-14</container></did><accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="eaedccce6a322747a43e566f8dfc2b7d" level="file"><did><unittitle>TML - Drugs of Choice</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="d63ff59e6f57ff30cdec3dad11e87aea" label="mixed materials [A0000000075860]" type="box">18</container><container id="895ba0cb13573b9561f2a76a52d4ca97" parent="d63ff59e6f57ff30cdec3dad11e87aea" type="folder">15-17</container></did><accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95b6682482a9d062317fcf262cc7f718" level="file"><did><unittitle>TML, 39-85 - Influenza vaccine</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="5c728c2dafeeec24d28e8c56af3e50c7" label="mixed materials [A0000000075860]" type="box">18</container><container id="00aa63a6f802b8b9d35c5886bac716ab" parent="5c728c2dafeeec24d28e8c56af3e50c7" type="folder">18</container></did><accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="9c5534af6d0a227ae1ad47876c813383" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="a12dc4c5763c836d9ff5ab510e995dd6" label="mixed materials [A0000000075860]" type="box">18</container><container id="303ff9531baf4e4aa41244d232b87fae" parent="a12dc4c5763c836d9ff5ab510e995dd6" type="folder">19</container></did><accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file"><did><unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="958e901bfb343a1d9b39ab045bd56127" label="mixed materials [A0000000075861]" type="box">19</container><container id="db2a9844cae22eaeb7b263ee6bb973e1" parent="958e901bfb343a1d9b39ab045bd56127" type="folder">1</container></did><accessrestrict id="36454ffdeab70b1b39646403fa3b2960"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0cdb2a091afd3228142c89eb37d2380a" level="file"><did><unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="5eeca4630cbb07f57f6339b03b4c4942" label="mixed materials [A0000000075861]" type="box">19</container><container id="942aeba6ad83ed424f2d27676f917e02" parent="5eeca4630cbb07f57f6339b03b4c4942" type="folder">2-3</container></did><accessrestrict id="d975c63ad23263fd275260f9460dcf1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f4d2ffb826a588ff6c493adbd06a92be" level="file"><did><unittitle>TML, 39-64 - Drugs for epilepsy</unittitle><unitdate type="inclusive">1997 February 6</unitdate><container altrender="Record Storage Box (Paige)" id="93b8c58b1cc224100adf34bbe8412db2" label="mixed materials [A0000000075861]" type="box">19</container><container id="7dc5922a2e13cb0b9a00306b7226cbb4" parent="93b8c58b1cc224100adf34bbe8412db2" type="folder">4-6</container></did><accessrestrict id="c20b70cbd97aa855e62537fb259a09f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="028b89ba84e332c879eab9899c191875" level="file"><did><unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle><unitdate type="inclusive">1997 July 18</unitdate><container altrender="Record Storage Box (Paige)" id="83b2580f2abcc6c8804814e08cdc1779" label="mixed materials [A0000000075861]" type="box">19</container><container id="8b996786d77b70ece3f28b091a7b747c" parent="83b2580f2abcc6c8804814e08cdc1779" type="folder">7-9</container></did><accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file"><did><unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle><unitdate type="inclusive">1997 September 12</unitdate><container altrender="Record Storage Box (Paige)" id="0bedcf3f6fb3697b463683bb2470852c" label="mixed materials [A0000000075861]" type="box">19</container><container id="c09c9619e71974839be173a7a7b2aca1" parent="0bedcf3f6fb3697b463683bb2470852c" type="folder">10-13</container></did><accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6bf77dfe11efd36cf8146b826560cb4c" level="file"><did><unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle><unitdate type="inclusive">1997 July 4</unitdate><container altrender="Record Storage Box (Paige)" id="2fa634d0628793d8c870b971083368c3" label="mixed materials [A0000000075861]" type="box">19</container><container id="9eb860424e19c6b17dba0568863b4912" parent="2fa634d0628793d8c870b971083368c3" type="folder">14-16</container></did><accessrestrict id="58267fbb42c582dd03ac8830411c1803"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f36ff800dacbd73013d42dab42cf5f5b" level="file"><did><unittitle>TML, 38-6 - Drugs for head lice</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="492e5abbf0a81a98404e74bda3522092" label="mixed materials [A0000000075861]" type="box">19</container><container id="7ee275672bc31ec12077acf875a493f3" parent="492e5abbf0a81a98404e74bda3522092" type="folder">17-18</container></did><accessrestrict id="92296119b0cbe67e59973a003090f421"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e13f3fa0ec576057f7033815a81111e1" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="3c5d68955ad5af7f8e3bcb3f5818f035" label="mixed materials [A0000000075861]" type="box">19</container><container id="a55609f930cd1935dea1d277a56337a8" parent="3c5d68955ad5af7f8e3bcb3f5818f035" type="folder">19-20</container></did><accessrestrict id="e7cb03a6203eb58d2833529692c66d60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file"><did><unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="ba5663f4959e715a0f5d1e89069ecb78" label="mixed materials [A0000000075862]" type="box">20</container><container id="8383b4fbbbbbb88d0d4b7a20dca3da12" parent="ba5663f4959e715a0f5d1e89069ecb78" type="folder">1-2</container></did><accessrestrict id="d913972842d3a79acf9b906df7f951e7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="95d8be151e4ef26242db019df375f791" level="file"><did><unittitle>TML, 39-94 - Drugs for hypertension</unittitle><unitdate type="inclusive">1997 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="e594dcd83309044ba1b72f94161c971d" label="mixed materials [A0000000075862]" type="box">20</container><container id="1912085118c40d0a032f3b4a1c2f8c92" parent="e594dcd83309044ba1b72f94161c971d" type="folder">3-5</container></did><accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="f8696aa81da52173ff18b97bd7eb4067" level="file"><did><unittitle>TML, 39-19 - Adapalene for acne</unittitle><unitdate type="inclusive">1997 February 28</unitdate><container altrender="Record Storage Box (Paige)" id="74d102730b713c2de8f8805fe89e3f79" label="mixed materials [A0000000075862]" type="box">20</container><container id="feba542760ef130a8066a2e9eb6bb2b6" parent="74d102730b713c2de8f8805fe89e3f79" type="folder">6-7</container></did><accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file"><did><unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="2d81f5c7595e0e0a6b545e3d72334ea0" label="mixed materials [A0000000075862]" type="box">20</container><container id="e20795436addaf744f9259211c75549d" parent="2d81f5c7595e0e0a6b545e3d72334ea0" type="folder">8-9</container></did><accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file"><did><unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1997 May 9</unitdate><container altrender="Record Storage Box (Paige)" id="9cbb577713b6930a1878ae9a5efd70a7" label="mixed materials [A0000000075862]" type="box">20</container><container id="f64554d134492702cd91110d492621d7" parent="9cbb577713b6930a1878ae9a5efd70a7" type="folder">10-13</container></did><accessrestrict id="2c8bdc164c637c083bf92b35d52554fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="36e76c3b20aacff333ba5d98cfca27de" level="file"><did><unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle><unitdate type="inclusive">1997 January 31</unitdate><container altrender="Record Storage Box (Paige)" id="bc58067b3f2d336142e659688ca277b0" label="mixed materials [A0000000075862]" type="box">20</container><container id="294e86fc46288c82c4ba67fdb50284cb" parent="bc58067b3f2d336142e659688ca277b0" type="folder">14-15</container></did><accessrestrict id="55bd4c86ccf4811f99aac2673693e945"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="e4ca902373c4579a78db0d3b8d513633" level="file"><did><unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="2473b6d04978ce6517b7c5204b1e1917" label="mixed materials [A0000000075862]" type="box">20</container><container id="9531022c2a351670b962c7e88c38ef12" parent="2473b6d04978ce6517b7c5204b1e1917" type="folder">16-17</container></did><accessrestrict id="18bd5ce580d159e1acce03ad34266cc9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file"><did><unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle><unitdate type="inclusive">1997 June 6</unitdate><container altrender="Record Storage Box (Paige)" id="df4533bede2784a0235a03687e7d533c" label="mixed materials [A0000000075862]" type="box">20</container><container id="5423057064fd7aa8efb2e859a7c390e1" parent="df4533bede2784a0235a03687e7d533c" type="folder">18-19</container></did><accessrestrict id="c12a956b010223394c6ca9d2025942d6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="56fc5093674d1372e80ed218ae8bd368" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="b7510878ec8fff469ec0621ff59840fd" label="mixed materials [A0000000075862]" type="box">20</container><container id="53f1f891d2286be2fa60912841ca9e21" parent="b7510878ec8fff469ec0621ff59840fd" type="folder">20</container></did><accessrestrict id="12b089183fda270bbeecc135b190b589"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="1f85013ec13e639596b728f22f1aafc4" level="file"><did><unittitle>TML, 39-13 - Safety of channel blockers</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="08bbc9d92fe530f17010c3484b5c72da" label="mixed materials [A0000000075863]" type="box">21</container><container id="f20c072591a2157bec00780c424ca3fe" parent="08bbc9d92fe530f17010c3484b5c72da" type="folder">1-2</container></did><accessrestrict id="8a33d90a046f00da2d8b9b030020c09e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4a11be555144c67db801913b3a95361" level="file"><did><unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="040be61ca267039576f6773f2e796fed" label="mixed materials [A0000000075863]" type="box">21</container><container id="34a149305d873e900514ee0e3f911c14" parent="040be61ca267039576f6773f2e796fed" type="folder">3-6</container></did><accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file"><did><unittitle>TML - Dovonex</unittitle><unitdate type="inclusive">1993</unitdate><container altrender="Record Storage Box (Paige)" id="28098596a91676eadd2414eb8396afc0" label="mixed materials [A0000000075863]" type="box">21</container><container id="cb7d71611857061cd69883cbf12d4d3a" parent="28098596a91676eadd2414eb8396afc0" type="folder">7</container></did><accessrestrict id="7ed0890a439df753466be5a70bc31770"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file"><did><unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="b6a3f3ae8eb41d979e90d51466ebd4d5" label="mixed materials [A0000000075863]" type="box">21</container><container id="eb2295ee77e0d90d761bfde5b16217df" parent="b6a3f3ae8eb41d979e90d51466ebd4d5" type="folder">8-9</container></did><accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="0f25168045c3874b852fc2566864c22b" level="file"><did><unittitle>TML, 37-1 - Drugs for asthma</unittitle><unitdate type="inclusive">1996 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="3bb270b0009e5c79858268fefd25c782" label="mixed materials [A0000000075863]" type="box">21</container><container id="5caf0f74eb92fa6cb2079c6d3d7d3396" parent="3bb270b0009e5c79858268fefd25c782" type="folder">10-14</container></did><accessrestrict id="5124cbd46d2a439f4f59c00468b6016b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="dbe0049fdc51d967d42b54af228c58ae" level="file"><did><unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle><unitdate type="inclusive">1997 March 28</unitdate><container altrender="Record Storage Box (Paige)" id="b2fd4b459c7eaf48d7a3acd178354a9a" label="mixed materials [A0000000075863]" type="box">21</container><container id="1579082e573b29c5c45ee6517c089505" parent="b2fd4b459c7eaf48d7a3acd178354a9a" type="folder">15-16</container></did><accessrestrict id="108454fd852ec91b5893f1a78b4694b9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3fff697896297fb5b3e546b99c7bb615" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="d5b62914b9a9b7ca54e870fa587a5675" label="mixed materials [A0000000075863]" type="box">21</container><container id="4179c2c2a1a687223baa0fc3e8f490dc" parent="d5b62914b9a9b7ca54e870fa587a5675" type="folder">17-21</container></did><accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="ac009d8a6eba90db98f499f6852dd496" level="file"><did><unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle><unitdate type="inclusive">1997 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="fe14c6600926df363d89a1b4b29cad4c" label="mixed materials [A0000000075864]" type="box">22</container><container id="1797664fc5ef07481afbcea5552bf229" parent="fe14c6600926df363d89a1b4b29cad4c" type="folder">1-3</container></did><accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="364c7d8d424593144cdef790c4e94d75" level="file"><did><unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle><unitdate type="inclusive">1997 December 12</unitdate><container altrender="Record Storage Box (Paige)" id="6cddd5d89317cbded08ac55a7745ecaa" label="mixed materials [A0000000075864]" type="box">22</container><container id="8588c430302b3627bf29d392535c7564" parent="6cddd5d89317cbded08ac55a7745ecaa" type="folder">4-9</container></did><accessrestrict id="a96e0ada70322de7df279993ca3ff3a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file"><did><unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1997 October 24</unitdate><container altrender="Record Storage Box (Paige)" id="65f1f39829906d100531b955d15df14f" label="mixed materials [A0000000075864]" type="box">22</container><container id="5d5df09c1eb94559dea1b7155bfdef7e" parent="65f1f39829906d100531b955d15df14f" type="folder">10-15</container></did><accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6568c1026445dec6f8e364671c21bd39" level="file"><did><unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle><unitdate type="inclusive">1997 December 19</unitdate><container altrender="Record Storage Box (Paige)" id="67ced03a837035dcad410c66fd578674" label="mixed materials [A0000000075864]" type="box">22</container><container id="2b0ffe44dbf675dbe12295a957a09f91" parent="67ced03a837035dcad410c66fd578674" type="folder">16-18</container></did><accessrestrict id="8df589a9af326009da84ebecd5cf8932"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b0b4f71d2ecf84b337ced4a504f89306" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="1b6b56e14744940d4a6cfe10eddde1de" label="mixed materials [A0000000075864]" type="box">22</container><container id="b8bdb152bebed1fd5b508af6df33a189" parent="1b6b56e14744940d4a6cfe10eddde1de" type="folder">19</container></did><accessrestrict id="8df622f363be5b50961c92589e209dc4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file"><did><unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle><unitdate type="inclusive">1997 October 10</unitdate><container altrender="Record Storage Box (Paige)" id="49a478a5f7cd2c8ce25381fcc1fd7032" label="mixed materials [A0000000075865]" type="box">23</container><container id="b334a9c68b59da47df22acba0ae8a9c2" parent="49a478a5f7cd2c8ce25381fcc1fd7032" type="folder">1-4</container></did><accessrestrict id="181d3a4b218653d1790e4861871f62dd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file"><did><unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle><unitdate type="inclusive">1997 September 26</unitdate><container altrender="Record Storage Box (Paige)" id="dffb5ccb9d6e131432cbf5460050bc6c" label="mixed materials [A0000000075865]" type="box">23</container><container id="758aa47b9079b071122c2e7506344c02" parent="dffb5ccb9d6e131432cbf5460050bc6c" type="folder">5-9</container></did><accessrestrict id="f5705dc19e306f206ec780b8d160e15c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="3f1ba5c10401cadfc440c87da71224cb" level="file"><did><unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle><unitdate type="inclusive">1997 June 20</unitdate><container altrender="Record Storage Box (Paige)" id="bda1e2dc5852f559f86ecf3b786e25dc" label="mixed materials [A0000000075865]" type="box">23</container><container id="12a9c0f66cbbaa4804d42484028ca145" parent="bda1e2dc5852f559f86ecf3b786e25dc" type="folder">10-11</container></did><accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="6311bd1ab3c17838b525980881eb7804" level="file"><did><unittitle>TML, 38-17 - Drugs for migraine</unittitle><unitdate type="inclusive">1995 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="b9bf4085f4254e12c9752db86c53c230" label="mixed materials [A0000000075865]" type="box">23</container><container id="3ddb1351fb5841d6c49a1ed23ab06ffa" parent="b9bf4085f4254e12c9752db86c53c230" type="folder">12-16</container></did><accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2022</p></accessrestrict></c><c id="d46efc5621917384073357b190321659" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="618852d44823460c6c0eb058951bfcc3" label="mixed materials [A0000000075865]" type="box">23</container><container id="bd2a1bc252144a8deebf4237c42716a7" parent="618852d44823460c6c0eb058951bfcc3" type="folder">17-21</container></did><accessrestrict id="663777121320adda427992b307d1db2f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="20eea24bb3c9708acbf747e0a64afdb8" label="mixed materials [A0000000075866]" type="box">24</container><container id="02f4688c962e3c33f4c275be2b1d6eb7" parent="20eea24bb3c9708acbf747e0a64afdb8" type="folder">1</container></did><accessrestrict id="702b01fd73a7deda0a72869d6f566a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="318ae2efe1275c93a47e9ae522f706ea" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="b353627256d263588ca5bd2d3349ebb8" label="mixed materials [A0000000075866]" type="box">24</container><container id="6b59798257311166272c91cd17e0579b" parent="b353627256d263588ca5bd2d3349ebb8" type="folder">2-3</container></did><accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file"><did><unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle><unitdate type="inclusive">1997 January 17</unitdate><container altrender="Record Storage Box (Paige)" id="b662ea9038e34f73bf91a41cc50a6e47" label="mixed materials [A0000000075866]" type="box">24</container><container id="c7ebeeea80ce44e8fef316ab86a87de4" parent="b662ea9038e34f73bf91a41cc50a6e47" type="folder">4-6</container></did><accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file"><did><unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle><unitdate type="inclusive">1996 December 20</unitdate><container altrender="Record Storage Box (Paige)" id="31a61cbe91f374c28f5a1c7cc870ff63" label="mixed materials [A0000000075866]" type="box">24</container><container id="6990bccd3e73a6dd716ebb78efdc0920" parent="31a61cbe91f374c28f5a1c7cc870ff63" type="folder">7-9</container></did><accessrestrict id="6a61863bdf42f359838de02eb3140260"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="c2e1fc197d7490d826da206b516a38a5" level="file"><did><unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1997</unitdate><container altrender="Record Storage Box (Paige)" id="cf3fee9b858abc49b98b55396b58343c" label="mixed materials [A0000000075866]" type="box">24</container><container id="668ffa68a2e3c44b1c8a794c1ca4bf5f" parent="cf3fee9b858abc49b98b55396b58343c" type="folder">10-16</container></did><accessrestrict id="5d151812a70ad7aab1e31b15864a8198"><head>Conditions Governing Access</head><p>Restricted material - Open in 2023</p></accessrestrict></c><c id="fc12244326436c163ce3062f2ee5441e" level="file"><did><unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="e0f6f1425cdc77bf12d70b67842bcaf9" label="mixed materials [A0000000075867]" type="box">25</container><container id="c45d3b2b381103e3e53c32f9614c7a20" parent="e0f6f1425cdc77bf12d70b67842bcaf9" type="folder">1-3</container></did><accessrestrict id="010c90cf26351f4881154a4f6ad41ad3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file"><did><unittitle>TML, 40-113 - Citalopram for depression</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="4a0896267e5a37477dacb658a81957ab" label="mixed materials [A0000000075867]" type="box">25</container><container id="e504a2adf90f0e834d2c574dcb9aeaaa" parent="4a0896267e5a37477dacb658a81957ab" type="folder">4-8</container></did><accessrestrict id="e132e378e63282bf8014cd21bd84bf26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="85788caeb20c27238d916bb497645405" level="file"><did><unittitle>TML, 40-52 - Anthrax vaccine</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="2b7b83e406b7a0e731581cdb3ab08254" label="mixed materials [A0000000075867]" type="box">25</container><container id="a0f3068e402385aeccf244a87820d3b9" parent="2b7b83e406b7a0e731581cdb3ab08254" type="folder">9-10</container></did><accessrestrict id="0a33ad6cdce119b325c656b5c6f11151"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7481cf56a926bcaa665f596bebcba058" level="file"><did><unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="72d3750d0d2a9c0349a6960d110f2e9e" label="mixed materials [A0000000075867]" type="box">25</container><container id="45781faa7efe8f64148f868d2ae35756" parent="72d3750d0d2a9c0349a6960d110f2e9e" type="folder">11-13</container></did><accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="276f7a6dda26470f835e467b2e300373" level="file"><did><unittitle>TML, Sildenafil - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="e38aedd0a7beb6e04b109d3360f17dc6" label="mixed materials [A0000000075867]" type="box">25</container><container id="f231fed9794db39d5d0322f64614b958" parent="e38aedd0a7beb6e04b109d3360f17dc6" type="folder">14-16</container></did><accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file"><did><unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="b4f70ed8a36e05d93a49a23c73aacf34" label="mixed materials [A0000000075867]" type="box">25</container><container id="f8dfdbe01551cc1f061cecc9d5e5c2a3" parent="b4f70ed8a36e05d93a49a23c73aacf34" type="folder">17-19</container></did><accessrestrict id="548bd13d1ee4dd091a7071fb17973086"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e605d151c50d15b7436fa8b95fabcc04" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="f1882c1b6ec920b489c80c0e1ac8756c" label="mixed materials [A0000000075867]" type="box">25</container><container id="2ae3d1952381d14727b9280e21e1bca2" parent="f1882c1b6ec920b489c80c0e1ac8756c" type="folder">20-21</container></did><accessrestrict id="72272d08b8d2095400f484d84b5c8623"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file"><did><unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="e28711fb9c7160fb2f96c0b83e572e40" label="mixed materials [A0000000075868]" type="box">26</container><container id="0eb0d189ec36df490e95abc7b4885641" parent="e28711fb9c7160fb2f96c0b83e572e40" type="folder">1</container></did><accessrestrict id="e61fbc122231a69d11de05471824b4f7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="58fc0933c16d75f16f20c226741f40fc" level="file"><did><unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle><unitdate type="inclusive">1998 February 13</unitdate><container altrender="Record Storage Box (Paige)" id="80bc003fde941672284fd8f91ad86782" label="mixed materials [A0000000075868]" type="box">26</container><container id="7245614e5922872e34b20ab8b1c135d6" parent="80bc003fde941672284fd8f91ad86782" type="folder">2-5</container></did><accessrestrict id="cd18c294101a7fb036bca53986751b48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f466040faafb3cd515b6f7e5924186a3" level="file"><did><unittitle>TML, 40-47 - Advice for Travelers</unittitle><unitdate type="inclusive">1998 April 24</unitdate><container altrender="Record Storage Box (Paige)" id="24a10c0a9e0a964e80e99b5e6fe0dd21" label="mixed materials [A0000000075868]" type="box">26</container><container id="8ba80ba46d6898df89d8e425845bf753" parent="24a10c0a9e0a964e80e99b5e6fe0dd21" type="folder">6-9</container></did><accessrestrict id="d3ea0598c816f490bd7b26c48572450a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d9d7051c247d055cb3a4caa57119bc34" level="file"><did><unittitle>TML, 40-68 - Fenofibrate</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="2ff243cdb88c38570861c0d071a3ca10" label="mixed materials [A0000000075868]" type="box">26</container><container id="e8da38b4b4acd189eea9b667142afe70" parent="2ff243cdb88c38570861c0d071a3ca10" type="folder">10-13</container></did><accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0902f98f4048374d057a60de2d1b7855" level="file"><did><unittitle>TML, 40-30 - Trovafloxacin</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="713ccef4f56a8c5a23dbb5d290533cce" label="mixed materials [A0000000075868]" type="box">26</container><container id="b5a9c039b5f19e7623f31c321bd9c2b7" parent="713ccef4f56a8c5a23dbb5d290533cce" type="folder">14-16</container></did><accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="40a127b41aba4ab1210aebb60355f7eb" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="5fb37592ea0248de999d4fae5038b758" label="mixed materials [A0000000075868]" type="box">26</container><container id="32794a68bda044166d8c54f02456fee5" parent="5fb37592ea0248de999d4fae5038b758" type="folder">17-18</container></did><accessrestrict id="aa2e94224c5f71c8078141e7e709d476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2821241f88ab33b4108c2fb8ef546a03" level="file"><did><unittitle>TML - Tuberculosis - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="eec2de80e8fadd204386fdb4e52e0b62" label="mixed materials [A0000000075869]" type="box">27</container><container id="ac43c7fb378752b0513e9b3580d0778f" parent="eec2de80e8fadd204386fdb4e52e0b62" type="folder">1-2</container></did><accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a5e3fba9d86330d4c75e3f31b4844108" level="file"><did><unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="5c460f17b7be65f6a930fb01cae396d1" label="mixed materials [A0000000075869]" type="box">27</container><container id="291097efe04e046f543206a7bb80cd98" parent="5c460f17b7be65f6a930fb01cae396d1" type="folder">3-4</container></did><accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="41484f1614916c304d00c6a0e2776c25" level="file"><did><unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle><unitdate type="inclusive">1998 July 3</unitdate><container altrender="Record Storage Box (Paige)" id="03be67b5c80086eb469a97eaa318b57c" label="mixed materials [A0000000075869]" type="box">27</container><container id="cb78ecf40a23794eca790e162d1e0e5a" parent="03be67b5c80086eb469a97eaa318b57c" type="folder">5-7</container></did><accessrestrict id="9e54423aecee12c7635588555d8c357f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="18a33071dfc9246e7c9a4f9970fc624f" level="file"><did><unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="56092c6b2cf673649a9c9b46e85d8502" label="mixed materials [A0000000075869]" type="box">27</container><container id="97874119fae69aaa5dd8964275bf3873" parent="56092c6b2cf673649a9c9b46e85d8502" type="folder">8-9</container></did><accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file"><did><unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1998 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="cb1f9a74125b5eee4c8fa0d1adf7b794" label="mixed materials [A0000000075869]" type="box">27</container><container id="aef25dc9a0805593a09d98f79f368b69" parent="cb1f9a74125b5eee4c8fa0d1adf7b794" type="folder">10-12</container></did><accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c689105113c5b23ebb896f340bf02ea0" level="file"><did><unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="c324fec7adf92b232faf76f4486307ed" label="mixed materials [A0000000075869]" type="box">27</container><container id="e9f1638a33a958cf3fa719ecf698ed1b" parent="c324fec7adf92b232faf76f4486307ed" type="folder">13</container></did><accessrestrict id="dc4b7b184944400de9cfe92635a05ead"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="705d7bf07e8ff402ef32c0df389a3828" level="file"><did><unittitle>TML, 40-89 - Antiplatelet</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="73b0501b5d095fa22345933c51f5b2a1" label="mixed materials [A0000000075869]" type="box">27</container><container id="5bb5745b0a7b115e4e90cb15cc22dcc3" parent="73b0501b5d095fa22345933c51f5b2a1" type="folder">14-16</container></did><accessrestrict id="ae0c798c535816e3564f3b350306c0eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="cc4045365330c91030e2afc2941ff362" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="7b1c721ac66220831b7134d139c8648c" label="mixed materials [A0000000075869]" type="box">27</container><container id="8b33664b8c539d1e2f5b950c24ce07de" parent="7b1c721ac66220831b7134d139c8648c" type="folder">17-19</container></did><accessrestrict id="d3830363a0deac040fb1a2187fcc43a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="74cd9f3df4304220a489f3cd523e97f4" level="file"><did><unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="8b850552ffd2db58480ab28e6b1e488e" label="mixed materials [A0000000075870]" type="box">28</container><container id="b760a4c5b351abf2e2e7fea4a0e02b3b" parent="8b850552ffd2db58480ab28e6b1e488e" type="folder">1</container></did><accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8f7886d013678b0f444c0e7ce3af676b" level="file"><did><unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">1998 June 19</unitdate><container altrender="Record Storage Box (Paige)" id="480a23a14b8d1d687b57f93c7dffe830" label="mixed materials [A0000000075870]" type="box">28</container><container id="25d492e21964d83b82d9c5d1a509a007" parent="480a23a14b8d1d687b57f93c7dffe830" type="folder">2</container></did><accessrestrict id="8e2b80b72a52938a5c321da498c8b722"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="236c02b396ea229adb1f079d93029f01" level="file"><did><unittitle>TML, 40-32 - Sibutramine for obesity</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="a0c7d370c7d72821b2f532fa47401e6b" label="mixed materials [A0000000075870]" type="box">28</container><container id="6de4bd5a62fd29ffa8b3002ed454616c" parent="a0c7d370c7d72821b2f532fa47401e6b" type="folder">3-5</container></did><accessrestrict id="83216716b614ac8cc38fcaa01b43355e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="34d5d1374a9121f748a24968ebe6c128" level="file"><did><unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="d307e9ed56245dced3b26e36e3a8e6fc" label="mixed materials [A0000000075870]" type="box">28</container><container id="cb5c59c3cefbcebeabe5a25be0c9788e" parent="d307e9ed56245dced3b26e36e3a8e6fc" type="folder">6-8</container></did><accessrestrict id="9f78fcde35549e85ae6f6ddddad23091"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file"><did><unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="5ef29e3b24c354d0029e92e648d5c464" label="mixed materials [A0000000075870]" type="box">28</container><container id="c4e90648b4cc0f5523daca63bc12bd7e" parent="5ef29e3b24c354d0029e92e648d5c464" type="folder">9</container></did><accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fae1826f224dc5554dd9d77d43d63320" level="file"><did><unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle><unitdate type="inclusive">1998 January 2</unitdate><container altrender="Record Storage Box (Paige)" id="511f165eddca760f3842bbc348444b65" label="mixed materials [A0000000075870]" type="box">28</container><container id="8e2eb78f32e8804a982c805d9a34fc04" parent="511f165eddca760f3842bbc348444b65" type="folder">10-11</container></did><accessrestrict id="3cf800c016782dc93e3a36b622f7b36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file"><did><unittitle>TML, 40-75 - Vitamin supplements</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="cd495b6af31a379742f5d7aa1a2bd10a" label="mixed materials [A0000000075870]" type="box">28</container><container id="dc3b0d9970a58c2d62af2cb8fba570af" parent="cd495b6af31a379742f5d7aa1a2bd10a" type="folder">12-16</container></did><accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="06914f95afdacb00ca224c63b35cc3e5" level="file"><did><unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="98156081c2a56605872b480c98a8fe54" label="mixed materials [A0000000075870]" type="box">28</container><container id="fbdbdfd22d416af316b5fb300caabfcc" parent="98156081c2a56605872b480c98a8fe54" type="folder">17-18</container></did><accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="8574de99563fb8577206078382facf23" label="mixed materials [A0000000075870]" type="box">28</container><container id="1a695121c5ea31504e06b4b73405141e" parent="8574de99563fb8577206078382facf23" type="folder">19</container></did><accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="affe52d2c58c562088c7d559dd8fd0fd" label="mixed materials [A0000000075871]" type="box">29</container><container id="92115ab556c5a059f64a6e181759c018" parent="affe52d2c58c562088c7d559dd8fd0fd" type="folder">1-5</container></did><accessrestrict id="530223b01deda9e053da32d105382b18"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="559cb584a41d6690a7e856498ab89795" level="file"><did><unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="acd67229794cad020896b05ccd43b176" label="mixed materials [A0000000075871]" type="box">29</container><container id="b0a8f678e3da447453f559618f6e5caa" parent="acd67229794cad020896b05ccd43b176" type="folder">6-7</container></did><accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ece2250f2916521ae284b1830da4848e" level="file"><did><unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle><unitdate type="inclusive">1998 December 4</unitdate><container altrender="Record Storage Box (Paige)" id="6a0952ce59b3fea703a31feb28aa84e9" label="mixed materials [A0000000075871]" type="box">29</container><container id="1cfbfac9ce6905a9e99a48481dafffa1" parent="6a0952ce59b3fea703a31feb28aa84e9" type="folder">8-11</container></did><accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7dd5458e0da29270a7d0b887632c23ac" level="file"><did><unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="ce6827fbad60381fefd4fb1624c20c88" label="mixed materials [A0000000075871]" type="box">29</container><container id="0a54fdc632d96739a0fd1467e08ee60e" parent="ce6827fbad60381fefd4fb1624c20c88" type="folder">12-14</container></did><accessrestrict id="0b261ea329af56d20325ac31bcf03cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file"><did><unittitle>TML, 40-53 - Dolasetron</unittitle><unitdate type="inclusive">1998 May 8</unitdate><container altrender="Record Storage Box (Paige)" id="709a65d50571cf41a84d8017e27c9bb1" label="mixed materials [A0000000075871]" type="box">29</container><container id="4efe910e3e947539022569628350aa95" parent="709a65d50571cf41a84d8017e27c9bb1" type="folder">15-18</container></did><accessrestrict id="2f191b313a6f595b28c9d77fec25b021"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file"><did><unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle><unitdate type="inclusive">1998 January 30</unitdate><container altrender="Record Storage Box (Paige)" id="b694d014a4f212af51056f5f3a788eb1" label="mixed materials [A0000000075872]" type="box">30</container><container id="fe49679123cbaa205c75cdb9aaa77b46" parent="b694d014a4f212af51056f5f3a788eb1" type="folder">1-4</container></did><accessrestrict id="5fe32f0354336c745f49eaad8ec99c60"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6332598d843148b2b6fcca7483c23ff2" level="file"><did><unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle><unitdate type="inclusive">1998 March 27</unitdate><container altrender="Record Storage Box (Paige)" id="68de7bae2be5c41c9f6a1dc5c760d07b" label="mixed materials [A0000000075872]" type="box">30</container><container id="1d138895c262b8d7317f3e5e5ae21642" parent="68de7bae2be5c41c9f6a1dc5c760d07b" type="folder">5-8</container></did><accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6062e376e8011b03bf27092730e8219d" level="file"><did><unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="3672e0678dea2169481cc17082c6cdaa" label="mixed materials [A0000000075872]" type="box">30</container><container id="2d888a4454b981c58c246fd6525974b3" parent="3672e0678dea2169481cc17082c6cdaa" type="folder">9-12</container></did><accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="de828b3fc932777396bebd27f5fab7dd" level="file"><did><unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle><unitdate type="inclusive">1998 December 18</unitdate><container altrender="Record Storage Box (Paige)" id="26b64a06e8b73188e6132185b0fcf9c7" label="mixed materials [A0000000075872]" type="box">30</container><container id="28ed45fe1b4add32c8c08ac3a3a80ce8" parent="26b64a06e8b73188e6132185b0fcf9c7" type="folder">13-16</container></did><accessrestrict id="ec87238d62e4af8195602bcb6756e8f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="ac1d030de1d72ba671a523aa9268349c" label="mixed materials [A0000000075872]" type="box">30</container><container id="bab8e916ed22cf60ede39c6b7517b53c" parent="ac1d030de1d72ba671a523aa9268349c" type="folder">17-19</container></did><accessrestrict id="e69b8784cca126a51aa694fe76fa93ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="13029629c9a2c8c4645ba910bddc0ec5" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="eee73e3f24b30a8d268cb8b9b2f82d24" label="mixed materials [A0000000075873]" type="box">31</container><container id="8227fbba64b77fa754cb57503fb18258" parent="eee73e3f24b30a8d268cb8b9b2f82d24" type="folder">1-3</container></did><accessrestrict id="efd535a28d84b26cb3f39bdbca07f951"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c768307fb6b27100b14034cebd5227a9" level="file"><did><unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="3bc62ed3b420220cf3df0b5fb37a7832" label="mixed materials [A0000000075873]" type="box">31</container><container id="2abf1e5524cfadf57dba7eef89171bd4" parent="3bc62ed3b420220cf3df0b5fb37a7832" type="folder">4-8</container></did><accessrestrict id="4fead382cbe8272480e24c54bdac4aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="edbc39d29ce93f5d2d89c1070b90a888" level="file"><did><unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="2226bb8002608fb85446084f2b98d074" label="mixed materials [A0000000075873]" type="box">31</container><container id="2c41f532faeb4a9c1ed3784b3e3a3f2b" parent="2226bb8002608fb85446084f2b98d074" type="folder">9-10</container></did><accessrestrict id="4761d1070aff6ae3d4f74655713baaa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="6d7c66707bdf53045a7ff953d6e108d3" level="file"><did><unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle><unitdate type="inclusive">1998 April 10</unitdate><container altrender="Record Storage Box (Paige)" id="fd9de2a41fc64e95f14d7ab64adf4d3a" label="mixed materials [A0000000075873]" type="box">31</container><container id="a47025ad101dd0d09e7bd0ce8c04d6b9" parent="fd9de2a41fc64e95f14d7ab64adf4d3a" type="folder">11-13</container></did><accessrestrict id="94fdedf900cf20f12d378b25deedc2ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a07a54028f90ac0076d2802b57942911" level="file"><did><unittitle>TML, 40-64 - A new rabies vaccine</unittitle><unitdate type="inclusive">1998 June 14</unitdate><container altrender="Record Storage Box (Paige)" id="616260d30793f5139230f6975a3e3b19" label="mixed materials [A0000000075873]" type="box">31</container><container id="6c6affaa8b9d104432f2931c8215c31e" parent="616260d30793f5139230f6975a3e3b19" type="folder">14-15</container></did><accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file"><did><unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle><unitdate type="inclusive">1998 March 13</unitdate><container altrender="Record Storage Box (Paige)" id="4d4bc6c47e254563a3800674e0c0bf44" label="mixed materials [A0000000075873]" type="box">31</container><container id="d7dc39f7e9c5d95c24ecd0cd2493121f" parent="4d4bc6c47e254563a3800674e0c0bf44" type="folder">16-18</container></did><accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fa4c88d1fa307e4c1c36721c687359e5" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="436ff7df264b7b9c89fa341a8d2907bd" label="mixed materials [A0000000075873]" type="box">31</container><container id="fc0fc12a6035ff916420efacd163d127" parent="436ff7df264b7b9c89fa341a8d2907bd" type="folder">19</container></did><accessrestrict id="4326873ad2b2259141a757cbab189cb2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="b31307f7682d799e34699487a403a926" level="file"><did><unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle><unitdate type="inclusive">1998 June 5</unitdate><container altrender="Record Storage Box (Paige)" id="5fef2e9a4bea49ce57a89404ef059e6f" label="mixed materials [A0000000075874]" type="box">32</container><container id="b62177bd93b57086f42be0ccbde3baea" parent="5fef2e9a4bea49ce57a89404ef059e6f" type="folder">1-2</container></did><accessrestrict id="2802926a9875868eb77bbf4162293dea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file"><did><unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="d09ae098e5549d6c05d83f31bcdff6f8" label="mixed materials [A0000000075874]" type="box">32</container><container id="eba0a811566be423a01c8768256fa58a" parent="d09ae098e5549d6c05d83f31bcdff6f8" type="folder">3-8</container></did><accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="fc1c9413add7682bf34765d07e37871c" level="file"><did><unittitle>TML - Cholesterol-Lowering - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="011155207bfff6ff0ac0126dc86cffeb" label="mixed materials [A0000000075874]" type="box">32</container><container id="d10ccd0fd80a7d1882b3ab29818fcdbf" parent="011155207bfff6ff0ac0126dc86cffeb" type="folder">9-10</container></did><accessrestrict id="263b366a38ae16d96e1447c8e1c8953b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="9212aaed4209e15330e340d1c8675d23" level="file"><did><unittitle>TML - Parasitic Infections - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="06f609747898cf600eaab5e0504c353c" label="mixed materials [A0000000075874]" type="box">32</container><container id="09db948fe69fb4bbca4f6820ba78ab8b" parent="06f609747898cf600eaab5e0504c353c" type="folder">11-14</container></did><accessrestrict id="5db4f9b0242f10ed336d20896e08899c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="367ee47d6747fc683d4571ad991fcb28" level="file"><did><unittitle>TML - Malaria - Drugs for parastic infections</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="ee8a50e3fa24878336a19b1a8785d3ff" label="mixed materials [A0000000075874]" type="box">32</container><container id="efbad9f2e04ebc1cfdc24e644cb1c5d9" parent="ee8a50e3fa24878336a19b1a8785d3ff" type="folder">15-16</container></did><accessrestrict id="e3f66807c02c01517706efbf9eeaff5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="dcd988e9f1d51466658159b9ce542fec" label="mixed materials [A0000000075874]" type="box">32</container><container id="73f7eaba82c6b08b9ed642cf70150391" parent="dcd988e9f1d51466658159b9ce542fec" type="folder">17</container></did><accessrestrict id="f6a6fff3786ff1d521cdf342567849ee"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d41d005cf4c13e14913cd67a32a5047" level="file"><did><unittitle>TML - Antimicrobial drugs - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="6de2e5b29dc18d59fe7893ba003fcd29" label="mixed materials [A0000000075875]" type="box">33</container><container id="8b4c23f5c13c58dec625863af3bd5174" parent="6de2e5b29dc18d59fe7893ba003fcd29" type="folder">1-2</container></did><accessrestrict id="8075ff059f0d4d931fa3535cefb097fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a70dd9355ee98a30aebc26b8daacffc8" level="file"><did><unittitle>TML - Psychiatric Symptoms - Reprints</unittitle><unitdate type="inclusive">1998</unitdate><container altrender="Record Storage Box (Paige)" id="3d14fcbe5da441e5201b14bd7f977e71" label="mixed materials [A0000000075875]" type="box">33</container><container id="91e941e13de28abf268c3b01a0beb509" parent="3d14fcbe5da441e5201b14bd7f977e71" type="folder">3</container></did><accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file"><did><unittitle>TML, 40-109 - Candesartan</unittitle><unitdate type="inclusive">1998 November 20</unitdate><container altrender="Record Storage Box (Paige)" id="34121c338833188d75f08872acc6b7fa" label="mixed materials [A0000000075875]" type="box">33</container><container id="62584a099bf7ab9de83d68960bb00333" parent="34121c338833188d75f08872acc6b7fa" type="folder">4-6</container></did><accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e61911867cf616602aa72255f38dc9ba" level="file"><did><unittitle>TML, 40-77 - Interleukin-11</unittitle><unitdate type="inclusive">1998 July 31</unitdate><container altrender="Record Storage Box (Paige)" id="7471a8c61024776fda7609fe66612e1f" label="mixed materials [A0000000075875]" type="box">33</container><container id="6ebb1048238a17a16c431603d511eb1f" parent="7471a8c61024776fda7609fe66612e1f" type="folder">7-9</container></did><accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4f7233bf7c77fcfc22d806ea70169968" level="file"><did><unittitle>TML, 40-85 - Cefdinir</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="68af960ac3fdd6f2bb90edc57445fdd9" label="mixed materials [A0000000075875]" type="box">33</container><container id="3ca9f71356ae6b8d5924ee4383ac40da" parent="68af960ac3fdd6f2bb90edc57445fdd9" type="folder">10-12</container></did><accessrestrict id="028c35e32d1addf3672d48cb03ad70d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="910ff3d576f61dcba1783abe6210dff1" level="file"><did><unittitle>TML, 40-79 - Drugs for pain</unittitle><unitdate type="inclusive">1998 August 14</unitdate><container altrender="Record Storage Box (Paige)" id="674fcbc96914c03cbb676a064d8ce41a" label="mixed materials [A0000000075875]" type="box">33</container><container id="839fe3ab4c2e69c22ff1ab6643500c29" parent="674fcbc96914c03cbb676a064d8ce41a" type="folder">13-17</container></did><accessrestrict id="72993e3876c2683037ab6df23f908193"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="960c1722fd9da508635b32ac38c60f80" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="0ec77f3dfd3d3dd281fc52172d4927e0" label="mixed materials [A0000000075875]" type="box">33</container><container id="987487b24da09f7cf86b26ea08063427" parent="0ec77f3dfd3d3dd281fc52172d4927e0" type="folder">18-19</container></did><accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="8e8879c55ee8242081f7f64851b4db08" level="file"><did><unittitle>TML, 40-87 - Risedronate</unittitle><unitdate type="inclusive">1998 August 28</unitdate><container altrender="Record Storage Box (Paige)" id="42b7303b1f818fdf08b68581a392c290" label="mixed materials [A0000000075876]" type="box">34</container><container id="82b5071c09bf57bbff174f30c09436eb" parent="42b7303b1f818fdf08b68581a392c290" type="folder">1-2</container></did><accessrestrict id="54d5c0c828c3316a8382b3f15461804c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="5d664f33dcd2cabbe962a4227379c390" level="file"><did><unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">1998 September 25</unitdate><container altrender="Record Storage Box (Paige)" id="90751673100cdcc2873c5f278c2fff8e" label="mixed materials [A0000000075876]" type="box">34</container><container id="ffa53b20f22d9c1ef592f4a7806b23ac" parent="90751673100cdcc2873c5f278c2fff8e" type="folder">3-4</container></did><accessrestrict id="df311ee9e0d78fb33b148774389da7c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3d76a36572332e4c480702f762cc9918" level="file"><did><unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle><unitdate type="inclusive">1998 February 27</unitdate><container altrender="Record Storage Box (Paige)" id="2119bba8eb87afa5039500823fd67f5d" label="mixed materials [A0000000075876]" type="box">34</container><container id="1f555929756e0b2d5a8c651fa1ea427c" parent="2119bba8eb87afa5039500823fd67f5d" type="folder">5-8</container></did><accessrestrict id="c3ab3185c9cf9153482322e821491aa5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="affe7599f3c787d823e95823bfc0cbfc" level="file"><did><unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle><unitdate type="inclusive">1998 November</unitdate><container altrender="Record Storage Box (Paige)" id="61d7c90c0671303e95eb76a55158860c" label="mixed materials [A0000000075876]" type="box">34</container><container id="b65528d7cb0d1cce061b39aead8ff36a" parent="61d7c90c0671303e95eb76a55158860c" type="folder">9-10</container></did><accessrestrict id="544789c77c743995f3e1041b8e18aab6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="2e2e66929019d8531954a7ad095700fb" level="file"><did><unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle><unitdate type="inclusive">1998 January 16</unitdate><container altrender="Record Storage Box (Paige)" id="403c573ee7764bcf004301610b2009b5" label="mixed materials [A0000000075876]" type="box">34</container><container id="372002a1ed21478a0366318925022297" parent="403c573ee7764bcf004301610b2009b5" type="folder">11-13</container></did><accessrestrict id="c00a8622a08054369fa43b3f435559cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="4043d39a1cb0cf7a9edea397c7574337" level="file"><did><unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="efc74cdb396e58c56493c59541ea413e" label="mixed materials [A0000000075876]" type="box">34</container><container id="955280a6006b481a9ae4b2bb3a866e28" parent="efc74cdb396e58c56493c59541ea413e" type="folder">14-16</container></did><accessrestrict id="5ed653620eb193653bb7be17c3823301"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e5341af61e6a0539c242e29242b615c6" level="file"><did><unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="a58ac475997b5c56b548dde1b25e9c47" label="mixed materials [A0000000075876]" type="box">34</container><container id="8d3a081c65d4e72b8ef1d4e5b0f1af91" parent="a58ac475997b5c56b548dde1b25e9c47" type="folder">17-18</container></did><accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="3f39fb343e118836671bfce7c8c9e0be" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="52457c650c3a3c4fed54adcfc4d3a03d" label="mixed materials [A0000000075876]" type="box">34</container><container id="856e674da1ee3ec09a7598c7ef3725d6" parent="52457c650c3a3c4fed54adcfc4d3a03d" type="folder">19</container></did><accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="e43a7710b28863a0de4803cfd4c0b542" level="file"><did><unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle><unitdate type="inclusive">1998 July 17</unitdate><container altrender="Record Storage Box (Paige)" id="3bb226c5a973bb063d49d68cc552c8ad" label="mixed materials [A0000000075877]" type="box">35</container><container id="3efae1ab0a248f5426389f9aeec3a027" parent="3bb226c5a973bb063d49d68cc552c8ad" type="folder">1-2</container></did><accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file"><did><unittitle>TML, 40-103 - Thalidomide</unittitle><unitdate type="inclusive">1998 October 23</unitdate><container altrender="Record Storage Box (Paige)" id="112b030b59aa2013a684dfee0886e97a" label="mixed materials [A0000000075877]" type="box">35</container><container id="a201b432e8695ba640a111119fb8fa2b" parent="112b030b59aa2013a684dfee0886e97a" type="folder">3-6</container></did><accessrestrict id="afd021cfb4388a63de5e218998fd47c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="31cfa0b79a02b7866aa0dc7e48743280" level="file"><did><unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle><unitdate type="inclusive">1998 October 9</unitdate><container altrender="Record Storage Box (Paige)" id="8beb2a49c9824f457293663d37c29c8e" label="mixed materials [A0000000075877]" type="box">35</container><container id="f5f2bda9ccd30cfa82a43ae06b8fed99" parent="8beb2a49c9824f457293663d37c29c8e" type="folder">7-12</container></did><accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="f35138cee47bea646beb32b2995d4598" level="file"><did><unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle><unitdate type="inclusive">1998 September 11</unitdate><container altrender="Record Storage Box (Paige)" id="ddf19d9a4f170310ef2f1b48327b1b1f" label="mixed materials [A0000000075877]" type="box">35</container><container id="695f3398244106fc929f66f9bc61c093" parent="ddf19d9a4f170310ef2f1b48327b1b1f" type="folder">13</container></did><accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="7c2b7e050833f74d66d0b600d186eae5" level="file"><did><unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle><unitdate type="inclusive">1998 November 6</unitdate><container altrender="Record Storage Box (Paige)" id="2f2cef0e5df26a84bfb5deddd4f737b0" label="mixed materials [A0000000075877]" type="box">35</container><container id="be59e1f8266f7c0f786c081133aec67c" parent="2f2cef0e5df26a84bfb5deddd4f737b0" type="folder">14-16</container></did><accessrestrict id="bcbeeba99d41f442379b4633e1dc7778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="a4342729d9ef2567742167972402009f" level="file"><did><unittitle>TML, 39-107 - St. John's Wort</unittitle><unitdate type="inclusive">1997 November 21</unitdate><container altrender="Record Storage Box (Paige)" id="61bb6740de8f0cce44f756f8d567b50e" label="mixed materials [A0000000075877]" type="box">35</container><container id="30a51c50ac37efa05cefc0ef6956a3ae" parent="61bb6740de8f0cce44f756f8d567b50e" type="folder">17-18</container></did><accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682"><head>Conditions Governing Access</head><p>Restricted material - Open in 2024</p></accessrestrict></c><c id="ddfb397d4b944785854d8ea719c202bd" level="file"><did><unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="c5a4406a97d6ef0ad70358012803ebd9" label="mixed materials [A0000000075878]" type="box">36</container><container id="c5baf2df2f3d444f5f3496b7d0140929" parent="c5a4406a97d6ef0ad70358012803ebd9" type="folder">1-2</container></did><accessrestrict id="854b0f58396665c4e2d4a0465f949fd7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="35b97709b422b46ecdc94c987c5952ec" level="file"><did><unittitle>TML, 41-39 - Advice for travelers</unittitle><unitdate type="inclusive">1999 April 23</unitdate><container altrender="Record Storage Box (Paige)" id="5b30fe102cabbc4633b74be2ac0fe205" label="mixed materials [A0000000075878]" type="box">36</container><container id="8d5d289930f8f3959c6ed67b1f6e389a" parent="5b30fe102cabbc4633b74be2ac0fe205" type="folder">3-4</container></did><accessrestrict id="04ad6f830bf72709637049c7b301499d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="f916a9e5c338ff7fc1707311815267f1" level="file"><did><unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="a63baf871045dd7d65759a2392485fd9" label="mixed materials [A0000000075878]" type="box">36</container><container id="c8d77b226a6843f63e357863ced2063e" parent="a63baf871045dd7d65759a2392485fd9" type="folder">5-7</container></did><accessrestrict id="113f676d893d247079b5e4ff614aec1e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2fc16ae414cf9dd501de68ee706014d5" level="file"><did><unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="5570c445a8b4b451f4d947f4aeee4ec8" label="mixed materials [A0000000075878]" type="box">36</container><container id="1cf387db78f4bfa8830a00ef4e375fd9" parent="5570c445a8b4b451f4d947f4aeee4ec8" type="folder">8-10</container></did><accessrestrict id="17d7935132e18e8bac890aeefcb5960f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3922b9c381c0b19cb3d63cbe803305a6" level="file"><did><unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="b3fc7615d3d9b03317bf43060d4a3c33" label="mixed materials [A0000000075878]" type="box">36</container><container id="b286d45dc1948c741c11e824f536a708" parent="b3fc7615d3d9b03317bf43060d4a3c33" type="folder">11-12</container></did><accessrestrict id="481e161096febedcc11b1ed837e0109b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file"><did><unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="f406e3666f19552549756d0e48b82c2a" label="mixed materials [A0000000075878]" type="box">36</container><container id="43f993b7588e3c9e2a4583a9a560bb7e" parent="f406e3666f19552549756d0e48b82c2a" type="folder">13-14</container></did><accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="65d972dc57e884b250ec76744f2d84f9" level="file"><did><unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="675f95ad330afb978d269cdfa89c79d2" label="mixed materials [A0000000075878]" type="box">36</container><container id="4ad7917bf417b7963d64edfa2aa97a47" parent="675f95ad330afb978d269cdfa89c79d2" type="folder">15-17</container></did><accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file"><did><unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle><unitdate type="inclusive">1999 October 8</unitdate><container altrender="Record Storage Box (Paige)" id="4441d26b4f8759718b2a23c6ad8b3614" label="mixed materials [A0000000075879]" type="box">37</container><container id="bbd5c3257822b08b580ec60ffd31d1a4" parent="4441d26b4f8759718b2a23c6ad8b3614" type="folder">1-4</container></did><accessrestrict id="b25acf713bbbe8621cf294856e16ba28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ec877eb8397cacf7d82d77f65b127412" level="file"><did><unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="e664f130ea96f04dae7c4b460362d3b1" label="mixed materials [A0000000075879]" type="box">37</container><container id="3460288abf0504c6ce3e44bf7b8b3425" parent="e664f130ea96f04dae7c4b460362d3b1" type="folder">5-6</container></did><accessrestrict id="5090105f2f60079c4d3f971adf860516"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file"><did><unittitle>TML, 41-123 - Temozolomide</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="423690923e361561001778bc3c09bc7d" label="mixed materials [A0000000075879]" type="box">37</container><container id="c18235810d9dd27b9a4b0d60312ee978" parent="423690923e361561001778bc3c09bc7d" type="folder">7-8</container></did><accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file"><did><unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle><unitdate type="inclusive">1999 June 4</unitdate><container altrender="Record Storage Box (Paige)" id="9062fa378d21a1d08d1e08c0e7c417fe" label="mixed materials [A0000000075879]" type="box">37</container><container id="a1e9703f3530704e890a5b585c733102" parent="9062fa378d21a1d08d1e08c0e7c417fe" type="folder">9-11</container></did><accessrestrict id="af177345fcae67c9d255185c0a10e870"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="024012e8b7f7de531d716961ead029ce" level="file"><did><unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="87086bd10614de04b403338a9d24769b" label="mixed materials [A0000000075879]" type="box">37</container><container id="eb685ea21383392ccb03962f65156a88" parent="87086bd10614de04b403338a9d24769b" type="folder">12-13</container></did><accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a9621527ed50246d7a862b61f10afb79" level="file"><did><unittitle>TML, 41-110 - Rabeprazole</unittitle><unitdate type="inclusive">1999 November 9</unitdate><container altrender="Record Storage Box (Paige)" id="766390885c128f76fd4a176c6a98ce6e" label="mixed materials [A0000000075879]" type="box">37</container><container id="defad0f4936e310d12a757629f759bad" parent="766390885c128f76fd4a176c6a98ce6e" type="folder">14-15</container></did><accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="fcec222c26512f8ebe8b672bf459fbe9" level="file"><did><unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="68d7101e994593c197b5bb2016bbf4f8" label="mixed materials [A0000000075879]" type="box">37</container><container id="0c668cb62f0b002cd9b819a28e5e1ae3" parent="68d7101e994593c197b5bb2016bbf4f8" type="folder">16-17</container></did><accessrestrict id="5eabb94693fe31a0f053df4c9645327d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c2530250616ca691ba7d71e8d92ca5e1" level="file"><did><unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="cadc08193d1b9cbf256547eaccd6e11d" label="mixed materials [A0000000075879]" type="box">37</container><container id="e57dba292d529cb59d8803def803106d" parent="cadc08193d1b9cbf256547eaccd6e11d" type="folder">18-19</container></did><accessrestrict id="96db099c24d150d666b7ebe07b50d611"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e80acff708763c79ba27fdf7b90311e5" level="file"><did><unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle><unitdate type="inclusive">1999 August 13</unitdate><container altrender="Record Storage Box (Paige)" id="071a4dd0232886bfb9c30aa7b3425efa" label="mixed materials [A0000000075880]" type="box">38</container><container id="49fa0e82ea9b396e36ea6f3dbc7d07c2" parent="071a4dd0232886bfb9c30aa7b3425efa" type="folder">1-3</container></did><accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="703b499487840917db1eeb7a3bbf97c3" level="file"><did><unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="64ae12bfed649f175c26fae40bf25bdc" label="mixed materials [A0000000075880]" type="box">38</container><container id="6413819151ee6e9ecd1ac6cbd5f40327" parent="64ae12bfed649f175c26fae40bf25bdc" type="folder">4-7</container></did><accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file"><did><unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Record Storage Box (Paige)" id="a95aed85633495792b119606acd8781b" label="mixed materials [A0000000075880]" type="box">38</container><container id="865efebba5fcf8c8a2e175958f17de13" parent="a95aed85633495792b119606acd8781b" type="folder">8-10</container></did><accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="755deaec93a3a8f46413cdb9d38a9847" level="file"><did><unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="9d12e26aa1bebd4e11355ff03593649d" label="mixed materials [A0000000075880]" type="box">38</container><container id="8c3f9d674f66482a2acbdd0d637ac0c8" parent="9d12e26aa1bebd4e11355ff03593649d" type="folder">11-13</container></did><accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file"><did><unittitle>TML, 41-20 - Homeopathic products</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="39128aa4b69ab811a5ecdb23201009fb" label="mixed materials [A0000000075880]" type="box">38</container><container id="2f0af466ef954f9a323f2d649cceb362" parent="39128aa4b69ab811a5ecdb23201009fb" type="folder">14-16</container></did><accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f8ace5b9ab967ce17459254fb17ca75" level="file"><did><unittitle>TML, 41-55 - Orlistat for obesity</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="19cc35be6b996451c2860c5c01594dcb" label="mixed materials [A0000000075880]" type="box">38</container><container id="d0d81fb0f744e6d870d12794bcdbf556" parent="19cc35be6b996451c2860c5c01594dcb" type="folder">17</container></did><accessrestrict id="3afad4f5d733d9716d22ba16c44983fc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="b2928e0b146edbf6a03684604b2f6230" level="file"><did><unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="407da8cf2cb6f9b39f63c07f1371d6c9" label="mixed materials [A0000000075880]" type="box">38</container><container id="0f9808427725149609b29bf75d7e64cf" parent="407da8cf2cb6f9b39f63c07f1371d6c9" type="folder">18</container></did><accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e394fdb910a180949b33fcfe30e8b17c" level="file"><did><unittitle>TML, 41-23 - Drugs for hypertension</unittitle><unitdate type="inclusive">1999 March 12</unitdate><container altrender="Record Storage Box (Paige)" id="ae1eb71403829a304154b4d5da23bf1f" label="mixed materials [A0000000075881]" type="box">39</container><container id="6b0f2c066e5aa00814a1dc714f06547d" parent="ae1eb71403829a304154b4d5da23bf1f" type="folder">1-6</container></did><accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file"><did><unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle><unitdate type="inclusive">1999 December 3</unitdate><container altrender="Record Storage Box (Paige)" id="1b1711c37b026378d97fd1e30861faf4" label="mixed materials [A0000000075881]" type="box">39</container><container id="1c004720ec312e2daf1d95812445a18f" parent="1b1711c37b026378d97fd1e30861faf4" type="folder">7-10</container></did><accessrestrict id="ddc058cf574899e5d0347e37efa9598e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e42d2f63edb58feb20931053061b1339" level="file"><did><unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle><unitdate type="inclusive">1999 November 19</unitdate><container altrender="Record Storage Box (Paige)" id="3c18174c57451a017d9a55325f572efa" label="mixed materials [A0000000075881]" type="box">39</container><container id="5e51ec178ca3ec3050a8a2a065978f85" parent="3c18174c57451a017d9a55325f572efa" type="folder">11</container></did><accessrestrict id="2bf75590065032d73df0e0fa13732a7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="28427104a307e9895b1500110c4ba78c" level="file"><did><unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="b34666656a7f535ce7de0e1b325b86da" label="mixed materials [A0000000075881]" type="box">39</container><container id="be0eaa50d1b0846dc4fe678dd6c2db77" parent="b34666656a7f535ce7de0e1b325b86da" type="folder">12-16</container></did><accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a4c7b991a97b85bed8305af27776e491" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="d2e51ea207895ae080e91aa46506e3f0" label="mixed materials [A0000000075881]" type="box">39</container><container id="0538e7eb3b4c5443fe512bb0f42bc2b8" parent="d2e51ea207895ae080e91aa46506e3f0" type="folder">17-18</container></did><accessrestrict id="9b77ea87c2f2795c19e71f426864b471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="efd202ef6564adfebc4106108c9561f2" level="file"><did><unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle><unitdate type="inclusive">1999 June 18</unitdate><container altrender="Record Storage Box (Paige)" id="36bd138676763ad2e1262b0a1ec7ad35" label="mixed materials [A0000000075882]" type="box">40</container><container id="7859a5adeb38299fc7102c6187375d94" parent="36bd138676763ad2e1262b0a1ec7ad35" type="folder">1-2</container></did><accessrestrict id="6304e26af10a0e94e7ef043fee53ad70"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5422bbde47d91ace2df22b5b7527a0e6" level="file"><did><unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="2f9c7fa7d399f05af7de31d3955ae9c2" label="mixed materials [A0000000075882]" type="box">40</container><container id="83a6657455bec22fabe64e31c6f91dde" parent="2f9c7fa7d399f05af7de31d3955ae9c2" type="folder">3-6</container></did><accessrestrict id="e16a540da639162df21cb6fa8cf623e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="087aeda452bdc8c1f70b599b752d152a" level="file"><did><unittitle>TML, 41-67 - A new conjugated estrogen</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="bfddabede1a2e590c678a366a24a2861" label="mixed materials [A0000000075882]" type="box">40</container><container id="4ef4ede503e431d76d26014cd4019d36" parent="bfddabede1a2e590c678a366a24a2861" type="folder">7-8</container></did><accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="e1ba3784eccce1db97752b63119a9737" level="file"><did><unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="4c19184bf67ccb5743fdc52340046d7e" label="mixed materials [A0000000075882]" type="box">40</container><container id="4d5e863c8dca6cf7c7df3e5665605eed" parent="4c19184bf67ccb5743fdc52340046d7e" type="folder">9</container></did><accessrestrict id="a078c6c919634b8920e26478d73bef6a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ee9f72d21997962aa5e1d76e60f28954" level="file"><did><unittitle>TML, 41-68 - Laser hair removal</unittitle><unitdate type="inclusive">1999 July 30</unitdate><container altrender="Record Storage Box (Paige)" id="4201cce79a3bc128e642e65cdfa4eabd" label="mixed materials [A0000000075882]" type="box">40</container><container id="764fb57dcdb5975efff4411e557a4c91" parent="4201cce79a3bc128e642e65cdfa4eabd" type="folder">10-11</container></did><accessrestrict id="0797b526bde059f59517ea165bdcb518"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="0f4d6a53975d9232738144f364667da0" level="file"><did><unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="ea758ab0fb79ebcdd969a0bad158c64c" label="mixed materials [A0000000075882]" type="box">40</container><container id="81a097a0c6ebb2b6f99e743bd460143a" parent="ea758ab0fb79ebcdd969a0bad158c64c" type="folder">12-16</container></did><accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="5db523527161519d86f176dd07137b4b" level="file"><did><unittitle>TML, 41-5 - Drugs for Asthma</unittitle><unitdate type="inclusive">1999 January 15</unitdate><container altrender="Record Storage Box (Paige)" id="474046113a156f4d8f514d78ddb8f6c6" label="mixed materials [A0000000075883]" type="box">41</container><container id="37f7530681d8fdd1c8b213d1eb8faf5a" parent="474046113a156f4d8f514d78ddb8f6c6" type="folder">1-5</container></did><accessrestrict id="24b467056399b27bd316ca395f5c8a5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="3c1f55d592280bce047dbd773f816697" level="file"><did><unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Record Storage Box (Paige)" id="ee0f9abf9a2e71547310096c9e7023b3" label="mixed materials [A0000000075883]" type="box">41</container><container id="949009ed2b57a2e1f298e65087105049" parent="ee0f9abf9a2e71547310096c9e7023b3" type="folder">6-8</container></did><accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="a5ef95fdd53a4ad00be13d575b720a90" level="file"><did><unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="59c4f1f67206b66949bc09f195d818ad" label="mixed materials [A0000000075883]" type="box">41</container><container id="e92c5cadd3786bd6d50edbb9cca12b91" parent="59c4f1f67206b66949bc09f195d818ad" type="folder">9</container></did><accessrestrict id="1246d47b99a5b28275ca7ac909e04e17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="c9b5394af1307b91512bebaa47987a03" level="file"><did><unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle><unitdate type="inclusive">1999 February 26</unitdate><container altrender="Record Storage Box (Paige)" id="cae604b50babd0372a70785b380be819" label="mixed materials [A0000000075883]" type="box">41</container><container id="8f4e49f9e1f362043a9114d3cefc147c" parent="cae604b50babd0372a70785b380be819" type="folder">10-11</container></did><accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9431f5004a39b8a0d9a05be98633933b" level="file"><did><unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="c697b2930260c6d760ed3d2bf2ea897e" label="mixed materials [A0000000075883]" type="box">41</container><container id="719fce5d54fcc3e3090e6d08354499f6" parent="c697b2930260c6d760ed3d2bf2ea897e" type="folder">12-13</container></did><accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa75d744d2b7b8eae4e0c83305434171" level="file"><did><unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle><unitdate type="inclusive">1999 September 10</unitdate><container altrender="Record Storage Box (Paige)" id="71b7f80aa6aeb4932514d15dfecfa103" label="mixed materials [A0000000075883]" type="box">41</container><container id="5a01fb96301e26476098e5c711c6cf5a" parent="71b7f80aa6aeb4932514d15dfecfa103" type="folder">14-15</container></did><accessrestrict id="4baffc7980c89aadb8cef585c345f731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12a411c26719cadf670414ea9db35b3a" level="file"><did><unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="7bdadfc5bc3e2e3507072cea6b785fad" label="mixed materials [A0000000075883]" type="box">41</container><container id="ea872a82233a636606503f166be89714" parent="7bdadfc5bc3e2e3507072cea6b785fad" type="folder">16-18</container></did><accessrestrict id="f46608e112550ebc9f422dd17a55e3b3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="50fdbec047db8cdec50f09ae8f09ce33" level="file"><did><unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">1999 February 12</unitdate><container altrender="Record Storage Box (Paige)" id="4d43a6dede8196073349aa4d89b0dafd" label="mixed materials [A0000000075884]" type="box">42</container><container id="495957b295d5e6dc2a048a4b2964f4dc" parent="4d43a6dede8196073349aa4d89b0dafd" type="folder">1-3</container></did><accessrestrict id="ebda9b553416d292abf3337874edf243"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="12974761e15d5b5a631f8a1708a1d0e6" level="file"><did><unittitle>TML, 41-107 - SAMe for depression</unittitle><unitdate type="inclusive">1999 November 5</unitdate><container altrender="Record Storage Box (Paige)" id="f7438336651002a015b0181bfe9d01be" label="mixed materials [A0000000075884]" type="box">42</container><container id="bef913c4ac12e68929e13a688dd12a15" parent="f7438336651002a015b0181bfe9d01be" type="folder">4-7</container></did><accessrestrict id="9f6ccc892b5225ac4e542904aba616bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="2891c6463578c91c35a01dfbc0867c34" level="file"><did><unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle><unitdate type="inclusive">1999 January 1</unitdate><container altrender="Record Storage Box (Paige)" id="12b6e1a63ccfa7ec5df6ea0819f27ccb" label="mixed materials [A0000000075884]" type="box">42</container><container id="3af724993cd746123d716da017b11f84" parent="12b6e1a63ccfa7ec5df6ea0819f27ccb" type="folder">8-9</container></did><accessrestrict id="b084224a8b4665a510e8da9d5962cae8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file"><did><unittitle>TML, 41:47 - Generic Drugs</unittitle><unitdate type="inclusive">1999 May 21</unitdate><container altrender="Record Storage Box (Paige)" id="566cdece52d5f29cbe87965b04b5a946" label="mixed materials [A0000000075884]" type="box">42</container><container id="ff8cf53252df0c2596a4f67282d2a7ce" parent="566cdece52d5f29cbe87965b04b5a946" type="folder">10-15</container></did><accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="d463206ca7312a03520c55b4035d6d7c" level="file"><did><unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="15a0cbb5d8c7fed4191b784c3c5c04fc" label="mixed materials [A0000000075884]" type="box">42</container><container id="964f017a1dabacb74aa3d6ed696b0596" parent="15a0cbb5d8c7fed4191b784c3c5c04fc" type="folder">16-17</container></did><accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="72006889939863d37ffaedebcc3ff405" label="mixed materials [A0000000075884]" type="box">42</container><container id="7525f31589ff468813c9248a53930f7b" parent="72006889939863d37ffaedebcc3ff405" type="folder">18</container></did><accessrestrict id="a555f10f258ebdc237376c5bf299600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="813dc879c0e4261b5ae728f45f81e536" level="file"><did><unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">1999 August 27</unitdate><container altrender="Record Storage Box (Paige)" id="7af5b3423e6a3133211db7c99bf1955d" label="mixed materials [A0000000075885]" type="box">43</container><container id="81308a3706630bf472f462709bc07f5b" parent="7af5b3423e6a3133211db7c99bf1955d" type="folder">1-3</container></did><accessrestrict id="64327b946a10f94bc40f30737c8f1cd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file"><did><unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle><unitdate type="inclusive">1999 October 22</unitdate><container altrender="Record Storage Box (Paige)" id="3f0b782ab0b41b114864b83f4c6e80b6" label="mixed materials [A0000000075885]" type="box">43</container><container id="ed68a6c3da59821215f1351902d95237" parent="3f0b782ab0b41b114864b83f4c6e80b6" type="folder">4-8</container></did><accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file"><did><unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle><unitdate type="inclusive">1999 July 16</unitdate><container altrender="Record Storage Box (Paige)" id="312822d07aceb001588b065991ff3168" label="mixed materials [A0000000075885]" type="box">43</container><container id="4c7244411a69a5bcce0c0d013f657e13" parent="312822d07aceb001588b065991ff3168" type="folder">9-12</container></did><accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file"><did><unittitle>TML, 41-29 - Lyme disease vaccine</unittitle><unitdate type="inclusive">1999 March 26</unitdate><container altrender="Record Storage Box (Paige)" id="b587b94dfed966e6918d01257ba58e5d" label="mixed materials [A0000000075885]" type="box">43</container><container id="47d96ef94cba39177519f08e614baf58" parent="b587b94dfed966e6918d01257ba58e5d" type="folder">13-16</container></did><accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="bb27af27ca7507bfd777f78da0d17147" level="file"><did><unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="34fefb6c226db459f6fd0cf1c207dd46" label="mixed materials [A0000000075885]" type="box">43</container><container id="77f343c5eb37be35193ffa7378ad2689" parent="34fefb6c226db459f6fd0cf1c207dd46" type="folder">17-18</container></did><accessrestrict id="86662934e660af89d7aeaa4e4d013446"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="99df827d3c50dbf0bd65fee9b7ba1bfd" label="mixed materials [A0000000075885]" type="box">43</container><container id="63c074c1a1bc8a4493aa7a3b45fb6b05" parent="99df827d3c50dbf0bd65fee9b7ba1bfd" type="folder">19</container></did><accessrestrict id="53ace92e24d776a3c07d0e679ac418eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="98fd7e915d5c04bccf9bfee05be98149" level="file"><did><unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">1999 September 24</unitdate><container altrender="Record Storage Box (Paige)" id="07fca5d5f5ce1668ad4e23d65d01b1d3" label="mixed materials [A0000000075886]" type="box">44</container><container id="d15e9bafb469a363405328296abcd1d4" parent="07fca5d5f5ce1668ad4e23d65d01b1d3" type="folder">1-3</container></did><accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47b865bf089a172b75b4d43ce7a1e447" level="file"><did><unittitle>TML, 41-33 - Depression and anxiety</unittitle><unitdate type="inclusive">1999 April 9</unitdate><container altrender="Record Storage Box (Paige)" id="d1c703f26444c82dfaf0b894b5fc0367" label="mixed materials [A0000000075886]" type="box">44</container><container id="a1a59515bfe5019be5349adc8cdd783e" parent="d1c703f26444c82dfaf0b894b5fc0367" type="folder">4-13</container></did><accessrestrict id="b0f422d658f31862e120da53fa05b6f9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="71225c0666898a85e784b2cb281888c6" level="file"><did><unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle><unitdate type="inclusive">1999 December 17</unitdate><container altrender="Record Storage Box (Paige)" id="f4ed1d017c08c310086df0cec656c78f" label="mixed materials [A0000000075886]" type="box">44</container><container id="bd3595b933019f38488a6cf67399a85c" parent="f4ed1d017c08c310086df0cec656c78f" type="folder">14-16</container></did><accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="85961ba2fb7caf65fa0bd98af3b298e5" label="mixed materials [A0000000075886]" type="box">44</container><container id="47c840fd046319cb0f9fb8e17c670c59" parent="85961ba2fb7caf65fa0bd98af3b298e5" type="folder">17-18</container></did><accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="7b70d3e894b4abcb4f6cf6c39086ce36" label="mixed materials [A0000000075887]" type="box">45</container><container id="c729f7960e6820e301bc4c78c1d44a3d" parent="7b70d3e894b4abcb4f6cf6c39086ce36" type="folder">1-3</container></did><accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="8d82b612550e56f5febd997b649248f6" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="822533574c042b8d21055fc732ef2ca5" label="mixed materials [A0000000075887]" type="box">45</container><container id="81e909be2bd778347807393cf37bb76c" parent="822533574c042b8d21055fc732ef2ca5" type="folder">4-9</container></did><accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="729c9bb0e1660ceb032fe6da8350333c" level="file"><did><unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle><unitdate type="inclusive">1999</unitdate><container altrender="Record Storage Box (Paige)" id="c6811580eade4a79fde85e425a0f0012" label="mixed materials [A0000000075887]" type="box">45</container><container id="74e1fb406640da173850e6162bcb4444" parent="c6811580eade4a79fde85e425a0f0012" type="folder">10-16</container></did><accessrestrict id="5ad67e35d3361f03756bfe78c6e60019"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="737148b055ba101acbd8ee7df7c07e4c" level="file"><did><unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle><unitdate type="inclusive">1999 May 7</unitdate><container altrender="Record Storage Box (Paige)" id="e42d7eddf5588b75df061497693c1571" label="mixed materials [A0000000075887]" type="box">45</container><container id="38ed8d1c4a68838215e4d54db1743c3a" parent="e42d7eddf5588b75df061497693c1571" type="folder">17-20</container></did><accessrestrict id="91985532c77a98b2be6619b3829a2c87"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="6e0f28a2b5a8cac84be32ec338816dac" level="file"><did><unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle><unitdate type="inclusive">1999 January 29</unitdate><container altrender="Letter Document Box" id="fe263175b41a074ec7cc60b542985b61" label="mixed materials [A0000000075888]" type="box">46</container><container id="9a1b7a039fd7340df0eb8504d7cb805a" parent="fe263175b41a074ec7cc60b542985b61" type="folder">1-4</container></did><accessrestrict id="5220646ffa341e43aaef650d57ef5cbb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="47ee2aa0e1414311aab659a0b7791d48" level="file"><did><unittitle>TML, 41-61 - Drug interactions</unittitle><unitdate type="inclusive">1999 July 2</unitdate><container altrender="Letter Document Box" id="638373d23ee927f93b4670c7b3c609cd" label="mixed materials [A0000000075945]" type="box">103</container><container id="19d59ae1f1d86d4442168f041544fb0d" parent="638373d23ee927f93b4670c7b3c609cd" type="folder">1-4</container></did><accessrestrict id="2310dca3aaada449df04e476753e097f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2025</p></accessrestrict></c><c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file"><did><unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="f8f6c479513318e71c08f0e999e0b732" label="mixed materials [A0000000075889]" type="box">47</container><container id="7f38d475bab431b7635aaa080cf6189a" parent="f8f6c479513318e71c08f0e999e0b732" type="folder">1-2</container></did><accessrestrict id="9580c594e1986354a883d0b4d0b71bc3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4b13f0ecb976a0758dff29129231c5ab" level="file"><did><unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="ea6f5b566c18bbdab91228372dc0368e" label="mixed materials [A0000000075889]" type="box">47</container><container id="b347c3a0a8c21117f47d9ffbcec0fdfa" parent="ea6f5b566c18bbdab91228372dc0368e" type="folder">3</container></did><accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="65fedbec948e0fc83c65d93e86ad6afd" level="file"><did><unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="555db7729187cc34c49fa579c11d0222" label="mixed materials [A0000000075889]" type="box">47</container><container id="4ac24ae93a458901233b4237c184414e" parent="555db7729187cc34c49fa579c11d0222" type="folder">4-6</container></did><accessrestrict id="7082abcbc2a52e308ef67322853d8731"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file"><did><unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="011a6f3147e22f3a68cee65b1193d9be" label="mixed materials [A0000000075889]" type="box">47</container><container id="b8efbcb4cac1896cc459b72997096e1c" parent="011a6f3147e22f3a68cee65b1193d9be" type="folder">7-9</container></did><accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file"><did><unittitle>TML, 42-27 - Curosurf</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="f36f75c3aa79c3657b0ae3cffc88ad0c" label="mixed materials [A0000000075889]" type="box">47</container><container id="c503eb754040def352c6930d4de08f33" parent="f36f75c3aa79c3657b0ae3cffc88ad0c" type="folder">10-12</container></did><accessrestrict id="a42091b45287859d025abbb92f4814dc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c1fd925b81d971c06ec273ef08f3cb74" level="file"><did><unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="e9981e9b11ab93dea802f3a1c9831fd9" label="mixed materials [A0000000075889]" type="box">47</container><container id="aaa158bdb2b475a6f481edc34a806ceb" parent="e9981e9b11ab93dea802f3a1c9831fd9" type="folder">13-15</container></did><accessrestrict id="25831287c40dd007e7ad4f179aa90da2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="259c3ccf591bab51ffdaba3a9994e765" level="file"><did><unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle><unitdate type="inclusive">2000 July 10</unitdate><container altrender="Record Storage Box (Paige)" id="3cb07a6b7b8792fc0d858f6d270cee34" label="mixed materials [A0000000075889]" type="box">47</container><container id="57f471ebcc37027a912f78f585ae033a" parent="3cb07a6b7b8792fc0d858f6d270cee34" type="folder">16-20</container></did><accessrestrict id="162cb0e7647f4a98954f5445c257c882"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="62b6871b865b6d75c47266161b21cb21" level="file"><did><unittitle>TML, 42-113 - Phenylpropanolamine</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="25417c521ba18992a17d21f12206663e" label="mixed materials [A0000000075890]" type="box">48</container><container id="931d0bda0d319d50fb3916e43ac5b78b" parent="25417c521ba18992a17d21f12206663e" type="folder">1</container></did><accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file"><did><unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle><unitdate type="inclusive">2000 August 1</unitdate><container altrender="Record Storage Box (Paige)" id="4a041be8365fcc2b1c81d07be3a82e05" label="mixed materials [A0000000075890]" type="box">48</container><container id="5ea8215beff4eca5ca990a66d3824be9" parent="4a041be8365fcc2b1c81d07be3a82e05" type="folder">2-4</container></did><accessrestrict id="af9a344f43755a6c943435e3e709888a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="505b60f40ff960c724ff856e304ce951" level="file"><did><unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="89282bac120ec3e5500b86eb7d969b10" label="mixed materials [A0000000075890]" type="box">48</container><container id="cb9a3fa0dafe75e735f0fc9497059fd6" parent="89282bac120ec3e5500b86eb7d969b10" type="folder">5</container></did><accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="86b41328d3a3f3bd0b39258221d169af" level="file"><did><unittitle>TML, 42-42 - Oral contraceptives</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="998cfe5ad59e28bb47826569eaf0aea7" label="mixed materials [A0000000075890]" type="box">48</container><container id="80ef63a8738fde6d0869a24593956e97" parent="998cfe5ad59e28bb47826569eaf0aea7" type="folder">6-11</container></did><accessrestrict id="362a441b3fc8d8a82b31585a57ea0665"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5af9d8711bf691d44ab3b1e5bb256681" level="file"><did><unittitle>TML, 42-17 - Phytoestrogens</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="6e23077cb566bfcc49ef3e05be7e2181" label="mixed materials [A0000000075890]" type="box">48</container><container id="c6ba43d0ddabde7dbf553f78c48a8502" parent="6e23077cb566bfcc49ef3e05be7e2181" type="folder">12-14</container></did><accessrestrict id="b6923da0f1e80e36ed724d7930240ab0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="408be2b8c6034a613b1211f2ecf9b661" level="file"><did><unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="bf442577854c8065b8e1285955a2be07" label="mixed materials [A0000000075890]" type="box">48</container><container id="5fc2eb20c89afc53a2bed3d00fb78691" parent="bf442577854c8065b8e1285955a2be07" type="folder">15-16</container></did><accessrestrict id="f012aa712ae69a791944518eafe15ae9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3335c85c5f584c0623918d305860bba9" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="193360070c8ec1c4aef4e45c48241d99" label="mixed materials [A0000000075890]" type="box">48</container><container id="07adddfe47dad8804f991dbfa6d42889" parent="193360070c8ec1c4aef4e45c48241d99" type="folder">17-18</container></did><accessrestrict id="55427e8bb48ad2b8315333c1ff339476"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c6d41dc2321b4992a2ce79264290f903" level="file"><did><unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="94ba8f8628ffc02b867f33e888ae6816" label="mixed materials [A0000000075891]" type="box">49</container><container id="2269c0d92cdc06551ff5126d3576abee" parent="94ba8f8628ffc02b867f33e888ae6816" type="folder">1</container></did><accessrestrict id="a4945089c03fcb0a219bdaccf387431a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file"><did><unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle><unitdate type="inclusive">2000 May 15</unitdate><container altrender="Record Storage Box (Paige)" id="5df0694dbac5d019e3b75a9b45317391" label="mixed materials [A0000000075891]" type="box">49</container><container id="dba507c0bee8dcedd47aac4c72ac0fb3" parent="5df0694dbac5d019e3b75a9b45317391" type="folder">2-4</container></did><accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="97e9932d34799dd8520be9e13f8a01ce" level="file"><did><unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="e403fca2d00f3e78afbafa504a7fca98" label="mixed materials [A0000000075891]" type="box">49</container><container id="d1a653af42e661fb4108c399042b8476" parent="e403fca2d00f3e78afbafa504a7fca98" type="folder">5</container></did><accessrestrict id="349dee1a0f2981a7afaffa486ad92400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file"><did><unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="fc1dac78f5616a7b11714050bc0dadf6" label="mixed materials [A0000000075891]" type="box">49</container><container id="4e213729e52444a51dcf1c1e1e18259f" parent="fc1dac78f5616a7b11714050bc0dadf6" type="folder">6</container></did><accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="e0e61fb5a1e14299b5769bb3645966af" level="file"><did><unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="0da30568d128f288c92537d7f1cd6e8f" label="mixed materials [A0000000075891]" type="box">49</container><container id="fe8368eb05ce04e3afeb566841d9293b" parent="0da30568d128f288c92537d7f1cd6e8f" type="folder">7-10</container></did><accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3d342507f2c128f34587c4f458c47ae3" level="file"><did><unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="9623dc90e244f16609b3acb2c421837c" label="mixed materials [A0000000075891]" type="box">49</container><container id="d1efbb3878eec4313691c5c5a0961186" parent="9623dc90e244f16609b3acb2c421837c" type="folder">11-14</container></did><accessrestrict id="175706ce1b1be1373cdbf4234daea11e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="89f1be4de95ddec6822bda7f0e83b385" level="file"><did><unittitle>TML, 42-8 - Prevention of malaria</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="0a11d86f22548ad99ad189276494b6b0" label="mixed materials [A0000000075891]" type="box">49</container><container id="e7d50ae66c1b9514c3254e1c24b0fc98" parent="0a11d86f22548ad99ad189276494b6b0" type="folder">15</container></did><accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da557a8aeefe93b11b7b65ef3275ee26" level="file"><did><unittitle>TML, 42-37 - Lyme disease</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="764a9e26487ee270c7b3aa8eb03cea22" label="mixed materials [A0000000075891]" type="box">49</container><container id="52ba5074c1748e2ff080411878b50cd8" parent="764a9e26487ee270c7b3aa8eb03cea22" type="folder">16-18</container></did><accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9d25758af7747ace6aaf80757aac85f" level="file"><did><unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="c6fce094431ec25f9322297fdbc6fad8" label="mixed materials [A0000000075891]" type="box">49</container><container id="dec7938b08f81a7ce004a222f60301c8" parent="c6fce094431ec25f9322297fdbc6fad8" type="folder">19-20</container></did><accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8827ef8acb277df2d477589d43015ed3" level="file"><did><unittitle>TML, 42-73 - Drugs for pain</unittitle><unitdate type="inclusive">2000 August 21</unitdate><container altrender="Record Storage Box (Paige)" id="77c0a636537c5ad15773746a1012c03c" label="mixed materials [A0000000075892]" type="box">50</container><container id="0869f976d3f941532b05ac0ce497443b" parent="77c0a636537c5ad15773746a1012c03c" type="folder">1-6</container></did><accessrestrict id="45351d67ab671d76012768894632e65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7ca68fc3cc569b193dc410a094f9a61f" level="file"><did><unittitle>TML, 42-19 - Drugs for Asthma</unittitle><unitdate type="inclusive">2000 March 6</unitdate><container altrender="Record Storage Box (Paige)" id="367bab8562765ed1ffedf1b23ed5b90a" label="mixed materials [A0000000075892]" type="box">50</container><container id="c7cff49ce927107ac91ef80b072e3b24" parent="367bab8562765ed1ffedf1b23ed5b90a" type="folder">7-10</container></did><accessrestrict id="843840cc3a1f4f944dcd68fb679ac778"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="11f2fac87764b93bfe43bd87321c6e78" level="file"><did><unittitle>TML, 42-49 - Androgel</unittitle><unitdate type="inclusive">2000 June 1</unitdate><container altrender="Record Storage Box (Paige)" id="22d987491c745c89d0dab660f13a73b7" label="mixed materials [A0000000075892]" type="box">50</container><container id="975fa853eed1653471bec98d783f0fc9" parent="22d987491c745c89d0dab660f13a73b7" type="folder">11-13</container></did><accessrestrict id="373b10f2aaf453294914d4fe78b9487f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f519c54c8f624fc16003fa1c04fa88f0" level="file"><did><unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle><unitdate type="inclusive">2000 October 16</unitdate><container altrender="Record Storage Box (Paige)" id="853eb570afd7d99543d5386b12ef534f" label="mixed materials [A0000000075892]" type="box">50</container><container id="f61c832bad55490f577b1a6496d17a29" parent="853eb570afd7d99543d5386b12ef534f" type="folder">14-18</container></did><accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="da9eaff7a676c3ce93fb52a83c4df992" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="0c7fc4bea1d593923a171654e60c7101" label="mixed materials [A0000000075892]" type="box">50</container><container id="97d25683f401d44e61e4fdca3f5c96f0" parent="0c7fc4bea1d593923a171654e60c7101" type="folder">19-20</container></did><accessrestrict id="0b717ab0083f68384631636b834fec64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f307fe5a6bafa6083a914965f47c224f" level="file"><did><unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="d619fc5d8ad2cf80c083304895522b77" label="mixed materials [A0000000075893]" type="box">51</container><container id="1b006dd813298c92a74828277fa50beb" parent="d619fc5d8ad2cf80c083304895522b77" type="folder">1</container></did><accessrestrict id="dc26934d88198182e177b592f4868a43"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file"><did><unittitle>TML, 42-31 - Bexrotene</unittitle><unitdate type="inclusive">2000 April 3</unitdate><container altrender="Record Storage Box (Paige)" id="28bc25559782e7019f8fd6057153eead" label="mixed materials [A0000000075893]" type="box">51</container><container id="8727c3969f597eea746d2f81c7bbc20c" parent="28bc25559782e7019f8fd6057153eead" type="folder">2-4</container></did><accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="78aad480d71976b1ac63856f8414b2de" level="file"><did><unittitle>TML, 42-116 - Portable Defibrillators</unittitle><unitdate type="inclusive">2000 December 11</unitdate><container altrender="Record Storage Box (Paige)" id="29ad57d67df49b85c0439153ce544808" label="mixed materials [A0000000075893]" type="box">51</container><container id="883d2d9125211cf124296030274db1ac" parent="29ad57d67df49b85c0439153ce544808" type="folder">5-6</container></did><accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8856ac6d297ba039f5f59b8393406463" level="file"><did><unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="66bdd75cbab443dce2ced3e76d6a53b0" label="mixed materials [A0000000075893]" type="box">51</container><container id="ac9c7ab8641f1bc7e91795898389fc7c" parent="66bdd75cbab443dce2ced3e76d6a53b0" type="folder">7-10</container></did><accessrestrict id="2247b3013b5d4bd66554d265282ec46f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file"><did><unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="32e77061dcd05cbef60d3bc428032adb" label="mixed materials [A0000000075893]" type="box">51</container><container id="3cd5c44ca3628727b4a41227070af58b" parent="32e77061dcd05cbef60d3bc428032adb" type="folder">11</container></did><accessrestrict id="35757c84324de4837de836a4d664e4bd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="390553fd7a4eea2f5cbee5002f2322bc" level="file"><did><unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle><unitdate type="inclusive">2000 November 27</unitdate><container altrender="Record Storage Box (Paige)" id="fbb7de96e4f3d5ee34f9f090f7c97aca" label="mixed materials [A0000000075893]" type="box">51</container><container id="05ddd88c0da05659a790e8cfa50636e8" parent="fbb7de96e4f3d5ee34f9f090f7c97aca" type="folder">12-15</container></did><accessrestrict id="717bd1e1f90c70ff656382467cc26f89"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file"><did><unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle><unitdate type="inclusive">2000 May 1</unitdate><container altrender="Record Storage Box (Paige)" id="ddddd7ded1904f76b235b95f34b57bc0" label="mixed materials [A0000000075893]" type="box">51</container><container id="5ff069aba5875b197e4a3c6ac83afad1" parent="ddddd7ded1904f76b235b95f34b57bc0" type="folder">16-17</container></did><accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="968dfa06d929ab040463fb621fb94e15" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="91e0fdedd525c58cb31c48f92e462997" label="mixed materials [A0000000075893]" type="box">51</container><container id="daa7b66fdc5a428ca683b70fb08cccb3" parent="91e0fdedd525c58cb31c48f92e462997" type="folder">18-19</container></did><accessrestrict id="a7608b2e6d21017e82cac99f4c300d04"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ffb773729eccb5c024461cb32728a1f5" level="file"><did><unittitle>TML - HAT - Systemic antifungal</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="7e413e659f4a4b4e50261f76b10384ec" label="mixed materials [A0000000075894]" type="box">52</container><container id="3cabc2e3af182abe4f295da736af4681" parent="7e413e659f4a4b4e50261f76b10384ec" type="folder">1-2</container></did><accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file"><did><unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle><unitdate type="inclusive">2000 October 2</unitdate><container altrender="Record Storage Box (Paige)" id="9a9b8f1d0382f48f74f8736c0b012c1f" label="mixed materials [A0000000075894]" type="box">52</container><container id="fa6fa2067eb4bef80004156fc9e35c64" parent="9a9b8f1d0382f48f74f8736c0b012c1f" type="folder">3</container></did><accessrestrict id="97998d665049bfafbdf7f044ef962ac2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c88b481d9cf92fe516e086aa696f2759" level="file"><did><unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="3863c0581f45b637c881042ceab131a3" label="mixed materials [A0000000075894]" type="box">52</container><container id="f18435e9caccc2c67b6ed8742a744f82" parent="3863c0581f45b637c881042ceab131a3" type="folder">4-5</container></did><accessrestrict id="8158423ad1861ed096a1f762bea5ed19"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file"><did><unittitle>TML, 42-52 - Atkin's diet</unittitle><unitdate type="inclusive">2000 June 12</unitdate><container altrender="Record Storage Box (Paige)" id="6d61a059154e8e6cd232652f9f9db3b3" label="mixed materials [A0000000075894]" type="box">52</container><container id="0ab675178f72da1c9d34454b67fd89ec" parent="6d61a059154e8e6cd232652f9f9db3b3" type="folder">6-8</container></did><accessrestrict id="0024c5f9b90643b42da0ff940f490484"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f039186b802088d6736b63d8692ff877" level="file"><did><unittitle>TML, 42-71 - Hypnotic drugs</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="1f74e56c6924284abe32c5e700825c19" label="mixed materials [A0000000075894]" type="box">52</container><container id="f276ddddd7941c2258a7cf2bbc9fd918" parent="1f74e56c6924284abe32c5e700825c19" type="folder">9-12</container></did><accessrestrict id="66081d4df14137512de48118dd485bfc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ddaac639270ba0e3369ea6c5bef18c02" level="file"><did><unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="112aae02006a35a9b699fc8a755f8a89" label="mixed materials [A0000000075894]" type="box">52</container><container id="30f2009b3166640ff10c05c546432ea3" parent="112aae02006a35a9b699fc8a755f8a89" type="folder">13-14</container></did><accessrestrict id="2370a9ec5de5c8b19f6823b89c720366"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="3b89f483901c2a204aeb8a707d5f619e" level="file"><did><unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="da0282bfbb2fbbf94a74d8fafc16f13f" label="mixed materials [A0000000075894]" type="box">52</container><container id="cdccd31229cdccf87f9d68909bda55fa" parent="da0282bfbb2fbbf94a74d8fafc16f13f" type="folder">15-17</container></did><accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file"><did><unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="1222f930cde94c6c3c432f902d75422c" label="mixed materials [A0000000075894]" type="box">52</container><container id="69a451c7bf51ee4655d8293919a84746" parent="1222f930cde94c6c3c432f902d75422c" type="folder">18-20</container></did><accessrestrict id="231c8f3761cd29bf8b9da59c1db76773"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="0535c95b0b4d8e97b8bd01117ce4fb4d" label="mixed materials [A0000000075894]" type="box">52</container><container id="584ddfcc26142e26de2a26c2cb1d8c99" parent="0535c95b0b4d8e97b8bd01117ce4fb4d" type="folder">21</container></did><accessrestrict id="ecde6f626cda50967973b161a20fcc74"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0670855c3da978011ef91e63b94b8614" level="file"><did><unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle><unitdate type="inclusive">2000 April 17</unitdate><container altrender="Record Storage Box (Paige)" id="444798edb29adc8673d0f9f72a33ad77" label="mixed materials [A0000000075895]" type="box">53</container><container id="442b506a3ed57c4eaadd8ba56da5a24a" parent="444798edb29adc8673d0f9f72a33ad77" type="folder">1-2</container></did><accessrestrict id="b1545fba52ccf81c38c8688169dab34a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file"><did><unittitle>TML - HAT - Adverse Effects</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="ff5bb155ba6efe4e309cf18fd1d5b025" label="mixed materials [A0000000075895]" type="box">53</container><container id="0b635b8ad6f531a9fc988065aaa11e50" parent="ff5bb155ba6efe4e309cf18fd1d5b025" type="folder">3-4</container></did><accessrestrict id="f035a5812a9a5ba9f187b537f909316a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file"><did><unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle><unitdate type="inclusive">2000 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="fb035acfec4961eedfec1a5ff764617d" label="mixed materials [A0000000075895]" type="box">53</container><container id="112a0adbb06b538090daf440ae9f3e68" parent="fb035acfec4961eedfec1a5ff764617d" type="folder">5-8</container></did><accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9370ffe6e8855002d778fc797c644238" level="file"><did><unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle><unitdate type="inclusive">2000 July 24</unitdate><container altrender="Record Storage Box (Paige)" id="117b1e65f829837247921814c1cde9d4" label="mixed materials [A0000000075895]" type="box">53</container><container id="ce0ae7f5b1a860346b8889f9ee1d54b3" parent="117b1e65f829837247921814c1cde9d4" type="folder">9-12</container></did><accessrestrict id="a1015b3acc8c847466def1105f15644b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="354614b4cdeb7c25dce7323acfe3837f" level="file"><did><unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle><unitdate type="inclusive">2000 February 21</unitdate><container altrender="Record Storage Box (Paige)" id="226aaaa3c62f9f0e739730ca10e57172" label="mixed materials [A0000000075895]" type="box">53</container><container id="d6de93f57e7a80f912380b26ab6b278e" parent="226aaaa3c62f9f0e739730ca10e57172" type="folder">13-18</container></did><accessrestrict id="5bf74d558644f64e23255ce061463c78"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ee26dc57604d2e8beb15f5282094c199" level="file"><did><unittitle>TML, HAT - Antimicrobial Dosage</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="f581c4df03f8602116acd92eab5ee9a7" label="mixed materials [A0000000075895]" type="box">53</container><container id="49a65c3593f8393f8fc41477e6496fa8" parent="f581c4df03f8602116acd92eab5ee9a7" type="folder">19</container></did><accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="a088080df443869d26625b88cfb8357c" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="60839651cd0e6d827371d63d39b3a235" label="mixed materials [A0000000075895]" type="box">53</container><container id="17cb4659b5143db8fbc1b8a6f1cfd779" parent="60839651cd0e6d827371d63d39b3a235" type="folder">20</container></did><accessrestrict id="204852f90f3648c6b6e5e6274cb652ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file"><did><unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle><unitdate type="inclusive">2000 November 13</unitdate><container altrender="Record Storage Box (Paige)" id="9b0f17e6f5e9492a03de31b1f3ad0e88" label="mixed materials [A0000000075896]" type="box">54</container><container id="62993195e16b8f50ccf250b7e9a77d05" parent="9b0f17e6f5e9492a03de31b1f3ad0e88" type="folder">1-2</container></did><accessrestrict id="19470d2540faf3143d53c5e0f0f04553"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="ff8898d4bdb05f23855cdb33eaefc878" level="file"><did><unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="3f761f07169efb5ffc3fe321b07cefae" label="mixed materials [A0000000075896]" type="box">54</container><container id="2e248317c97ac5d488fc281e7b86520a" parent="3f761f07169efb5ffc3fe321b07cefae" type="folder">3-4</container></did><accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file"><did><unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle><unitdate type="inclusive">2000 March 20</unitdate><container altrender="Record Storage Box (Paige)" id="f0e4a6185d653d9f0e0b6a938394157b" label="mixed materials [A0000000075896]" type="box">54</container><container id="66c5ba50ab7be996c78f40836dcd29e1" parent="f0e4a6185d653d9f0e0b6a938394157b" type="folder">5-7</container></did><accessrestrict id="aee461894cb0482b20c2792522b46e12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file"><did><unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle><unitdate type="inclusive">2000 August 7</unitdate><container altrender="Record Storage Box (Paige)" id="50d8638c704077e0a85861366203ab2c" label="mixed materials [A0000000075896]" type="box">54</container><container id="d0117334b55f40b8f9fa5735b79c5525" parent="50d8638c704077e0a85861366203ab2c" type="folder">8-9</container></did><accessrestrict id="df37cebc2f1268161ba89264e0aa24c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f8521e46162fc0e16135537e8fe60e0e" level="file"><did><unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle><unitdate type="inclusive">2000 September 4</unitdate><container altrender="Record Storage Box (Paige)" id="01241072212f0d531a8dd88dd619b745" label="mixed materials [A0000000075896]" type="box">54</container><container id="e9807acf4fd40aaa4346beb78c3d4d56" parent="01241072212f0d531a8dd88dd619b745" type="folder">10-11</container></did><accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="77d873ab9fa6653d75e07ecd29388474" level="file"><did><unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle><unitdate type="inclusive">2000 January 24</unitdate><container altrender="Record Storage Box (Paige)" id="24dbd586068d6049da9b63af8c61072b" label="mixed materials [A0000000075896]" type="box">54</container><container id="322fbeee13eea805d4e41d192e11735a" parent="24dbd586068d6049da9b63af8c61072b" type="folder">12-14</container></did><accessrestrict id="c4cc72e54e77645b47ebceda334dae90"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2c3c36361f7d26d6245b10967d53cba6" level="file"><did><unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle><unitdate type="inclusive">2000 May 29</unitdate><container altrender="Record Storage Box (Paige)" id="bcfe781c9d1a0d3998412948c20c4c3d" label="mixed materials [A0000000075896]" type="box">54</container><container id="1d2c36c9e5f0f490de7f27f7dde4e4ca" parent="bcfe781c9d1a0d3998412948c20c4c3d" type="folder">15-18</container></did><accessrestrict id="134bd94a116d4a00868b6be7c821b669"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="36706c0d4996298a42f722e725f30247" label="mixed materials [A0000000075896]" type="box">54</container><container id="2d6cbbe869f22e4cdcdbfac42b85180a" parent="36706c0d4996298a42f722e725f30247" type="folder">19-21</container></did><accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="c29c016865d236b6f578b647c46a6676" level="file"><did><unittitle>TML, 42-1 - Drugs for HIV</unittitle><unitdate type="inclusive">2000 January 10</unitdate><container altrender="Record Storage Box (Paige)" id="6e7f014d2b5c6935388afb285a1fd626" label="mixed materials [A0000000075897]" type="box">55</container><container id="8a3fe2cfc72c86d678a05b7a097a9410" parent="6e7f014d2b5c6935388afb285a1fd626" type="folder">1-2</container></did><accessrestrict id="8e3afc9c0897bcf7957059afb787d613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="9f4ee005459000b909639ecee2ef1018" label="mixed materials [A0000000075897]" type="box">55</container><container id="aebac503a37dd2762f5ebd8520bbefce" parent="9f4ee005459000b909639ecee2ef1018" type="folder">3-6</container></did><accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file"><did><unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle><unitdate type="inclusive">2000 February 7</unitdate><container altrender="Record Storage Box (Paige)" id="01dbd032df0e4f2f8ae3acb48eb95d8d" label="mixed materials [A0000000075897]" type="box">55</container><container id="bde2e3bf2556b77b0b0af9b2119e0ce0" parent="01dbd032df0e4f2f8ae3acb48eb95d8d" type="folder">7-8</container></did><accessrestrict id="b6c3f76765c91d59d07d1942830fb182"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file"><did><unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle><unitdate type="inclusive">2000 June 26</unitdate><container altrender="Record Storage Box (Paige)" id="7905dbaa80d2c4dd3bec43f6251582fb" label="mixed materials [A0000000075897]" type="box">55</container><container id="ff3ae7bb2d59e7b72db1dfcf6ae9e91b" parent="7905dbaa80d2c4dd3bec43f6251582fb" type="folder">9-13</container></did><accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file"><did><unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle><unitdate type="inclusive">2000 September 18</unitdate><container altrender="Record Storage Box (Paige)" id="1bf458b95349f3c6deb8cdacbfd0f794" label="mixed materials [A0000000075897]" type="box">55</container><container id="83ebf513879fcb30e0e677530a400a49" parent="1bf458b95349f3c6deb8cdacbfd0f794" type="folder">14-18</container></did><accessrestrict id="fdc72de4846ddb965722a850fb816e7f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="85452dc178e1dadec0332fe42563215d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="357ac61ff46446a5121c524758f54f0a" label="mixed materials [A0000000075898]" type="box">56</container><container id="00a6649d714e6fdf3e2118619aa376dc" parent="357ac61ff46446a5121c524758f54f0a" type="folder">1-4</container></did><accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file"><did><unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle><unitdate type="inclusive">2000 October 30</unitdate><container altrender="Record Storage Box (Paige)" id="208ddbb11e2523c742fa44cce24ae50f" label="mixed materials [A0000000075898]" type="box">56</container><container id="103e48ad9fd9e2e86c7b88f778628f27" parent="208ddbb11e2523c742fa44cce24ae50f" type="folder">5-8</container></did><accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41cb55e32ff2281af228fcf98e48db43" level="file"><did><unittitle>TML - Osteoporosis - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="343bb7b5accd4fddf99313d972af0265" label="mixed materials [A0000000075898]" type="box">56</container><container id="2d4163ae9e54827cad84ebb3bd10ea43" parent="343bb7b5accd4fddf99313d972af0265" type="folder">9-12</container></did><accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file"><did><unittitle>TML - Asthma - Reprints</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="c109c3d448777a70d6d494376949d182" label="mixed materials [A0000000075898]" type="box">56</container><container id="93e6ace493ae904013169bd6c81a4585" parent="c109c3d448777a70d6d494376949d182" type="folder">13-16</container></did><accessrestrict id="38e2af006895a52bd2de3eb894293ec3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Record Storage Box (Paige)" id="4645dd634e3e090617fc5c0bffaf303a" label="mixed materials [A0000000075898]" type="box">56</container><container id="07307dd7d1c061b0a67df8259c74b9ff" parent="4645dd634e3e090617fc5c0bffaf303a" type="folder">17-20</container></did><accessrestrict id="d8d94d63528159d44953c7215892b5f2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="1716a9979d5479baf368216eb3017f50" level="file"><did><unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="9f6aec9a9167d50d07ed130e7445aec4" label="mixed materials [A0000000075899]" type="box">57</container><container id="2008910441717191831ce9c33bbdda1a" parent="9f6aec9a9167d50d07ed130e7445aec4" type="folder">1-4</container></did><accessrestrict id="7be18115960dc69ccd463738ce3438d7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="296856f8c0a6139989dec83e2967a3f6" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="ea2262d26d8062b99accc2a4e6e88b41" label="mixed materials [A0000000075899]" type="box">57</container><container id="cb3cc0ed361fbf95075fe63e1f5cecec" parent="ea2262d26d8062b99accc2a4e6e88b41" type="folder">5</container></did><accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2000</unitdate><container altrender="Letter Document Box" id="7230d1abd8d1ac47e2c7f372241d0a97" label="mixed materials [A0000000075900]" type="box">58</container><container id="05383db9a6888880d26c44644ae803fc" parent="7230d1abd8d1ac47e2c7f372241d0a97" type="folder">1-3</container></did><accessrestrict id="aae3719b7a851cb67c17470197b044d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2026</p></accessrestrict></c><c id="8d745390980b9c7fe7639600ac855496" level="file"><did><unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="c40b4ec15316949661b025604b5efd23" label="mixed materials [A0000000075901]" type="box">59</container><container id="cbb5e8c5e27bcb7dc0ab9bba0be70d87" parent="c40b4ec15316949661b025604b5efd23" type="folder">1-3</container></did><accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c8e27cfe3b70673df671446dc0f171dd" level="file"><did><unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle><unitdate type="inclusive">2001 May 28</unitdate><container altrender="Record Storage Box (Paige)" id="a4190870ecd173e3cecce4bd2248dd82" label="mixed materials [A0000000075901]" type="box">59</container><container id="8bd3823bf9b378805ac1078de68c53a7" parent="a4190870ecd173e3cecce4bd2248dd82" type="folder">4-10</container></did><accessrestrict id="12c485e70ce77057b564f5f005de3180"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b12b140d39cce8b86f62018ce31197dd" level="file"><did><unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="9ae83a8e0744bbf0a583c230be5b87cf" label="mixed materials [A0000000075901]" type="box">59</container><container id="90ef96a89cf7fddb9d9d68a944d3b5f1" parent="9ae83a8e0744bbf0a583c230be5b87cf" type="folder">11-13</container></did><accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file"><did><unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle><unitdate type="inclusive">2001 October 19</unitdate><container altrender="Record Storage Box (Paige)" id="36fcda0d89fa119580fdda0e6a4421c2" label="mixed materials [A0000000075901]" type="box">59</container><container id="11f4acd92c5dbcefd60a75ac9867b2a5" parent="36fcda0d89fa119580fdda0e6a4421c2" type="folder">14-17</container></did><accessrestrict id="19d192e97e549e2b446276124a3eb6b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="2df4ad166fc9111a73b3ada45ad44e1f" label="mixed materials [A0000000075901]" type="box">59</container><container id="7df7f88100a335ddd5156af3a379d9ae" parent="2df4ad166fc9111a73b3ada45ad44e1f" type="folder">18</container></did><accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3283e79cbed2dd24ba8423865f0e23c0" level="file"><did><unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="ed5481f21e308c83ebd0cdaef516a43c" label="mixed materials [A0000000075902]" type="box">60</container><container id="92fc5e7ac38d032ca2b4ae1860c3df2a" parent="ed5481f21e308c83ebd0cdaef516a43c" type="folder">1</container></did><accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file"><did><unittitle>TML, 43-9 - Beta-Blockers</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="d5458bd533e5ddf04d1f6f8a817dd7be" label="mixed materials [A0000000075902]" type="box">60</container><container id="e67462a5723f62e03d19a142205af040" parent="d5458bd533e5ddf04d1f6f8a817dd7be" type="folder">2-6</container></did><accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="efb930d3872ae9d77c1298a07d7d5921" level="file"><did><unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle><unitdate type="inclusive">2001 July</unitdate><container altrender="Record Storage Box (Paige)" id="7aa2b26b3b7746a34e6701266369b217" label="mixed materials [A0000000075902]" type="box">60</container><container id="426b9d16f460089d5375159f1eecabda" parent="7aa2b26b3b7746a34e6701266369b217" type="folder">7-9</container></did><accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="b522bd1a5159bd2d2194d2263cc22904" level="file"><did><unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle><unitdate type="inclusive">2001 February 5</unitdate><container altrender="Record Storage Box (Paige)" id="8ab4f2861335db272c82e928efbee194" label="mixed materials [A0000000075902]" type="box">60</container><container id="53a0855f9d236b7007cb6eaded33a9b8" parent="8ab4f2861335db272c82e928efbee194" type="folder">10-12</container></did><accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="46514d81205269c17a4b19d49a573235" level="file"><did><unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="80ae44d9c008fed4257533ce2c9cfb67" label="mixed materials [A0000000075902]" type="box">60</container><container id="a38ee73dbd39a7e67f6f6b03b11bd3ba" parent="80ae44d9c008fed4257533ce2c9cfb67" type="folder">13-15</container></did><accessrestrict id="0ac715d063832982eec2283c964a4110"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6dc4850ed3f15e6085336df184251532" level="file"><did><unittitle>TML - Drugs of Choice - Osteoporosis</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="c3d5f645b87d4faa51c799eb8063e555" label="mixed materials [A0000000075902]" type="box">60</container><container id="c4d175f9dffd991943d664b469ec09b9" parent="c3d5f645b87d4faa51c799eb8063e555" type="folder">16</container></did><accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="02fc378d7f3b4b93e45c3eef89379858" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="c1b97d34cd213dfafbc10fe86b9721b4" label="mixed materials [A0000000075902]" type="box">60</container><container id="db8e6c728d0c38b12114009587048a70" parent="c1b97d34cd213dfafbc10fe86b9721b4" type="folder">17-18</container></did><accessrestrict id="a1e5c73ef6115e61a317948cb85a9927"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c6bff42d1f14c6a829324e9782c498a" level="file"><did><unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle><unitdate type="inclusive">2001 August 20</unitdate><container altrender="Record Storage Box (Paige)" id="650698fa707bd0b95f9a67b1e30d3ecc" label="mixed materials [A0000000075903]" type="box">61</container><container id="ee92bdcb6b3d8e1ea9b04bf0315170ba" parent="650698fa707bd0b95f9a67b1e30d3ecc" type="folder">1-3</container></did><accessrestrict id="5b52a18cd7491854824957b6528aa161"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6bf6928a0695a21bf35c621f43a5b338" level="file"><did><unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="30aad0c1554d7150f11ec647fb939a08" label="mixed materials [A0000000075903]" type="box">61</container><container id="3c8618c49754b7e6140afa7b3a3bc6a1" parent="30aad0c1554d7150f11ec647fb939a08" type="folder">4-6</container></did><accessrestrict id="7c855f662c00758a77e6169900e656ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file"><did><unittitle>TML - AIDS - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="8f3496802075656f383c2bd02c3a88ec" label="mixed materials [A0000000075903]" type="box">61</container><container id="b189d6bfcdd573cd6150772f35e9a2c9" parent="8f3496802075656f383c2bd02c3a88ec" type="folder">7-11</container></did><accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file"><did><unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle><unitdate type="inclusive">2001 October 29</unitdate><container altrender="Record Storage Box (Paige)" id="5562fbb0fb9922f8b4c2be658f67e8f6" label="mixed materials [A0000000075903]" type="box">61</container><container id="9a188a6d9ccdec3d4635afc2a542329d" parent="5562fbb0fb9922f8b4c2be658f67e8f6" type="folder">12-13</container></did><accessrestrict id="c107fed35cdd31085f732308990ad842"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41aa0763a7e36f6ce380706ce01181e3" level="file"><did><unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="2973d4dfdcb88411db78dbfb46c2bb5f" label="mixed materials [A0000000075903]" type="box">61</container><container id="ad4b4e7161d7c53cc0b4b7c302d3cd84" parent="2973d4dfdcb88411db78dbfb46c2bb5f" type="folder">14-16</container></did><accessrestrict id="10b78f31b326647359759629918503ac"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21f79f7c6b4acd8a596b33dacb48841b" level="file"><did><unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="bf9804d6e52b07aaff1ce416950e1dd1" label="mixed materials [A0000000075903]" type="box">61</container><container id="0e880d400f4a8c723a21988e82669c95" parent="bf9804d6e52b07aaff1ce416950e1dd1" type="folder">17-19</container></did><accessrestrict id="ce544613fec94a632b764ccaa6155e27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2eed515acb400c24339036029a7a8f49" level="file"><did><unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="76a5c2418e8bc2a7f701d20d56a34665" label="mixed materials [A0000000075904]" type="box">62</container><container id="d6f567fe7bf7cc121eaef5c53ce7d7e7" parent="76a5c2418e8bc2a7f701d20d56a34665" type="folder">1-3</container></did><accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ccba2cedcccf56cdefa0e205fc19e877" level="file"><did><unittitle>TML - Drugs of Choice - Cancer</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="a9dd054ddbc7c923fb5fea483f929fb8" label="mixed materials [A0000000075904]" type="box">62</container><container id="ea0f4494c44cf81d1da5e988f06968a2" parent="a9dd054ddbc7c923fb5fea483f929fb8" type="folder">4-5</container></did><accessrestrict id="d687a473729a78247a1c380123065159"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file"><did><unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="14f58056143d4d0edd7e131447739739" label="mixed materials [A0000000075904]" type="box">62</container><container id="4c627ed7730f10009e620f8ec14d03a9" parent="14f58056143d4d0edd7e131447739739" type="folder">6-9</container></did><accessrestrict id="60722a1253dc5c989a1fb84363bf8347"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file"><did><unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="41853f1c21b9e3efb03afaecdf6d0fe4" label="mixed materials [A0000000075904]" type="box">62</container><container id="d62eea5d3ed521b0fe89826fe1584721" parent="41853f1c21b9e3efb03afaecdf6d0fe4" type="folder">10-13</container></did><accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file"><did><unittitle>TML, 43-17 - Drugs for hypertension</unittitle><unitdate type="inclusive">2001 March 5</unitdate><container altrender="Record Storage Box (Paige)" id="d08653852c3c5ec136930de500884480" label="mixed materials [A0000000075904]" type="box">62</container><container id="9790e26e51c57b5224601a7e7a8649af" parent="d08653852c3c5ec136930de500884480" type="folder">14-18</container></did><accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="ace5604a336fd41f904d9660da9a763a" label="mixed materials [A0000000075904]" type="box">62</container><container id="40ef231846d29cb3e3106eea9131784e" parent="ace5604a336fd41f904d9660da9a763a" type="folder">19</container></did><accessrestrict id="bedf8436e8ecc88cef43b4466703321f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2a3e11c7291578855058677f583ba4cc" level="file"><did><unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="47843be505f7cabb0ba9842bb91f03f4" label="mixed materials [A0000000075905]" type="box">63</container><container id="ff217b6b01d4281b3153ee2bae1c495c" parent="47843be505f7cabb0ba9842bb91f03f4" type="folder">1-2</container></did><accessrestrict id="1faf2fbe4c747499b17f777c7da8d367"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="7aeba34ec44547fe9581d43a0fc4043e" level="file"><did><unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle><unitdate type="inclusive">2001 January 27</unitdate><container altrender="Record Storage Box (Paige)" id="afd55e34208e712e8d33c185246aed40" label="mixed materials [A0000000075905]" type="box">63</container><container id="caac41c5830f9583476376fc6db5f143" parent="afd55e34208e712e8d33c185246aed40" type="folder">3-7</container></did><accessrestrict id="d1f83bcd9d1dba630ab83fe624589365"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9011b2319d9d385461bdca83ff03a269" level="file"><did><unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="432341655385ab15c1325b1092c71181" label="mixed materials [A0000000075905]" type="box">63</container><container id="5528815824049f64d955a0d756eb8998" parent="432341655385ab15c1325b1092c71181" type="folder">8-10</container></did><accessrestrict id="d1142cfc576dc71445c5513786f60e47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="43f128e719abd7716a8b552dab41b4ca" level="file"><did><unittitle>TML, 43-84 - Cord Blood Banks</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="afd9246242e91d2d559db9bf044d3473" label="mixed materials [A0000000075905]" type="box">63</container><container id="b946af47c17f6bf6ab410298a2cd0e13" parent="afd9246242e91d2d559db9bf044d3473" type="folder">11-14</container></did><accessrestrict id="d355e32a24f6cffb35162f5a565f8aad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2ca4ec46f32a50a21f55760304d5080b" level="file"><did><unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="63831cc525d873eb4ebe5d7f44fb9b8a" label="mixed materials [A0000000075905]" type="box">63</container><container id="63244592fe61303d08bdafb44acce47c" parent="63831cc525d873eb4ebe5d7f44fb9b8a" type="folder">15-16</container></did><accessrestrict id="12449f363aa33b967622999d1c656f25"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="f4881e412a79293a02fce06ab7ada62d" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="d40f57641fac8fb572e259df87bf8fa1" label="mixed materials [A0000000075905]" type="box">63</container><container id="6206f82e73d3eb6f19f18a3056605045" parent="d40f57641fac8fb572e259df87bf8fa1" type="folder">17-20</container></did><accessrestrict id="762520a711ae5cf2f881c37d75c585e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="076a7f8b55c4644de3dc62c6db843a72" level="file"><did><unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="4a16b4eb6fbb8fcabe991153681410ae" label="mixed materials [A0000000075906]" type="box">64</container><container id="1bb6ba3290b923500808ac337b8a3f4a" parent="4a16b4eb6fbb8fcabe991153681410ae" type="folder">1-2</container></did><accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="98d5e522f0e12ef676f68b6296b375c4" level="file"><did><unittitle>TML, 43-61 - Lung Cancer screening</unittitle><unitdate type="inclusive">2001 July 23</unitdate><container altrender="Record Storage Box (Paige)" id="9407ecbd733e9270e2be82ac81fb80b1" label="mixed materials [A0000000075906]" type="box">64</container><container id="bfd068e0ff853acc28b4695cdef10bd2" parent="9407ecbd733e9270e2be82ac81fb80b1" type="folder">3-5</container></did><accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bbfbf04fd92af083cfe5f2803138df54" level="file"><did><unittitle>TML, 43-7 - Mirena</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="587bd26fb775ed647b7cba9bdf84edc4" label="mixed materials [A0000000075906]" type="box">64</container><container id="24afbd384aaa90533dd430fd4dea26ac" parent="587bd26fb775ed647b7cba9bdf84edc4" type="folder">6-8</container></did><accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b86dfd5896dc8ed385111ad16cbd218" level="file"><did><unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="ae5b9d8ad3f92e08f3c6888331b4f2ab" label="mixed materials [A0000000075906]" type="box">64</container><container id="60aadf8f467acb784b00eda6bd0584c9" parent="ae5b9d8ad3f92e08f3c6888331b4f2ab" type="folder">9-10</container></did><accessrestrict id="f505d3982f99b3e642ccbf40fbd75883"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0f9927bdf850374dd901cc030c68dc7c" level="file"><did><unittitle>TML - Drugs for chronic heart failure</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="db7c6dd0c583a687a088f4798e59b974" label="mixed materials [A0000000075906]" type="box">64</container><container id="06daf4ce8877cdb0bc7ecea246d918ea" parent="db7c6dd0c583a687a088f4798e59b974" type="folder">11-14</container></did><accessrestrict id="6be4b2a90096d23f4c7270994aa74f17"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="97fc093a6a8e4909bb2c604168b0b754" level="file"><did><unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="859376d9be97a02791ae5b82b0423615" label="mixed materials [A0000000075906]" type="box">64</container><container id="9bd02b0dfbc05cbccf6b4b7d7db18ec4" parent="859376d9be97a02791ae5b82b0423615" type="folder">15-18</container></did><accessrestrict id="f836855e02f4d6fe9f63b628886a4c85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="6da20ff4a72dc0604ae511c5634291e7" level="file"><did><unittitle>TML, 43-55 - A new snake antivenin</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="f3f4fbca67c49fb4a6e5c0f08b7e1c16" label="mixed materials [A0000000075906]" type="box">64</container><container id="e02750f5a318b3185d5a1e94d246ab47" parent="f3f4fbca67c49fb4a6e5c0f08b7e1c16" type="folder">19-20</container></did><accessrestrict id="f08173f37c2607c4d273372be7fedab1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ede8d569017eb650ffb86947aa817ebe" level="file"><did><unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="8908e6a64c97cef7a02e7ef4c2f0f75a" label="mixed materials [A0000000075907]" type="box">65</container><container id="6974d138e3f8d1b5467ebe5933904c3f" parent="8908e6a64c97cef7a02e7ef4c2f0f75a" type="folder">1-3</container></did><accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file"><did><unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="4fea77711f8338fbb30488a88de28939" label="mixed materials [A0000000075907]" type="box">65</container><container id="5294f124cd8c9801bac9efe1daac6517" parent="4fea77711f8338fbb30488a88de28939" type="folder">4-7</container></did><accessrestrict id="810ad5d825ba01f69c55af09b52e33af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8068f52546b65b321ac2f5fa6a731f4c" level="file"><did><unittitle>TML, - Drugs for depression and anxiety</unittitle><unitdate type="inclusive">2001 February 14</unitdate><container altrender="Record Storage Box (Paige)" id="b300168c58b12b28812bc7aed48de9fb" label="mixed materials [A0000000075907]" type="box">65</container><container id="3f9cab57b4ce533d74357f077d9c90f2" parent="b300168c58b12b28812bc7aed48de9fb" type="folder">8-10</container></did><accessrestrict id="67940cb71724cb07bb1c047808a223cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="55a8ca16b598343eb87537a2d296ecd1" level="file"><did><unittitle>TML, 43-15 - PC-Spes</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="6c61e9cf7068a6d2f99879bd73fd7ea4" label="mixed materials [A0000000075907]" type="box">65</container><container id="17941e9454061ee213b2984afb77f72d" parent="6c61e9cf7068a6d2f99879bd73fd7ea4" type="folder">11-12</container></did><accessrestrict id="75c2794ebd1f11660bcef03019daccd2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file"><did><unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle><unitdate type="inclusive">2001 October 1</unitdate><container altrender="Record Storage Box (Paige)" id="ce90263f1cabdce6bc9a9a278a9870cb" label="mixed materials [A0000000075907]" type="box">65</container><container id="6e693021e9b94e4c4552a0139c362e03" parent="ce90263f1cabdce6bc9a9a278a9870cb" type="folder">13-16</container></did><accessrestrict id="07f8b933648e23ed47138c1bef096df8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="833ebff3fb7c7c45c0c064414304d04f" level="file"><did><unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle><unitdate type="inclusive">2001 June 11</unitdate><container altrender="Record Storage Box (Paige)" id="8e6d037f12a15c4058b0487e85d05cb0" label="mixed materials [A0000000075907]" type="box">65</container><container id="cbc8fe41216c57099ae954de75255c1d" parent="8e6d037f12a15c4058b0487e85d05cb0" type="folder">17-18</container></did><accessrestrict id="8a48c9bb323707808cd2699c098b90df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="de8769256ccd0603cce92c3714dfd4bc" label="mixed materials [A0000000075907]" type="box">65</container><container id="f32c04c2336a6601396451565837eae4" parent="de8769256ccd0603cce92c3714dfd4bc" type="folder">19</container></did><accessrestrict id="5b72b0c715fd854e87ba957e71353a88"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file"><did><unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="97ec045b569cb281bfe7b23d31d3314d" label="mixed materials [A0000000075908]" type="box">66</container><container id="ee8bb5f8a27f2e1e69b894cb74fd579f" parent="97ec045b569cb281bfe7b23d31d3314d" type="folder">1</container></did><accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a3e98844edbadfd1126f96dcee9fa072" level="file"><did><unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle><unitdate type="inclusive">2001 October 15</unitdate><container altrender="Record Storage Box (Paige)" id="11975f4697c7eac0f6ff49de89cfc02c" label="mixed materials [A0000000075908]" type="box">66</container><container id="a8b06a09d00667917523340dc7f7e82d" parent="11975f4697c7eac0f6ff49de89cfc02c" type="folder">2-3</container></did><accessrestrict id="95db9e419544c222951aae12dd139e45"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="2330e815d4bdfd9c12c459306864dcca" level="file"><did><unittitle>TML, 43-103 - Drugs for HIV infection</unittitle><unitdate type="inclusive">2001 November 26</unitdate><container altrender="Record Storage Box (Paige)" id="bbf1a96fcc01e1174a951525e9c13659" label="mixed materials [A0000000075908]" type="box">66</container><container id="496acfa2c9124d901a6461d4216acaed" parent="bbf1a96fcc01e1174a951525e9c13659" type="folder">4-7</container></did><accessrestrict id="ba5d1519c239af0bb83357cd9431cc00"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file"><did><unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="07c13330d7d4c909d7c0f5d915097c60" label="mixed materials [A0000000075908]" type="box">66</container><container id="4e3d586c48b03cd93149af23a06fa098" parent="07c13330d7d4c909d7c0f5d915097c60" type="folder">8</container></did><accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9f44342b0f523de0bfcb639e0134e8" level="file"><did><unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="df281e82880cf074dd21f0b8d22bf251" label="mixed materials [A0000000075908]" type="box">66</container><container id="eff1b23f4913a0465af1b82e482e887d" parent="df281e82880cf074dd21f0b8d22bf251" type="folder">9-10</container></did><accessrestrict id="9d4ad8765f4f79883181f256eb7f9879"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file"><did><unittitle>TML, Drugs of Choice - Pain</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="4d6469acc5fcf9a31e8974fdd7996d94" label="mixed materials [A0000000075908]" type="box">66</container><container id="126717184ca16469c8686aeb0a65b7fc" parent="4d6469acc5fcf9a31e8974fdd7996d94" type="folder">11</container></did><accessrestrict id="3b2728fff814b6aa47a93b6386e34381"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="468e734f765a9be3853dd86c21c17c5d" level="file"><did><unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="a39293e111748c3f60ee63fadeb6c778" label="mixed materials [A0000000075908]" type="box">66</container><container id="ed8d4f18d1e366c4618ec430281e0e33" parent="a39293e111748c3f60ee63fadeb6c778" type="folder">12</container></did><accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d63b61dd440fbe48748ed3adaaa153a3" level="file"><did><unittitle>TML, 43-13 - Palivizumab update</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="6155a328978fcf3db2535d03c7fd7f0d" label="mixed materials [A0000000075908]" type="box">66</container><container id="47d54c950da1868d2d1dc229f7e5f6b1" parent="6155a328978fcf3db2535d03c7fd7f0d" type="folder">13-14</container></did><accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="07c5a88addbecee925056539789a95ce" level="file"><did><unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle><unitdate type="inclusive">2001 February 19</unitdate><container altrender="Record Storage Box (Paige)" id="0436145fb85c67afb49e33a06c59ab7f" label="mixed materials [A0000000075908]" type="box">66</container><container id="b40653832a2c52190fc60c59eb3bc82e" parent="0436145fb85c67afb49e33a06c59ab7f" type="folder">15-17</container></did><accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3c99102c3cbe6573776800745f8ae469" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="0c5034127b048387978d602b4212ff94" label="mixed materials [A0000000075908]" type="box">66</container><container id="5fe30f507d8af00a523be3d5a4d0e0f0" parent="0c5034127b048387978d602b4212ff94" type="folder">18-20</container></did><accessrestrict id="0e83e8dd8e86709df7f972ac81515598"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="c6baca4f86fe997597684780a50afb04" level="file"><did><unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="a453b5a7f7680a208ea176798814262a" label="mixed materials [A0000000075909]" type="box">67</container><container id="8d57041b7ea83d3f078af8d1b3840343" parent="a453b5a7f7680a208ea176798814262a" type="folder">1</container></did><accessrestrict id="a04d9293e94b60a9e39c9b4189abc925"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="21563c371ed6d15964e3cc6b122e8325" level="file"><did><unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle><unitdate type="inclusive">2001 April 6</unitdate><container altrender="Record Storage Box (Paige)" id="2f1d7f2b8aa52e53084e8db6bfbe5eb2" label="mixed materials [A0000000075909]" type="box">67</container><container id="2a586c5af273a01c7ae167da8d6ba56b" parent="2f1d7f2b8aa52e53084e8db6bfbe5eb2" type="folder">2-5</container></did><accessrestrict id="591f5ce0464ac805e58c930e1f206114"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a56fc8ba008f5ec96cb059f94525d216" level="file"><did><unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle><unitdate type="inclusive">2001 January 22</unitdate><container altrender="Record Storage Box (Paige)" id="9b0414c26e3cea8d4474f64e32cdcc29" label="mixed materials [A0000000075909]" type="box">67</container><container id="b636554fb14da9f40c568e4f91560cf5" parent="9b0414c26e3cea8d4474f64e32cdcc29" type="folder">6-8</container></did><accessrestrict id="516c40c3c42f23a1ef834fac3280423d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file"><did><unittitle>TML, 43-57 - Levothyroxine</unittitle><unitdate type="inclusive">2001 July 9</unitdate><container altrender="Record Storage Box (Paige)" id="2c2e1e536c19ead82edd171247fa60d3" label="mixed materials [A0000000075909]" type="box">67</container><container id="a8b1a98e3ab4c7b02996151ff01abd92" parent="2c2e1e536c19ead82edd171247fa60d3" type="folder">9-11</container></did><accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d2d95b76affb3a4c9b22a381ae08576d" level="file"><did><unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="633ffb0879e0a34d3b7bc550998d0a81" label="mixed materials [A0000000075909]" type="box">67</container><container id="21087d1355d380fba4b9f4951729528c" parent="633ffb0879e0a34d3b7bc550998d0a81" type="folder">12-13</container></did><accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file"><did><unittitle>TML, 43-27 - Prozac Weekly</unittitle><unitdate type="inclusive">2001 April 2</unitdate><container altrender="Record Storage Box (Paige)" id="68670420bf37c43f70eafa2e5e3619ec" label="mixed materials [A0000000075909]" type="box">67</container><container id="07a03b9b9689368edb089f9ab32c6e29" parent="68670420bf37c43f70eafa2e5e3619ec" type="folder">14</container></did><accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="33ab00004501b20b4ce3fe3c58a49f30" label="mixed materials [A0000000075909]" type="box">67</container><container id="644e8e7d34bf3a84367484e72c604b88" parent="33ab00004501b20b4ce3fe3c58a49f30" type="folder">15-17</container></did><accessrestrict id="81584269571599c2534c39747bee7f6e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file"><did><unittitle>TML - Drugs for migraine</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="7d925f9f9fec433dc1315ec9b50f9cf9" label="mixed materials [A0000000075910]" type="box">68</container><container id="dc5555d866c5b88c3b41ad7d0c6f4226" parent="7d925f9f9fec433dc1315ec9b50f9cf9" type="folder">1</container></did><accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file"><did><unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle><unitdate type="inclusive">2001 August 6</unitdate><container altrender="Record Storage Box (Paige)" id="46cfa3143c0a2023af04748e32d5db81" label="mixed materials [A0000000075910]" type="box">68</container><container id="9cae8c429f4aa299030108a87678bd3a" parent="46cfa3143c0a2023af04748e32d5db81" type="folder">2-4</container></did><accessrestrict id="c860c07bca67d0f682cba26ca6577767"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="50348bc86f79794dd7d3880f772dc9fb" level="file"><did><unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="831db6b6ee2bdaa525b0b6df4f391672" label="mixed materials [A0000000075910]" type="box">68</container><container id="d97144ee4c7e9e49a878ff1d741d3b92" parent="831db6b6ee2bdaa525b0b6df4f391672" type="folder">5-8</container></did><accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file"><did><unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle><unitdate type="inclusive">2001 April 16</unitdate><container altrender="Record Storage Box (Paige)" id="210aa9e8c428e7f187e3a90421da5d88" label="mixed materials [A0000000075910]" type="box">68</container><container id="021f2a0dbf83a4cd1603bc3b55490c0a" parent="210aa9e8c428e7f187e3a90421da5d88" type="folder">9-12</container></did><accessrestrict id="524857adc52fa0f183b069d3ae7050b5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="41122ea5a6e7981f0132dc387c47d526" level="file"><did><unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="4352ce73feaf19b5f04b7e1f41a2bd5e" label="mixed materials [A0000000075910]" type="box">68</container><container id="b1ee771fe0aabdb336fe8f5ac7dc1a6d" parent="4352ce73feaf19b5f04b7e1f41a2bd5e" type="folder">13-14</container></did><accessrestrict id="8a2f04b8e85fd19c93d31127f994912c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file"><did><unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle><unitdate type="inclusive">2001 November 12</unitdate><container altrender="Record Storage Box (Paige)" id="c3919632d5c1b0a77a8aa79b17f40572" label="mixed materials [A0000000075910]" type="box">68</container><container id="3d1ac5961eee42453ff73a652eac33de" parent="c3919632d5c1b0a77a8aa79b17f40572" type="folder">15-17</container></did><accessrestrict id="ed26092ce8449e46cf63b80b2a291816"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c5905505fca4831e512fb2648100be7" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="424c8e1a242c124db413d991fd0ebe90" label="mixed materials [A0000000075910]" type="box">68</container><container id="86b9f979a146d824b260da6ed5971ed0" parent="424c8e1a242c124db413d991fd0ebe90" type="folder">18</container></did><accessrestrict id="75c6bb282a1bebd46a6a30af50403e35"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d83158c1d6d2339140e8e837daa705b4" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="3dcbe29a3dddf517aee1bafc8c1d692f" label="mixed materials [A0000000075910]" type="box">68</container><container id="971a290cde3bb5c6926c51e894aeb383" parent="3dcbe29a3dddf517aee1bafc8c1d692f" type="folder">19-21</container></did><accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file"><did><unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle><unitdate type="inclusive">2001 March 19</unitdate><container altrender="Record Storage Box (Paige)" id="7b80b1fad5b90defac0d5acff93fba0c" label="mixed materials [A0000000075911]" type="box">69</container><container id="d9cd562e6078674cef3b7ebce58a377c" parent="7b80b1fad5b90defac0d5acff93fba0c" type="folder">1</container></did><accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="4cdec89511203afd4fe2dc98bb7107a3" level="file"><did><unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle><unitdate type="inclusive">2001 January 8</unitdate><container altrender="Record Storage Box (Paige)" id="11c25085ee4361ff89ba655fcaa8786d" label="mixed materials [A0000000075911]" type="box">69</container><container id="ffd3603975828db6141f18a7e81a0dde" parent="11c25085ee4361ff89ba655fcaa8786d" type="folder">2-4</container></did><accessrestrict id="721d15062edf16474f8c9615e7343c9b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9c93f14bdbe03244367dc9260f841c8a" level="file"><did><unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle><unitdate type="inclusive">2001 May 14</unitdate><container altrender="Record Storage Box (Paige)" id="f6b2ba9f9345b2f020db2a3d5bff9676" label="mixed materials [A0000000075911]" type="box">69</container><container id="4f02746049119473e72907eda5e69c1a" parent="f6b2ba9f9345b2f020db2a3d5bff9676" type="folder">5-8</container></did><accessrestrict id="0834865471315b83cd87445af0b5d964"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="8c1db8b64ee78c1dea2315fd90476615" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="e96bff502487b0112587f7cf5a5a9f86" label="mixed materials [A0000000075911]" type="box">69</container><container id="6e98c0ca5946e66c308cdf3d395bba11" parent="e96bff502487b0112587f7cf5a5a9f86" type="folder">9-12</container></did><accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file"><did><unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle><unitdate type="inclusive">2001 April 30</unitdate><container altrender="Record Storage Box (Paige)" id="145d208bb3e734e3592036db6092eb8d" label="mixed materials [A0000000075911]" type="box">69</container><container id="e9c62dc794e36c49f3afb3ee1d9ec9de" parent="145d208bb3e734e3592036db6092eb8d" type="folder">13-14</container></did><accessrestrict id="cc2db5a946dc97445662edf403135cfe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="dde7a8f4a1c15dd762a0160728804b73" level="file"><did><unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle><unitdate type="inclusive">2001 December 10</unitdate><container altrender="Record Storage Box (Paige)" id="71170ccb91bafcd601d2e60b31817aa6" label="mixed materials [A0000000075911]" type="box">69</container><container id="ca8b351914bdf57ec19bcde27ffe70e7" parent="71170ccb91bafcd601d2e60b31817aa6" type="folder">15-17</container></did><accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9666394f9b7e1594ab6d9d740833bf6d" level="file"><did><unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle><unitdate type="inclusive">2001 June 25</unitdate><container altrender="Record Storage Box (Paige)" id="c59e8eae5a0b9daef6a8580cc2007616" label="mixed materials [A0000000075911]" type="box">69</container><container id="8b7f38ba76763e5ae1a59656108421d1" parent="c59e8eae5a0b9daef6a8580cc2007616" type="folder">18-20</container></did><accessrestrict id="64351c947d34d22cef39ad4007296824"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9e514faa1eb026a69873e6b610137535" level="file"><did><unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle><unitdate type="inclusive">2001 September 17</unitdate><container altrender="Record Storage Box (Paige)" id="9ff15aca0090497afd7d0a90200bc159" label="mixed materials [A0000000075912]" type="box">70</container><container id="b773a7f5d9f0612d0cf7d2d46496dac5" parent="9ff15aca0090497afd7d0a90200bc159" type="folder">1-4</container></did><accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file"><did><unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="44afcb3fdde06ad6bf419a3a0cc89e60" label="mixed materials [A0000000075912]" type="box">70</container><container id="a6b18b7271f0d766621e5db563e4131a" parent="44afcb3fdde06ad6bf419a3a0cc89e60" type="folder">5-7</container></did><accessrestrict id="753a55d97a80d113ee2476718a3d1661"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file"><did><unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="9788369a21680f7b67d5221d5f46a429" label="mixed materials [A0000000075912]" type="box">70</container><container id="f12aa55550cf2ff3304ff71258897e65" parent="9788369a21680f7b67d5221d5f46a429" type="folder">8-10</container></did><accessrestrict id="d504ebc62c5421f5e1d907042650019a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="28985057e383ceb12ff871b5d26e61da" level="file"><did><unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="e2e00c8cfa20a562e5122fa50661af44" label="mixed materials [A0000000075912]" type="box">70</container><container id="cae192ce146e13a0d3a8bfdf906baa9a" parent="e2e00c8cfa20a562e5122fa50661af44" type="folder">11-13</container></did><accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file"><did><unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="91552c6b613bb2a6ed3ec1342c0a250e" label="mixed materials [A0000000075912]" type="box">70</container><container id="f895929e515e23c9babad4e4107aeef8" parent="91552c6b613bb2a6ed3ec1342c0a250e" type="folder">14-15</container></did><accessrestrict id="b5d06faa04330361ca1ca75b21c017fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="a8579ee641a8d372e5b92c341780d2f0" level="file"><did><unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle><unitdate type="inclusive">2001</unitdate><container altrender="Record Storage Box (Paige)" id="2b1bfebcaedf2adb3d75c9f83d07f93e" label="mixed materials [A0000000075912]" type="box">70</container><container id="655bcd96c4f1f92829ecc535849674f0" parent="2b1bfebcaedf2adb3d75c9f83d07f93e" type="folder">16-17</container></did><accessrestrict id="85e3914a93c77fea32c035bd079cdf38"><head>Conditions Governing Access</head><p>Restricted material - Open in 2027</p></accessrestrict></c><c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file"><did><unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="70855877871187545c989891f8c09d52" label="mixed materials [A0000000075913]" type="box">71</container><container id="9809cf2be7e10b85065f9379bc319702" parent="70855877871187545c989891f8c09d52" type="folder">1-4</container></did><accessrestrict id="5e9a358af553725b2b7a0e754e583db4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a52ad11ec1e3f4d9273267e959212194" level="file"><did><unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="e14853991e71f4ae4fca6d3ba458af11" label="mixed materials [A0000000075913]" type="box">71</container><container id="47316ca6029823b8360916ac897fad81" parent="e14853991e71f4ae4fca6d3ba458af11" type="folder">5-8</container></did><accessrestrict id="44f937981b03e47fe5b48832e2bc3c06"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="524bcd1ef0983fc228db57fdceccbd8a" level="file"><did><unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle><unitdate type="inclusive">2002 January 7</unitdate><container altrender="Record Storage Box (Paige)" id="858f7ac3096991518c19351a948f63d1" label="mixed materials [A0000000075913]" type="box">71</container><container id="fba8d56c303af1ce6df8dab6588d3dcc" parent="858f7ac3096991518c19351a948f63d1" type="folder">9-11</container></did><accessrestrict id="41a008738c8b0cf8972cf6b24432d838"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bad1e6f9e4ec0f760e77c31253787c34" level="file"><did><unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="527bf594c82559e2e909146ac8a83a47" label="mixed materials [A0000000075913]" type="box">71</container><container id="6d9764f05a4d819bb5027dd2c5e59632" parent="527bf594c82559e2e909146ac8a83a47" type="folder">12-13</container></did><accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ba78803aaafb030f1962308400163490" level="file"><did><unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="49b14ffaf853cc2883dafd76ba844ba7" label="mixed materials [A0000000075913]" type="box">71</container><container id="f37e18aed71c4c7fd74807ce61b5105e" parent="49b14ffaf853cc2883dafd76ba844ba7" type="folder">14-16</container></did><accessrestrict id="261eac7e701cc4253a133eadd4895b0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file"><did><unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="669926b9d4ec5227b35e25d73badb5bb" label="mixed materials [A0000000075913]" type="box">71</container><container id="8bd91e09da4f72c348ea02afab09ff01" parent="669926b9d4ec5227b35e25d73badb5bb" type="folder">17-19</container></did><accessrestrict id="06663a53b51c9f32469146874e6a53fd"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a4e45a144c74f16ab14378047e5576f1" level="file"><did><unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="8c188c9040dded347f26802eabaa8d04" label="mixed materials [A0000000075913]" type="box">71</container><container id="526623345f6c50a0262d062c830512bc" parent="8c188c9040dded347f26802eabaa8d04" type="folder">20-21</container></did><accessrestrict id="344623fd522ad204005bd4713a3a7eaa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9f13d0adec34e41920a5e68ddd64292c" level="file"><did><unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="c57abf304e60dd7b4c68dfe51c8a75f6" label="mixed materials [A0000000075914]" type="box">72</container><container id="c90776d7f9c83e6442460d6c6584babf" parent="c57abf304e60dd7b4c68dfe51c8a75f6" type="folder">1</container></did><accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9263ee3a396996d1f6c92f91c990e8b4" level="file"><did><unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="4f48955bab40276b5af5839841a6b131" label="mixed materials [A0000000075914]" type="box">72</container><container id="d6953609d0090d73247eef9e9fa3d6b8" parent="4f48955bab40276b5af5839841a6b131" type="folder">2-7</container></did><accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fec2a29720e66cc581b066877ffa632d" level="file"><did><unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="05d6ccfa055af7a2fd32a7dbc640b875" label="mixed materials [A0000000075914]" type="box">72</container><container id="8cecffa7530892eeba83d7acd75cd2c2" parent="05d6ccfa055af7a2fd32a7dbc640b875" type="folder">8-9</container></did><accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ea19cfea9c41aa789e87a27139849cc9" level="file"><did><unittitle>TML, 44-42 - Copyright violations</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="a8807eb7b5bf8282e17b943088779bdd" label="mixed materials [A0000000075914]" type="box">72</container><container id="065d197bb5030550b8fdcbc5e37ffe1d" parent="a8807eb7b5bf8282e17b943088779bdd" type="folder">10</container></did><accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="573b9aa7949c2b6064549d58f22d1ef4" level="file"><did><unittitle>TML, 44-89 - Generic drugs</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="d86382f481bc93117f3352a033f5dc8c" label="mixed materials [A0000000075914]" type="box">72</container><container id="94d09aa25cd77fd92893d078111fd008" parent="d86382f481bc93117f3352a033f5dc8c" type="folder">11-13</container></did><accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="eca6e6e8880da77ade266c114c4c3ef8" level="file"><did><unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="3fe8c1a0cee99e006aa31145adbee2db" label="mixed materials [A0000000075914]" type="box">72</container><container id="ef1d5f1aa1570590c276c8af7997e9bf" parent="3fe8c1a0cee99e006aa31145adbee2db" type="folder">14-16</container></did><accessrestrict id="e52979497dde6f1c31a59d9d3764a403"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file"><did><unittitle>TML, 44-103 - GHB for nacolepsy</unittitle><unitdate type="inclusive">2002 December 9</unitdate><container altrender="Record Storage Box (Paige)" id="6caadc73c9cfba76f0cef3986a12555a" label="mixed materials [A0000000075914]" type="box">72</container><container id="8c14554bbd7e33887d838d14cf271387" parent="6caadc73c9cfba76f0cef3986a12555a" type="folder">17-19</container></did><accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="5f1f43a60e3a918e61f1524dd78e1670" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="1a18ab3b10df4b26ea44daf04b525e6e" label="mixed materials [A0000000075914]" type="box">72</container><container id="bb68b297ec70497d028da4798a8686a7" parent="1a18ab3b10df4b26ea44daf04b525e6e" type="folder">20</container></did><accessrestrict id="43b31e9dd0e56b4393c587638541da8a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d0277fd8830f2d769496c88f15bb859c" level="file"><did><unittitle>TML - Fungal Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="fd62c77d0ced36e8414c89b0f8e8e95a" label="mixed materials [A0000000075915]" type="box">73</container><container id="1f6e5481fd48128f190ad175c79b2162" parent="fd62c77d0ced36e8414c89b0f8e8e95a" type="folder">1</container></did><accessrestrict id="0374c695f899676ae2f0f4ab46c32079"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="38f15317a1ab04ccab7ddf87c59865ca" level="file"><did><unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="fcdff206380c15b3002070e799f3ea96" label="mixed materials [A0000000075915]" type="box">73</container><container id="9da9383552057794396c683da7b10858" parent="fcdff206380c15b3002070e799f3ea96" type="folder">2-4</container></did><accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c2dd44962d67176662e4db78dd0a66d1" level="file"><did><unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle><unitdate type="inclusive">2002 January 21</unitdate><container altrender="Record Storage Box (Paige)" id="c73c4f23a457c58e4bef9e0eca3c4231" label="mixed materials [A0000000075915]" type="box">73</container><container id="9c419d52fd083cddc7b298bd2e4899a1" parent="c73c4f23a457c58e4bef9e0eca3c4231" type="folder">5-7</container></did><accessrestrict id="a137a040fd97e7017313ae9a82d2fe86"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="70993f6f906adca6d28b7cec87c5cbab" level="file"><did><unittitle>TML, 44-93 - Drugs past their expiration date</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="bf99f7fc59d9ad26f87e8c38def57067" label="mixed materials [A0000000075915]" type="box">73</container><container id="3327e616c7059bc1a4b21794e70ebce9" parent="bf99f7fc59d9ad26f87e8c38def57067" type="folder">8-10</container></did><accessrestrict id="e06690c5813977cdcc6c8a5a7653718f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f9bc602671296cc3d2de922401f1986e" level="file"><did><unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="25827f8701537f5509bfa95b556bab6d" label="mixed materials [A0000000075915]" type="box">73</container><container id="f2f08a5a66a477e5451d31f21c5467fd" parent="25827f8701537f5509bfa95b556bab6d" type="folder">11-12</container></did><accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="88bf2c423e244a87d79645badbf2e9f3" level="file"><did><unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="bf18365bbd950b05f89ed43d8580d5a1" label="mixed materials [A0000000075915]" type="box">73</container><container id="d825fbe10eeb00a677974a69d44a0c2b" parent="bf18365bbd950b05f89ed43d8580d5a1" type="folder">13-15</container></did><accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="05b64e3022467a23598c9201bc74dfdf" level="file"><did><unittitle>TML - Cefepime</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="8e4114b5d07f7f527aed8cdf3db50cfa" label="mixed materials [A0000000075915]" type="box">73</container><container id="ad4d4f0534001619ea0c78b5881fdef3" parent="8e4114b5d07f7f527aed8cdf3db50cfa" type="folder">16-18</container></did><accessrestrict id="394b3115bcff39760eac5c39dc81bdb6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0b79a2b45ac5a48beb03988b3255f34c" level="file"><did><unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="d4727e6cb1285f80e828c5fffafbac9d" label="mixed materials [A0000000075915]" type="box">73</container><container id="a48ce0824c5d01a95b39a3046a90baef" parent="d4727e6cb1285f80e828c5fffafbac9d" type="folder">19-21</container></did><accessrestrict id="556a688586b09ef7523a269879e4d606"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file"><did><unittitle>TML - Echinacea</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="add1622fd77964515cb12f076145ddc9" label="mixed materials [A0000000075916]" type="box">74</container><container id="9b694dcad0001ab0e68caba12ac29c9d" parent="add1622fd77964515cb12f076145ddc9" type="folder">1-3</container></did><accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="af85bd11efe07fd729751c8c218f32d2" level="file"><did><unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="5f5f012de628b813bdbf35b70ae2cfce" label="mixed materials [A0000000075916]" type="box">74</container><container id="e48e8110a79a621a37c6d155d283fec9" parent="5f5f012de628b813bdbf35b70ae2cfce" type="folder">4-6</container></did><accessrestrict id="e67c688500af00baeca0146003fa4b6f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45aa8fe42fd0ddc4536be77350df4b57" level="file"><did><unittitle>TML - Fungal Infections - Reprints</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="2238e98552fc147c0b93c395ae29cc75" label="mixed materials [A0000000075916]" type="box">74</container><container id="e3a68d763efbf5412520c6662638202e" parent="2238e98552fc147c0b93c395ae29cc75" type="folder">7</container></did><accessrestrict id="1f1099e38699970b363bae0c6975a70b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2e47b4ee1607009a90bcdea23b07a404" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="c71bb0a8fd809395dae6c01533d84c90" label="mixed materials [A0000000075916]" type="box">74</container><container id="ae9e6788c506d7f2a2f9ddeb34d3fcb7" parent="c71bb0a8fd809395dae6c01533d84c90" type="folder">8-19</container></did><accessrestrict id="831283e78ef78563e6f6b9e3060a60fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file"><did><unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="61183608a5618bd776e487c2c595fb0b" label="mixed materials [A0000000075917]" type="box">75</container><container id="5ff10fe713c5731d579a8b086fc45eb0" parent="61183608a5618bd776e487c2c595fb0b" type="folder">1-2</container></did><accessrestrict id="37075cc131616efa32d821ddec70e19a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0785dbde88fe25acb019e68e53796851" level="file"><did><unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="9cf91219caee4c6aeaf3a0a31d46a4ae" label="mixed materials [A0000000075917]" type="box">75</container><container id="cc406999afe2952d611ae6c4672e8080" parent="9cf91219caee4c6aeaf3a0a31d46a4ae" type="folder">3-4</container></did><accessrestrict id="423a699022dfc41e5a19356b8ede358f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daec721a5877ed667e3be025c5b3972b" level="file"><did><unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="08aecc79fbf9a3669257d5aac06eb58e" label="mixed materials [A0000000075917]" type="box">75</container><container id="f2e127b4bc3fb31ad52ac2d42efc933c" parent="08aecc79fbf9a3669257d5aac06eb58e" type="folder">5-6</container></did><accessrestrict id="65275a0edfafc2779f6f3b12b167613d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file"><did><unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 November 1</unitdate><container altrender="Record Storage Box (Paige)" id="0def444da35b9e9a208e03432a52b712" label="mixed materials [A0000000075917]" type="box">75</container><container id="69a0b4e20db4ba8fc7ca53cd782784fa" parent="0def444da35b9e9a208e03432a52b712" type="folder">7-10</container></did><accessrestrict id="66fca14cfc643877b243d938549ef683"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6c5c80d095e7afd1c721854326e0f8cc" level="file"><did><unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle><unitdate type="inclusive">2002 February 4</unitdate><container altrender="Record Storage Box (Paige)" id="0f43378597d4c3baac1c663997e3ddf2" label="mixed materials [A0000000075917]" type="box">75</container><container id="41788326a6c0df7c712ee53504e00a4c" parent="0f43378597d4c3baac1c663997e3ddf2" type="folder">11-17</container></did><accessrestrict id="bdf05fc38d86db9b72f37658b33c4730"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="bcfed60146a9353c15a7810e066eb562" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="0d43aefe2e5d19b6c2dacbc4165fc6c3" label="mixed materials [A0000000075917]" type="box">75</container><container id="220e6bdb00ce94fd90bc16c04256954a" parent="0d43aefe2e5d19b6c2dacbc4165fc6c3" type="folder">18-19</container></did><accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="26f9f680797154013e700d36b1ee02cc" level="file"><did><unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="73e2637efd439134eeabbf1dfd089da8" label="mixed materials [A0000000075918]" type="box">76</container><container id="bed5e7b51f6403a56852f675b9033c50" parent="73e2637efd439134eeabbf1dfd089da8" type="folder">1-2</container></did><accessrestrict id="538e6db36155fc336b5cd7453b267830"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file"><did><unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="d822576ea903a2474daf2ae88344d3b5" label="mixed materials [A0000000075918]" type="box">76</container><container id="a4d77c3601570e1fb9eeb2ca1a951004" parent="d822576ea903a2474daf2ae88344d3b5" type="folder">3-5</container></did><accessrestrict id="009827e7a43d5b337cbe6459416c7913"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4e2f11c3afbd278cc01889db51cc3594" level="file"><did><unittitle>TML - Safety of antimicrobials in pregnancy</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="82d81c4c8d7ba51f7c6d4ec6397dd237" label="mixed materials [A0000000075918]" type="box">76</container><container id="4c32a564c1bb50da285e3ecc670bf20f" parent="82d81c4c8d7ba51f7c6d4ec6397dd237" type="folder">6-9</container></did><accessrestrict id="4077280e1fc84a55fa2f33342e312820"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d9af5da201c75753edd17152b98006c9" level="file"><did><unittitle>TML, 44-63 - Voriconazole</unittitle><unitdate type="inclusive">2002 July 22</unitdate><container altrender="Record Storage Box (Paige)" id="63af72acf0217134d6d6255f21350784" label="mixed materials [A0000000075918]" type="box">76</container><container id="5968b55fc34f367f180135d9562e590f" parent="63af72acf0217134d6d6255f21350784" type="folder">10-14</container></did><accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file"><did><unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 December</unitdate><container altrender="Record Storage Box (Paige)" id="4159305224c19b8f0d7ee0035e529eaa" label="mixed materials [A0000000075918]" type="box">76</container><container id="e87b2e6ede620c403393dfcb86419e1f" parent="4159305224c19b8f0d7ee0035e529eaa" type="folder">15-20</container></did><accessrestrict id="d78727a12815fb45316cee4c1bb66369"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="4536f53d88709a34f9764f238002f522" level="file"><did><unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="3be96a22c6cf9932a69b9a3a16671070" label="mixed materials [A0000000075919]" type="box">77</container><container id="b0f44f239d3c314185cc2a82c17f6fe2" parent="3be96a22c6cf9932a69b9a3a16671070" type="folder">1-4</container></did><accessrestrict id="3f564956f49faf84f827624973a86572"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8319ac1e74f3772c55f953d49d1fe802" level="file"><did><unittitle>TML - Drugs for Tuberculosis</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="55359e1276a631a14739e3b4323813f7" label="mixed materials [A0000000075919]" type="box">77</container><container id="07bbfa7e1a330af12648ae0412679101" parent="55359e1276a631a14739e3b4323813f7" type="folder">5-8</container></did><accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c61123a9a767eb2a2f0665b7e710f056" level="file"><did><unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="bad07ee8ffc3b078e923d7484dd04e14" label="mixed materials [A0000000075919]" type="box">77</container><container id="c85445ab53e81cdd19755fbadc62d686" parent="bad07ee8ffc3b078e923d7484dd04e14" type="folder">9-11</container></did><accessrestrict id="96d0a14409c624606417824206c572f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file"><did><unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle><unitdate type="inclusive">2002 July 8</unitdate><container altrender="Record Storage Box (Paige)" id="b7e1d08a8971cea3d7a3a3fdb3d832d8" label="mixed materials [A0000000075919]" type="box">77</container><container id="77d40bc401f9650a613ff16bb9720b5e" parent="b7e1d08a8971cea3d7a3a3fdb3d832d8" type="folder">12-16</container></did><accessrestrict id="049b266831555277c80bf92411b09f0b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file"><did><unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle><unitdate type="inclusive">2002 September 16</unitdate><container altrender="Record Storage Box (Paige)" id="80bdc02b58d830c934ad5f6140b33b2f" label="mixed materials [A0000000075919]" type="box">77</container><container id="1f54c65ab2da488da401616f93c73a18" parent="80bdc02b58d830c934ad5f6140b33b2f" type="folder">17-19</container></did><accessrestrict id="6b6e7ca2998642d620f912e4ae273e58"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="702df7b3933e28f25249b7010b1efc23" level="file"><did><unittitle>TML - HAT</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="3cad9e844f757bec973ca7647714edc8" label="mixed materials [A0000000075919]" type="box">77</container><container id="f7f5e82e32e0bb50d2a4c8cdf2157f2b" parent="3cad9e844f757bec973ca7647714edc8" type="folder">20</container></did><accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="4b1aa547146bb2fb7d492c992ad6cf9f" label="mixed materials [A0000000075919]" type="box">77</container><container id="238ce42ab8deda43723015ef71f9dec2" parent="4b1aa547146bb2fb7d492c992ad6cf9f" type="folder">21</container></did><accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="3238875c71befee0c843bfb578b0af6f" level="file"><did><unittitle>TML - Drugs for sexually transmitted infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="73300fd70442255a3265a42b7f94e5b1" label="mixed materials [A0000000075920]" type="box">78</container><container id="18f393e4b85c548c1cabe94b73e4f81a" parent="73300fd70442255a3265a42b7f94e5b1" type="folder">1-3</container></did><accessrestrict id="f07baa851539686de763d2f786c2177e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0f73f901dbd4ead91b01d80ceed67c30" level="file"><did><unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="d55d285601f6a537786907e1c5db4e6b" label="mixed materials [A0000000075920]" type="box">78</container><container id="c013b781109fa6f2019b2263149d1ea7" parent="d55d285601f6a537786907e1c5db4e6b" type="folder">4-6</container></did><accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="23ee674858aa228c8597cb11a5363b5d" level="file"><did><unittitle>TML, 44-33 - Advice for travelers</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="5f82407e575cd2f2d9e2b686c21e2f01" label="mixed materials [A0000000075920]" type="box">78</container><container id="9a4d177e8b6744e7a7fe0e4354d60a32" parent="5f82407e575cd2f2d9e2b686c21e2f01" type="folder">7-9</container></did><accessrestrict id="687d9c16855007cc90b89408873e9116"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="c3ff86733b644974c019ea29b403f49f" level="file"><did><unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="40429cdc6e9cd348914a1d57d56f83b0" label="mixed materials [A0000000075920]" type="box">78</container><container id="9dcf95948d38e26a2a30bf0c8470dad1" parent="40429cdc6e9cd348914a1d57d56f83b0" type="folder">10-11</container></did><accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="24af9a9128ef19b87942303f71c93a4b" level="file"><did><unittitle>TML, 44-91 - Acetaminophen safety</unittitle><unitdate type="inclusive">2002 October 28</unitdate><container altrender="Record Storage Box (Paige)" id="1fed2c7a76abf113546f0f1435242a6d" label="mixed materials [A0000000075920]" type="box">78</container><container id="be9bfe2128e3c65f531c69bef921302a" parent="1fed2c7a76abf113546f0f1435242a6d" type="folder">12-16</container></did><accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="c1483fa819a69b853576c0759063c772" label="mixed materials [A0000000075920]" type="box">78</container><container id="2800d5a6957d96e27c11c059823f6f8b" parent="c1483fa819a69b853576c0759063c772" type="folder">17-19</container></did><accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="8104e8da1a3aff8455ce0008f38fee5a" level="file"><did><unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle><unitdate type="inclusive">2002 June 24</unitdate><container altrender="Record Storage Box (Paige)" id="d021c8dbeaf7186d5401ad82d8fe4267" label="mixed materials [A0000000075921]" type="box">79</container><container id="bb4f5b1da50462925dd5676830143ac5" parent="d021c8dbeaf7186d5401ad82d8fe4267" type="folder">1-2</container></did><accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="02479e2c1173076c05f34aa17007ba49" level="file"><did><unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle><unitdate type="inclusive">2002 March 4</unitdate><container altrender="Record Storage Box (Paige)" id="1e4ea04d834e8d2f360eff1363584949" label="mixed materials [A0000000075921]" type="box">79</container><container id="5a47051793bff644936270369b0e6ed6" parent="1e4ea04d834e8d2f360eff1363584949" type="folder">3-6</container></did><accessrestrict id="c95f7f827b4be73752d104280c14ae0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="d1098818233489d81f3ee9a35c491fda" level="file"><did><unittitle>TML, 44-71 - Tests for drug abuse</unittitle><unitdate type="inclusive">2002 August 19</unitdate><container altrender="Record Storage Box (Paige)" id="91af3824b227f2b6558a3d0261d383c0" label="mixed materials [A0000000075921]" type="box">79</container><container id="bb21c31fb35855fb05a0562a7b2a48e5" parent="91af3824b227f2b6558a3d0261d383c0" type="folder">7-10</container></did><accessrestrict id="6b5deed194656d7a78e4584eaf23da1c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a2d97df9926c22348169dc85fc2da466" level="file"><did><unittitle>TML, 44-82 - Accutane</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="b5004962ec7a6d1d25c95731a70ac999" label="mixed materials [A0000000075921]" type="box">79</container><container id="1e49a201c66495644e286eff603d5881" parent="b5004962ec7a6d1d25c95731a70ac999" type="folder">11-12</container></did><accessrestrict id="811a73112a0f3db0c61460c6f50c3a83"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="77f6dda8f57e4d024c751d9255cb8084" level="file"><did><unittitle>TML, 44-50 - Spinal Manipulation</unittitle><unitdate type="inclusive">2002 May 22</unitdate><container altrender="Record Storage Box (Paige)" id="e8e9715f5bce992f84404ceb34285f97" label="mixed materials [A0000000075921]" type="box">79</container><container id="8d8437a6439429bcf531fb678a42ce5c" parent="e8e9715f5bce992f84404ceb34285f97" type="folder">13-15</container></did><accessrestrict id="c6a5678b6a97ed4390bd98a720535a47"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="f2d67b68df47dbcfadd016a88fd080ba" label="mixed materials [A0000000075921]" type="box">79</container><container id="390ebe7d872bbefb43f4a1776345abb1" parent="f2d67b68df47dbcfadd016a88fd080ba" type="folder">16-17</container></did><accessrestrict id="1fde5116b8525bf37872775d4c998b9e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2af7784d4333e1386ceb5387b0141573" level="file"><did><unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="ca8b84494f0b486e4764ec20d65343ba" label="mixed materials [A0000000075922]" type="box">80</container><container id="dfac1478b29c4edb9829e68c2c3da068" parent="ca8b84494f0b486e4764ec20d65343ba" type="folder">1-2</container></did><accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="45b86f5c46903225f479639e02061c91" level="file"><did><unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle><unitdate type="inclusive">2002 February 18</unitdate><container altrender="Record Storage Box (Paige)" id="14e15cb1db5e3de838cc11578a1c70a6" label="mixed materials [A0000000075922]" type="box">80</container><container id="c2968e202c4dcddc97fd3096fb4acb71" parent="14e15cb1db5e3de838cc11578a1c70a6" type="folder">3-7</container></did><accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file"><did><unittitle>TML, 44-78 - Hormone replacement therapy</unittitle><unitdate type="inclusive">2002 September 2</unitdate><container altrender="Record Storage Box (Paige)" id="a040125907c89e2313a7daac96d2afd6" label="mixed materials [A0000000075922]" type="box">80</container><container id="0b05c14efc3d31d8fe2be5a3e2d8753e" parent="a040125907c89e2313a7daac96d2afd6" type="folder">8-9</container></did><accessrestrict id="25fbac45d92806e8263c700a8600b817"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="79ecc959704f5a99033f6383c71d5e2b" level="file"><did><unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle><unitdate type="inclusive">2002 April 11</unitdate><container altrender="Record Storage Box (Paige)" id="5eacf257b42f32bdd32f8c454f4180c8" label="mixed materials [A0000000075922]" type="box">80</container><container id="a19dfeb1b0c8b3362eeeeb20a578bb1c" parent="5eacf257b42f32bdd32f8c454f4180c8" type="folder">10-12</container></did><accessrestrict id="c218a513a6535a5ceb72241f53f1083c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file"><did><unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="dc1d0000296ce2df6cb31e4ea561d55b" label="mixed materials [A0000000075922]" type="box">80</container><container id="9c45290a495df40057ec7dfeadc5c6c2" parent="dc1d0000296ce2df6cb31e4ea561d55b" type="folder">13-14</container></did><accessrestrict id="daa9fc43588271721e9668e6387b1ecc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="9cf28c7502d38a3253794dc0aff81d12" level="file"><did><unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle><unitdate type="inclusive">2002 June 10</unitdate><container altrender="Record Storage Box (Paige)" id="0820b6f292cf830831588f91cf0c5f58" label="mixed materials [A0000000075922]" type="box">80</container><container id="831f45e837aca18fdefbbb0f781620d1" parent="0820b6f292cf830831588f91cf0c5f58" type="folder">15-16</container></did><accessrestrict id="9343665bbaab14cdc391de9fbda39aab"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="037a4523e063f09b403c4b86b056b0b9" level="file"><did><unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle><unitdate type="inclusive">2002 September 30</unitdate><container altrender="Record Storage Box (Paige)" id="092c6d605e70e37e5acd95fd9861ee83" label="mixed materials [A0000000075922]" type="box">80</container><container id="1fca94c44e3f71b724a20d21b4614b80" parent="092c6d605e70e37e5acd95fd9861ee83" type="folder">17-19</container></did><accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file"><did><unittitle>TML, 44-96 - Rasburicase</unittitle><unitdate type="inclusive">2002 November 11</unitdate><container altrender="Record Storage Box (Paige)" id="732e9afd6afbf6c8e5635be6d43bf8b0" label="mixed materials [A0000000075923]" type="box">81</container><container id="64400b0f1cbdb0dc9812aa72810a8e80" parent="732e9afd6afbf6c8e5635be6d43bf8b0" type="folder">1-2</container></did><accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file"><did><unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="306e6684c8769227843d4496f7439869" label="mixed materials [A0000000075923]" type="box">81</container><container id="4774b41adc32b44f651ec784bbc5b166" parent="306e6684c8769227843d4496f7439869" type="folder">3-6</container></did><accessrestrict id="de5073ebce08ff223cdc3bac4b44096d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="cd35b74adb66fbee3caa77d502914319" level="file"><did><unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle><unitdate type="inclusive">2002 November 25</unitdate><container altrender="Record Storage Box (Paige)" id="21765445799b7226d18d1ad839d9fa1d" label="mixed materials [A0000000075923]" type="box">81</container><container id="894480bb5a18980336640c92e9a69f8e" parent="21765445799b7226d18d1ad839d9fa1d" type="folder">7-9</container></did><accessrestrict id="44a756d7626a6484624c170f3c9fe601"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file"><did><unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle><unitdate type="inclusive">2002 September</unitdate><container altrender="Record Storage Box (Paige)" id="96a44b656f7d58cd2c9b8896a955acb5" label="mixed materials [A0000000075923]" type="box">81</container><container id="a19f9f67acb93ab52370b434016b0886" parent="96a44b656f7d58cd2c9b8896a955acb5" type="folder">10-13</container></did><accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0cdc8024ee854934a00a2e6cc658127c" level="file"><did><unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle><unitdate type="inclusive">2002 October 14</unitdate><container altrender="Record Storage Box (Paige)" id="331763d44f6e03e061aeeeb86f20e326" label="mixed materials [A0000000075923]" type="box">81</container><container id="12b62f5caaba4477f65c95fa6b420408" parent="331763d44f6e03e061aeeeb86f20e326" type="folder">14-15</container></did><accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="6373e1ea574b03380381b604f8f317ea" level="file"><did><unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle><unitdate type="inclusive">2002 May 27</unitdate><container altrender="Record Storage Box (Paige)" id="0077a5926137d5b0714facfd3b33fc30" label="mixed materials [A0000000075923]" type="box">81</container><container id="4bb8b0b6d5d6600c675b701ac2908831" parent="0077a5926137d5b0714facfd3b33fc30" type="folder">16-17</container></did><accessrestrict id="c8982cc8907e5273994dc146b1a74168"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file"><did><unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle><unitdate type="inclusive">2002 December 23</unitdate><container altrender="Record Storage Box (Paige)" id="9461124d13846df3f38990caa6b97bcf" label="mixed materials [A0000000075924]" type="box">82</container><container id="4f3e49ca82fefa5cc63abb1cca33ec1f" parent="9461124d13846df3f38990caa6b97bcf" type="folder">1-3</container></did><accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file"><did><unittitle>TML, 44-27 - Desloratadine</unittitle><unitdate type="inclusive">2002 March 18</unitdate><container altrender="Record Storage Box (Paige)" id="a09ba985138077e3e215190f52571bb6" label="mixed materials [A0000000075924]" type="box">82</container><container id="c241a99075a80e8b1a9eff5bc1ab40a8" parent="a09ba985138077e3e215190f52571bb6" type="folder">4-6</container></did><accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="b7991b9a56fe105d30e6587c04553698" level="file"><did><unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle><unitdate type="inclusive">2002 April 29</unitdate><container altrender="Record Storage Box (Paige)" id="8bcbdf4c346e56d794a78435ca495ffd" label="mixed materials [A0000000075924]" type="box">82</container><container id="399c2baf1e6a83507290bf079f13bca7" parent="8bcbdf4c346e56d794a78435ca495ffd" type="folder">7-8</container></did><accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="e886d7140f04a51e798f5685595d8a64" level="file"><did><unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle><unitdate type="inclusive">2002 August 5</unitdate><container altrender="Record Storage Box (Paige)" id="e1430fa2f21b1c23c74232e7c66af458" label="mixed materials [A0000000075924]" type="box">82</container><container id="1b87a16e78f97eb768dc896af8c34d3e" parent="e1430fa2f21b1c23c74232e7c66af458" type="folder">9-12</container></did><accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file"><did><unittitle>TML - Drugs for Parasitic Infections</unittitle><unitdate type="inclusive">2002</unitdate><container altrender="Record Storage Box (Paige)" id="34a528fa53900df501e1c0f2b5d38e34" label="mixed materials [A0000000075924]" type="box">82</container><container id="03940e65bee1cf6a8ce91fc03b1087db" parent="34a528fa53900df501e1c0f2b5d38e34" type="folder">13-16</container></did><accessrestrict id="a1761f494a6aadd735240b5f6234da0c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file"><did><unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle><unitdate type="inclusive">2002 May 13</unitdate><container altrender="Record Storage Box (Paige)" id="3083a8caee877797dcb6672e51bc2898" label="mixed materials [A0000000075924]" type="box">82</container><container id="0581f1a8a5443a569faea78e4103cdda" parent="3083a8caee877797dcb6672e51bc2898" type="folder">17-19</container></did><accessrestrict id="a69e5af2889f08c295264781d0dc1080"><head>Conditions Governing Access</head><p>Restricted material - Open in 2028</p></accessrestrict></c><c id="f777550cceb72905734014265970ba2d" level="file"><did><unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="0041dc1f43c87dbaee5ce9d2eb7a3efb" label="mixed materials [A0000000075925]" type="box">83</container><container id="68d7782d6f7819fddcf4e4d9694253be" parent="0041dc1f43c87dbaee5ce9d2eb7a3efb" type="folder">1-3</container></did><accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="755a5cb278c5674c278d62217583d0dc" level="file"><did><unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="98e9261670ef6c1ede00fdf3d9994a47" label="mixed materials [A0000000075925]" type="box">83</container><container id="10f846d09625ac5c34a68860f9a0ebfc" parent="98e9261670ef6c1ede00fdf3d9994a47" type="folder">4-6</container></did><accessrestrict id="a72cbce0a6c64d80126a119167b5dc50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file"><did><unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="cd16f6315e69ae3c840c4a4086f3e574" label="mixed materials [A0000000075925]" type="box">83</container><container id="78416056b489a750201eddc57166c3bd" parent="cd16f6315e69ae3c840c4a4086f3e574" type="folder">7</container></did><accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="32827b05df08c432fb2cbb3d952c316a" level="file"><did><unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle><unitdate type="inclusive">2003 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="c816d29ce045c9b20bda42c9c30662d8" label="mixed materials [A0000000075925]" type="box">83</container><container id="a7338b0d075ae8f804a8c827ffd8b39a" parent="c816d29ce045c9b20bda42c9c30662d8" type="folder">8-10</container></did><accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2dcb5260bf184933786c79514811276a" level="file"><did><unittitle>TML, 45-5 - Augmentin XR</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="92006a23b73765b92033d9f7c271f558" label="mixed materials [A0000000075925]" type="box">83</container><container id="a8d647dc0da60c95cbe9a81fe9a629e9" parent="92006a23b73765b92033d9f7c271f558" type="folder">11-13</container></did><accessrestrict id="352c7f8bef5faa523d50be8830568d03"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="6719542efa0dd7e6ff2199fb0fc45784" level="file"><did><unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="6d492af0672099794d81a68d9d178a56" label="mixed materials [A0000000075925]" type="box">83</container><container id="f7fa97c16f2560d2cc84661adf5f4dfd" parent="6d492af0672099794d81a68d9d178a56" type="folder">14-15</container></did><accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="face99254c656f96b64bf580e5f85bcf" level="file"><did><unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="72ce86c14f216aa96b9c4f6c8192a0d0" label="mixed materials [A0000000075925]" type="box">83</container><container id="90b7868201a6aea8b2127c564cb83899" parent="72ce86c14f216aa96b9c4f6c8192a0d0" type="folder">16-18</container></did><accessrestrict id="5b737b9395121e3828a6f6fa407666da"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9ec231ed3611900061caae3128c95513" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="032e63b285dc112789b2a38dfab3e610" label="mixed materials [A0000000075925]" type="box">83</container><container id="7c043b2f93bbeb78bfff64b8ad99c5d8" parent="032e63b285dc112789b2a38dfab3e610" type="folder">19</container></did><accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c6404194bb02ecf2496bacd146a0cc60" level="file"><did><unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="f1a135715ae5885d147ddec53dde1e26" label="mixed materials [A0000000075926]" type="box">84</container><container id="51b36ca8998db34c9ea91821b4f7e64c" parent="f1a135715ae5885d147ddec53dde1e26" type="folder">1-3</container></did><accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2ddbc741772355d7dce54b4b63ef6749" level="file"><did><unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="46bf11fc413ad84325cd3c704ccc551e" label="mixed materials [A0000000075926]" type="box">84</container><container id="25e0b19950eefa756c9e4835c56272fe" parent="46bf11fc413ad84325cd3c704ccc551e" type="folder">4-5</container></did><accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0f45b082b3a08c7cce74229a00644b02" level="file"><did><unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="0ed60111293028d700b8a13a76417fbc" label="mixed materials [A0000000075926]" type="box">84</container><container id="f70694319f85d456868008b02be9af20" parent="0ed60111293028d700b8a13a76417fbc" type="folder">6-8</container></did><accessrestrict id="f517a35e209156fcce5cddbc43b68b14"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="94948e6e42424f89ec840de91511a768" level="file"><did><unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="7e3732ffe1cf288cc984f77f2644c643" label="mixed materials [A0000000075926]" type="box">84</container><container id="efc0490976dadd016855066d4746af96" parent="7e3732ffe1cf288cc984f77f2644c643" type="folder">9-11</container></did><accessrestrict id="a3551a188d335a0b903727fcd2a48fa4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="48f4b3c522fa705a3ae202735e45ac3b" level="file"><did><unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="a47dbb901c4e19434c1f0449411158ee" label="mixed materials [A0000000075926]" type="box">84</container><container id="18866258b6709cdc7050a2be7c84bfc2" parent="a47dbb901c4e19434c1f0449411158ee" type="folder">12-14</container></did><accessrestrict id="3229644ce53e8795f97a65d5d61f18e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="780d425bdbd53ceafd83133223d279a7" level="file"><did><unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="203b7ae8f47733114cb36b8151306524" label="mixed materials [A0000000075926]" type="box">84</container><container id="2f5b2521485e70ce4e98dbd3ba789fc6" parent="203b7ae8f47733114cb36b8151306524" type="folder">15-18</container></did><accessrestrict id="12994eea68e1f09108df54e255ae8cff"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e27a4c127b0269848618ade1805962f" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="fa138921f37384a28cd264186bbb7197" label="mixed materials [A0000000075926]" type="box">84</container><container id="b10ad4fe471fccb2bad7fbfc57dec5a2" parent="fa138921f37384a28cd264186bbb7197" type="folder">19</container></did><accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="732aaf61ce82ace45c4354ea0038b752" level="file"><did><unittitle>TML, 45-7 - Oxalipatin</unittitle><unitdate type="inclusive">2003 January 20</unitdate><container altrender="Record Storage Box (Paige)" id="528d6d183ba1d859303233736a9a55e1" label="mixed materials [A0000000075927]" type="box">85</container><container id="5244e4b8fb70df3bf1221d33b0b89ee4" parent="528d6d183ba1d859303233736a9a55e1" type="folder">1-2</container></did><accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c4617feb74a721aa21a7112babed977f" level="file"><did><unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="98b47cc44cc94b187c3e748b84f73af7" label="mixed materials [A0000000075927]" type="box">85</container><container id="7984b3c23d23dcd76713ca858cf1ebb5" parent="98b47cc44cc94b187c3e748b84f73af7" type="folder">3-4</container></did><accessrestrict id="09ded828b852ae6c86297bc23c88adc0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file"><did><unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="b9c5588c37384c55f0483063b8c8cedf" label="mixed materials [A0000000075927]" type="box">85</container><container id="bb7bc8cbca2cd9a258a92bd66a8646a1" parent="b9c5588c37384c55f0483063b8c8cedf" type="folder">5-8</container></did><accessrestrict id="9d74192e21e6502b4dff990dec4cbb50"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file"><did><unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="c470c735aa4fc01f5beee9156ae53085" label="mixed materials [A0000000075927]" type="box">85</container><container id="bc538cbf6c1eb832a702d10f7429c4af" parent="c470c735aa4fc01f5beee9156ae53085" type="folder">9-12</container></did><accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fdd62d893c6f422fd7c183e65efa7835" level="file"><did><unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="143f85105d200ab86d5fd4241c80ccf9" label="mixed materials [A0000000075927]" type="box">85</container><container id="5ea7582548c0cf220ec4f14a60f47c9b" parent="143f85105d200ab86d5fd4241c80ccf9" type="folder">13-15</container></did><accessrestrict id="36610a7149adbc1f92cfdc7751128db1"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="35402d0a4356ba61f6f491a96f89217a" level="file"><did><unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle><unitdate type="inclusive">2013 February 17</unitdate><container altrender="Record Storage Box (Paige)" id="e6b56a4b82ce405101b70f40b1884b2b" label="mixed materials [A0000000075927]" type="box">85</container><container id="69b695b92bc7e985325054691c02555f" parent="e6b56a4b82ce405101b70f40b1884b2b" type="folder">16-20</container></did><accessrestrict id="136a1315a2303fa111e5d01cb0517e7d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file"><did><unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="6872c9ffdbd0b122e3bea0cc0478b875" label="mixed materials [A0000000075928]" type="box">86</container><container id="7267ab71fe744b030f57e06fbd2baf30" parent="6872c9ffdbd0b122e3bea0cc0478b875" type="folder">1-3</container></did><accessrestrict id="aab1089a7327f8fc78a2fc319190599a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file"><did><unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle><unitdate type="inclusive">2003 May 12</unitdate><container altrender="Record Storage Box (Paige)" id="bcc84d68d2d0b87278748b81cb3404dd" label="mixed materials [A0000000075928]" type="box">86</container><container id="789fc7ffdaed0ba42f4f3c6cf359c779" parent="bcc84d68d2d0b87278748b81cb3404dd" type="folder">4-6</container></did><accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="19fc064c09e3806caaddbb51b70e4090" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="e85ada4513a76fa7bc75556106b7bced" label="mixed materials [A0000000075928]" type="box">86</container><container id="dd905b2fc0253f3a5a4fc40b7c220713" parent="e85ada4513a76fa7bc75556106b7bced" type="folder">5A-6A</container></did><accessrestrict id="60b6213d43e89633056c4a067f8c54e8"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file"><did><unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle><unitdate type="inclusive">2003 December 8</unitdate><container altrender="Record Storage Box (Paige)" id="74cc14dd0165d3dcab5e09b6650da1e1" label="mixed materials [A0000000075928]" type="box">86</container><container id="2bee03a0566ebe4dff66fb7cfc76c3d3" parent="74cc14dd0165d3dcab5e09b6650da1e1" type="folder">7-9</container></did><accessrestrict id="7a45da012d9d8375ab9c62d057d20b13"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d1e93fdc68ebf64e073b0d53c908f073" level="file"><did><unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle><unitdate type="inclusive">2003 December 22</unitdate><container altrender="Record Storage Box (Paige)" id="c0490fd9ecca6ab599df5b8c3a002665" label="mixed materials [A0000000075928]" type="box">86</container><container id="0b61e614a129287d11b395d7c5f457fe" parent="c0490fd9ecca6ab599df5b8c3a002665" type="folder">10-11</container></did><accessrestrict id="a187e298156d35ecb24bf62acbaa2162"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file"><did><unittitle>TML, 45-95 - Tattoo Removal</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="56584c107133c65ca729371284843ae8" label="mixed materials [A0000000075928]" type="box">86</container><container id="c3b195f07ffe08ad9089cf106376df84" parent="56584c107133c65ca729371284843ae8" type="folder">12-13</container></did><accessrestrict id="1cb8774dfbec0195c1be0234b77205c6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a857cbd537b23d5351b0c89499d70d8e" level="file"><did><unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle><unitdate type="inclusive">2003 June 23</unitdate><container altrender="Record Storage Box (Paige)" id="a111dad343f1019824fb7f13b1d761d6" label="mixed materials [A0000000075928]" type="box">86</container><container id="15d4c62a750467f4a887c5956e90dfa7" parent="a111dad343f1019824fb7f13b1d761d6" type="folder">14</container></did><accessrestrict id="4b2308536bb701384ee28edb8995985a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1ed11b7c73752bdb0689383a30c1baf5" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="ca68f11cbedcd3fe9f03070ff286475f" label="mixed materials [A0000000075928]" type="box">86</container><container id="4bf57e1a03f7bbb74ab7736daeb3f7b2" parent="ca68f11cbedcd3fe9f03070ff286475f" type="folder">15-16</container></did><accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c48f05a528d95bdfee4855de30cb54e2" level="file"><did><unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle><unitdate type="inclusive">2003 August 18</unitdate><container altrender="Record Storage Box (Paige)" id="0211e25e642e39afca82bec3cee8286c" label="mixed materials [A0000000075929]" type="box">87</container><container id="b7cf278573ff19d547939f2522c16580" parent="0211e25e642e39afca82bec3cee8286c" type="folder">1</container></did><accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file"><did><unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="a4f684039548e23d7d7ddc1594f6e287" label="mixed materials [A0000000075929]" type="box">87</container><container id="cc18e30b0dec19b4911336fbc37e55ff" parent="a4f684039548e23d7d7ddc1594f6e287" type="folder">2-4</container></did><accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7d40fbe976113721e79b64dd1d00e27d" level="file"><did><unittitle>TML, 45-3 - OTC Loratadine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="acf6f2df3cc328fec3e79dd92afb243d" label="mixed materials [A0000000075929]" type="box">87</container><container id="65ab0cefcfe9904c206828eeb5401fc4" parent="acf6f2df3cc328fec3e79dd92afb243d" type="folder">5</container></did><accessrestrict id="68d83db5324a44659c1dd3f51c2e2864"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1823eedc9d0074c8a4265ac61efdfda5" level="file"><did><unittitle>TML, 45-41 - Insect repellents</unittitle><unitdate type="inclusive">2003 May 26</unitdate><container altrender="Record Storage Box (Paige)" id="a220fbce2e3f73c8966ac385df74769f" label="mixed materials [A0000000075929]" type="box">87</container><container id="eadbd13b32c1878fd5fbbe2179972681" parent="a220fbce2e3f73c8966ac385df74769f" type="folder">6-8</container></did><accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="2f3bcea3a484b983f63233e648e58d71" level="file"><did><unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="3c7f05d98adfb84cd3afc8a5d0348d19" label="mixed materials [A0000000075929]" type="box">87</container><container id="9cd25202dca4297d0a3fddb3bcc9f22c" parent="3c7f05d98adfb84cd3afc8a5d0348d19" type="folder">9-12</container></did><accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file"><did><unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle><unitdate type="inclusive">2003 April 28</unitdate><container altrender="Record Storage Box (Paige)" id="ea3701738efd42233c40edd43905a82a" label="mixed materials [A0000000075929]" type="box">87</container><container id="5c4aee05f96514e14dba3189e1e15737" parent="ea3701738efd42233c40edd43905a82a" type="folder">13-15</container></did><accessrestrict id="68c074ca5c7b85d99e37109be8f03f26"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file"><did><unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle><unitdate type="inclusive">2003 September 15</unitdate><container altrender="Record Storage Box (Paige)" id="967d8cb58555d4c23a2fe1dc19ea6802" label="mixed materials [A0000000075929]" type="box">87</container><container id="a6b53fb5c68f7aa02437d897bc4f23e7" parent="967d8cb58555d4c23a2fe1dc19ea6802" type="folder">16-18</container></did><accessrestrict id="349dea74056b705fe12a6e58b6be4a61"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="11bdec471c430a38763f1ea9a86eab38" level="file"><did><unittitle>TML, 45-58 - Treatment of heat injury</unittitle><unitdate type="inclusive">2003 July 21</unitdate><container altrender="Record Storage Box (Paige)" id="4e37a50eda646f0974dfbe3cb81c7c31" label="mixed materials [A0000000075930]" type="box">88</container><container id="0137ad35a9e16d70abf20954b5d9edd3" parent="4e37a50eda646f0974dfbe3cb81c7c31" type="folder">1-2</container></did><accessrestrict id="b32e89185eafe8ec72db09448de5ce28"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="806d8942533d66de734e65e88b3304ee" level="file"><did><unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle><unitdate type="inclusive">2003 November 10</unitdate><container altrender="Record Storage Box (Paige)" id="a63b9fb58509820f8e61dc6e51976cb2" label="mixed materials [A0000000075930]" type="box">88</container><container id="2f18000724b9256a117a13be04bf3218" parent="a63b9fb58509820f8e61dc6e51976cb2" type="folder">3-6</container></did><accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="04dee614a81cacb32c43ef5b0a88af03" level="file"><did><unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="bec0b0efa77ddb4e0b3b281d7dff91fe" label="mixed materials [A0000000075930]" type="box">88</container><container id="2ff61948528d3705afb46491482bbbac" parent="bec0b0efa77ddb4e0b3b281d7dff91fe" type="folder">7-8</container></did><accessrestrict id="b53a56596e6cd54c520d93ec764edd68"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9233509af152396c7a0be4f4a4690cec" level="file"><did><unittitle>TML, 45-46 - Drug Interactions</unittitle><unitdate type="inclusive">2003 June 9</unitdate><container altrender="Record Storage Box (Paige)" id="ac8b7a72e91df45950083085f4a233c3" label="mixed materials [A0000000075930]" type="box">88</container><container id="c1dc4231687c416151cfe1e8368cd87d" parent="ac8b7a72e91df45950083085f4a233c3" type="folder">9-12</container></did><accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="95a2b9eb73be12648888070a03ead474" level="file"><did><unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="99ccfd0ff8faac5edf5ee5415a29c8d1" label="mixed materials [A0000000075930]" type="box">88</container><container id="39e6329486adbcf0cafcba7d3a57de4e" parent="99ccfd0ff8faac5edf5ee5415a29c8d1" type="folder">13-17</container></did><accessrestrict id="150bc9e4636bdbb6ef444d31120758f6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dad27947e40b662edd3cc5a90a0be625" level="file"><did><unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle><unitdate type="inclusive">2003 October 13</unitdate><container altrender="Record Storage Box (Paige)" id="692c6d7b99924a6b83c240c836fc952f" label="mixed materials [A0000000075930]" type="box">88</container><container id="6655906a216c36f0f37ed9b97d6114b5" parent="692c6d7b99924a6b83c240c836fc952f" type="folder">18-19</container></did><accessrestrict id="7bacb749d5cace7b77c6d20686088469"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e617e6eea5f9996628c705dd200e1ffa" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="0f2631395c4c75c4768583ec9f47e146" label="mixed materials [A0000000075930]" type="box">88</container><container id="965307b7282732da2cbaadce77c60575" parent="0f2631395c4c75c4768583ec9f47e146" type="folder">20</container></did><accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file"><did><unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="d2f201cff307c19ac048087e4431d44c" label="mixed materials [A0000000075931]" type="box">89</container><container id="6dc43262b0d823e084906ac69a88bb9a" parent="d2f201cff307c19ac048087e4431d44c" type="folder">1-4</container></did><accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="edaf8bc319227fe95dce9ce1973f3621" level="file"><did><unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle><unitdate type="inclusive">2003 October 27</unitdate><container altrender="Record Storage Box (Paige)" id="13794e336db96aefaffbd9477ff89b5a" label="mixed materials [A0000000075931]" type="box">89</container><container id="8fa7cb5316e3147a381adc816b65ce85" parent="13794e336db96aefaffbd9477ff89b5a" type="folder">5-9</container></did><accessrestrict id="a9e5f083314a82f3692a841eac51a5ca"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f8dc69e4bf109c9986cc722051633070" level="file"><did><unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle><unitdate type="inclusive">2003 March 31</unitdate><container altrender="Record Storage Box (Paige)" id="af8004fced9894d4e8828ff513388ba8" label="mixed materials [A0000000075931]" type="box">89</container><container id="4c257fedee22a50e8c77d729c0b1e374" parent="af8004fced9894d4e8828ff513388ba8" type="folder">10-11</container></did><accessrestrict id="e59f218612780c21cd1831f3c38ec08e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="cc9f06be346fedef1f6102477bee9cb2" level="file"><did><unittitle>TML, 45-78 - Influenza Prevention</unittitle><unitdate type="inclusive">2003 September 29</unitdate><container altrender="Record Storage Box (Paige)" id="895b728ca70886accce473c1281c490a" label="mixed materials [A0000000075931]" type="box">89</container><container id="61dc2cb67b981061eb36efde82ec2abf" parent="895b728ca70886accce473c1281c490a" type="folder">12-14</container></did><accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="39d9d76dedec7d6057d3eb65d8744ded" level="file"><did><unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle><unitdate type="inclusive">2003 March 3</unitdate><container altrender="Record Storage Box (Paige)" id="e698b133607631422d7ef74efb7d13e7" label="mixed materials [A0000000075931]" type="box">89</container><container id="f4f4787b5cffba0e04712a7b44f2e65b" parent="e698b133607631422d7ef74efb7d13e7" type="folder">15-16</container></did><accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file"><did><unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="211ff60b4b73d2789b95ad26f63206a1" label="mixed materials [A0000000075931]" type="box">89</container><container id="7beccdfa187c589ff98a4555538de7ea" parent="211ff60b4b73d2789b95ad26f63206a1" type="folder">17-20</container></did><accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="e809ce901af88811ad1fd0cb5bc5882c" level="file"><did><unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle><unitdate type="inclusive">2003 February 3</unitdate><container altrender="Record Storage Box (Paige)" id="b7e37f0c81c3a5532e237967dddb8df2" label="mixed materials [A0000000075932]" type="box">90</container><container id="475ec22cc484ee4f7289f3510e3dab6b" parent="b7e37f0c81c3a5532e237967dddb8df2" type="folder">1-4</container></did><accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="acd944256fa6e191f50b1c636b7b7bf4" level="file"><did><unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="4dbdbad45ab30cadec6aebd50662a20d" label="mixed materials [A0000000075932]" type="box">90</container><container id="68e6b39abcb1d3df1987bda57c32faa5" parent="4dbdbad45ab30cadec6aebd50662a20d" type="folder">5-8</container></did><accessrestrict id="56655a641344d4055a005097ec27c5cb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file"><did><unittitle>TML, 45-1 - Smallpox vaccine</unittitle><unitdate type="inclusive">2003 January 6</unitdate><container altrender="Record Storage Box (Paige)" id="98eb0ca58fa0f7b3fa51d1814f44de96" label="mixed materials [A0000000075932]" type="box">90</container><container id="afed47697ad0a45ed18e965b85b944f4" parent="98eb0ca58fa0f7b3fa51d1814f44de96" type="folder">9-12</container></did><accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d9642438ec124cd82d8e135b0198ede7" level="file"><did><unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle><unitdate type="inclusive">2003 September 1</unitdate><container altrender="Record Storage Box (Paige)" id="68cc013be93b7a4ed254e5a2f7e69c8e" label="mixed materials [A0000000075932]" type="box">90</container><container id="06c4969ddb7b844f10480d7105a6dfec" parent="68cc013be93b7a4ed254e5a2f7e69c8e" type="folder">13-16</container></did><accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="f2d01a9103e0c033ffc45c6d6954f5d5" label="mixed materials [A0000000075932]" type="box">90</container><container id="f49488439d742d73cec628c8fa0bb2e9" parent="f2d01a9103e0c033ffc45c6d6954f5d5" type="folder">17-19</container></did><accessrestrict id="91472bcb765db5980f76960bca69f7bb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file"><did><unittitle>TML, 45-23 - Drug-eluting Stents</unittitle><unitdate type="inclusive">2003 March 17</unitdate><container altrender="Record Storage Box (Paige)" id="d5971e1426febc73988479658a6f5498" label="mixed materials [A0000000075933]" type="box">91</container><container id="71c1d498ffe09aef19d09c262bee8fb4" parent="d5971e1426febc73988479658a6f5498" type="folder">1</container></did><accessrestrict id="ad37cdcd99a2044624e749e1cd39779d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="f9a9c4fc1896553a888be142b1758016" level="file"><did><unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle><unitdate type="inclusive">2003 August 4</unitdate><container altrender="Record Storage Box (Paige)" id="f8b9d3bace700e531c5af5df33a7ef64" label="mixed materials [A0000000075933]" type="box">91</container><container id="2edce2c2e8b6a31c82c9d0eeb00ef94d" parent="f8b9d3bace700e531c5af5df33a7ef64" type="folder">2-3</container></did><accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="839fb8691411f959bd1aac5c4ebf7d26" level="file"><did><unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle><unitdate type="inclusive">2003 April 14</unitdate><container altrender="Record Storage Box (Paige)" id="fdfca54c377c92be530c96be41a94a01" label="mixed materials [A0000000075933]" type="box">91</container><container id="816c5b2a251ccc880a4417b49ac65258" parent="fdfca54c377c92be530c96be41a94a01" type="folder">4-5</container></did><accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="55365ce4b3ea2d58db64e9416965cb4e" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="02cca35fc387a676d940b6cdd73bc091" label="mixed materials [A0000000075933]" type="box">91</container><container id="f4ace6e4e29052051260c21b04b62df3" parent="02cca35fc387a676d940b6cdd73bc091" type="folder">6-17</container></did><accessrestrict id="0ed20f41fac45d1a638a3740752cb703"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="668d7e7e07b5750eb2c823e11c095964" level="file"><did><unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="005a902133d2b5e4f8c1278d9074031a" label="mixed materials [A0000000075934]" type="box">92</container><container id="f8cd91b17de7485129de5c1f74876547" parent="005a902133d2b5e4f8c1278d9074031a" type="folder">1-4</container></did><accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file"><did><unittitle>TML - Weight Loss - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 December</unitdate><container altrender="Record Storage Box (Paige)" id="085d51cff3a0246da356ae5e0ffd5f62" label="mixed materials [A0000000075934]" type="box">92</container><container id="a68af2bb11f6912137e0be15d54f6519" parent="085d51cff3a0246da356ae5e0ffd5f62" type="folder">5-13</container></did><accessrestrict id="6dd9eece4a3c89e40bca2442781a600d"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ee60c4bf66a25475983425024da14c39" level="file"><did><unittitle>TML - Heart Failure - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 April</unitdate><container altrender="Record Storage Box (Paige)" id="fbe4c29304afd791a34808636da0f4f5" label="mixed materials [A0000000075934]" type="box">92</container><container id="d824da4fd436cbd8fb22f3cacecaa3a7" parent="fbe4c29304afd791a34808636da0f4f5" type="folder">14-18</container></did><accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file"><did><unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="1ad866a0890d62c05385998218215512" label="mixed materials [A0000000075935]" type="box">93</container><container id="aa00db530764f5b6035d2a911509e9b0" parent="1ad866a0890d62c05385998218215512" type="folder">1-7</container></did><accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="c0978c508033828e366f1d55950a308e" level="file"><did><unittitle>TML - Drugs for Psychiatric Disorders</unittitle><unitdate type="inclusive">2003 July</unitdate><container altrender="Record Storage Box (Paige)" id="93b4a8205308a4f92e9c6b97430af89a" label="mixed materials [A0000000075935]" type="box">93</container><container id="15f6214d3876186ba7b739aecc3ba5e6" parent="93b4a8205308a4f92e9c6b97430af89a" type="folder">8-18</container></did><accessrestrict id="03781a219ff982acf63e0290b3b87f0e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a9906d72f32382fa1bb39c1ccd388091" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="c4b685af7389153271de13f0aae541d2" label="mixed materials [A0000000075935]" type="box">93</container><container id="ee71a64fadef5f7b07518f95b60f51e0" parent="c4b685af7389153271de13f0aae541d2" type="folder">19</container></did><accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file"><did><unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle><unitdate type="inclusive">2003 January</unitdate><container altrender="Record Storage Box (Paige)" id="993f718dd3ebbcd29e236bd9ce8b3f51" label="mixed materials [A0000000075936]" type="box">94</container><container id="6b303dfadf1d55528491060706ab5a24" parent="993f718dd3ebbcd29e236bd9ce8b3f51" type="folder">1-4</container></did><accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="380c664090534851fbc806e0558fde2f" level="file"><did><unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 October</unitdate><container altrender="Record Storage Box (Paige)" id="4685e57ba87048ab1794c0e25859c342" label="mixed materials [A0000000075936]" type="box">94</container><container id="974e29e1754da3dbb3de70ce44ed3a78" parent="4685e57ba87048ab1794c0e25859c342" type="folder">5-13</container></did><accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="dfe820ca0d9eb165533f652cbc41ee32" level="file"><did><unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 February</unitdate><container altrender="Record Storage Box (Paige)" id="6be247912048a003ba01d0ef31e6732a" label="mixed materials [A0000000075936]" type="box">94</container><container id="d3ff1cd522cd2bad3684d0c35f4d56dc" parent="6be247912048a003ba01d0ef31e6732a" type="folder">14-17</container></did><accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3ce9ce08c457fba44042e2deea5066f7" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="d788ceebddb054126498002774ff11da" label="mixed materials [A0000000075936]" type="box">94</container><container id="b072a776ebc6d9798ab400fc1f9f6281" parent="d788ceebddb054126498002774ff11da" type="folder">18</container></did><accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="d475b54c5095880adce7b8263966fe2d" level="file"><did><unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 March</unitdate><container altrender="Record Storage Box (Paige)" id="b01f3761d14f50d09d9416e31d4c1f92" label="mixed materials [A0000000075937]" type="box">95</container><container id="bf5fec45713504221a6e16bf15ecd8ef" parent="b01f3761d14f50d09d9416e31d4c1f92" type="folder">1-8</container></did><accessrestrict id="d727ecc0d3636f553591f418559bc721"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file"><did><unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 May</unitdate><container altrender="Record Storage Box (Paige)" id="08d4286930f55350257a221c1a14746a" label="mixed materials [A0000000075937]" type="box">95</container><container id="49229789ef993dab84ef2144c626df9f" parent="08d4286930f55350257a221c1a14746a" type="folder">9-14</container></did><accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file"><did><unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 August</unitdate><container altrender="Record Storage Box (Paige)" id="f0fb5616af981a2a673d8dc3ac629db6" label="mixed materials [A0000000075937]" type="box">95</container><container id="45f4ac40f938ea069a9711c0e1352127" parent="f0fb5616af981a2a673d8dc3ac629db6" type="folder">15-18</container></did><accessrestrict id="334e64660b4fc298f4d1c26e9a76a343"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="fe2b0bfc2f03a32fe2ca7c734d5719ea" label="mixed materials [A0000000075937]" type="box">95</container><container id="644b1cf8824f0e4177d7da4fd4a26ae4" parent="fe2b0bfc2f03a32fe2ca7c734d5719ea" type="folder">19</container></did><accessrestrict id="7cdf942787e0cbed8326189a2020f299"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="ddf6b73987ce0637989f66584610c6ea" level="file"><did><unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle><unitdate type="inclusive">2003 July 7</unitdate><container altrender="Record Storage Box (Paige)" id="ba6ba5b05fe22cbc192d151afaf8360d" label="mixed materials [A0000000075938]" type="box">96</container><container id="482a8f46a16d601509e94d95b1b011e0" parent="ba6ba5b05fe22cbc192d151afaf8360d" type="folder">1</container></did><accessrestrict id="2b960cecbba771988110df8a9cd33742"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file"><did><unittitle>TML, 45-93 - Which SSRI</unittitle><unitdate type="inclusive">2003 November 24</unitdate><container altrender="Record Storage Box (Paige)" id="3810d6d76ae171206ed6feddafceb75a" label="mixed materials [A0000000075938]" type="box">96</container><container id="bc813215df66536ca6709968096ea3fb" parent="3810d6d76ae171206ed6feddafceb75a" type="folder">2-5</container></did><accessrestrict id="72e10bfbf01df945876de61f8480a08b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="1e5a72f232d4e116685aff32e9ed9f87" level="file"><did><unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 November</unitdate><container altrender="Record Storage Box (Paige)" id="833467d9772830246a3e563a1a2df736" label="mixed materials [A0000000075938]" type="box">96</container><container id="cfba8f26cab45f6591bf5ce77ffcc361" parent="833467d9772830246a3e563a1a2df736" type="folder">6-9</container></did><accessrestrict id="ce922dcf8bde445758a34a54106e0ec6"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="7621ca9e85272fb03e367f6102650bf9" level="file"><did><unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle><unitdate type="inclusive">2003 September</unitdate><container altrender="Record Storage Box (Paige)" id="1508a71df2635669e599598bf4ffb32d" label="mixed materials [A0000000075938]" type="box">96</container><container id="5b3dc62557473e27fcc074efd93e7141" parent="1508a71df2635669e599598bf4ffb32d" type="folder">10-17</container></did><accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2029</p></accessrestrict></c><c id="68e729c691bb49c8be35f332fbb1e32b" level="file"><did><unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="f95edbc6ecd5bf6bef291c26e176a612" label="mixed materials [A0000000075939]" type="box">97</container><container id="75b678a4f7cff282c146995df711dd56" parent="f95edbc6ecd5bf6bef291c26e176a612" type="folder">1-10</container></did><accessrestrict id="084a4278da0f4581918db07f8eb825b4"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="07f19737b5f6d3009e9e85a8b0528533" level="file"><did><unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="f7267f4b69c6ddcccb700cdf8550013a" label="mixed materials [A0000000075939]" type="box">97</container><container id="b1b1123baaaddc90814a135276e6e5ae" parent="f7267f4b69c6ddcccb700cdf8550013a" type="folder">11-18</container></did><accessrestrict id="8f26a61c71898392ee05f246c39c61b0"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="c099bb967206188345dcdbf9c2975e6d" level="file"><did><unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="16f8c4296f038d431a0bf160bdec5914" label="mixed materials [A0000000075940]" type="box">98</container><container id="396b559afe115b2d0d7eb807a3bfc5c5" parent="16f8c4296f038d431a0bf160bdec5914" type="folder">1-9</container></did><accessrestrict id="e0b7814bc924716eb27275e9522cf9ae"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="237497500e700200226282634e319af9" level="file"><did><unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle><unitdate type="inclusive">2004</unitdate><container altrender="Record Storage Box (Paige)" id="8371538d47630b316b3e3a37ac51bd9b" label="mixed materials [A0000000075940]" type="box">98</container><container id="e94fe0eedf556a0be3d18da8af270d6e" parent="8371538d47630b316b3e3a37ac51bd9b" type="folder">10-15</container></did><accessrestrict id="00d75b64dab2398628516bc88ce53406"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="423b8c383be805c9a485a8fecfe9ddb1" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="d182002a3452ba37eddcf9d751cacece" label="mixed materials [A0000000075940]" type="box">98</container><container id="ec36827bf9c16f87b978635323e0f3b5" parent="d182002a3452ba37eddcf9d751cacece" type="folder">16</container></did><accessrestrict id="98f8b37e529ccb193a51c645e7d19af9"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="26700edc7d4dff9bb83e29c005e8dedd" level="file"><did><unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 December</unitdate><container altrender="Record Storage Box (Paige)" id="39092960e89e19df8118557649393a09" label="mixed materials [A0000000075941]" type="box">99</container><container id="873d5ba476d8ba40ba2d1dd82d0aad7d" parent="39092960e89e19df8118557649393a09" type="folder">1-5</container></did><accessrestrict id="ff906c4305f7b289ec47141f34c41d10"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file"><did><unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 October</unitdate><container altrender="Record Storage Box (Paige)" id="fd7a9d4f79e6dd00eb7d637fff4de8a0" label="mixed materials [A0000000075941]" type="box">99</container><container id="cdcc1fe81002e2910784128d0b0073de" parent="fd7a9d4f79e6dd00eb7d637fff4de8a0" type="folder">6-12</container></did><accessrestrict id="6db6900a0738aa418a1db1239ba995f3"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="ef8b77a4a9168df66dbaa1d35328f051" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="46d20e79d51decd15e23c8a97c2b979c" label="mixed materials [A0000000075941]" type="box">99</container><container id="982d506ca63399a17774d1abdb93bc00" parent="46d20e79d51decd15e23c8a97c2b979c" type="folder">13-18</container></did><accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="4122c98e47eb1d53ed958233e91ca5d6" level="file"><did><unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 June</unitdate><container altrender="Record Storage Box (Paige)" id="630423dbe9622a9df97d70b718041c1f" label="mixed materials [A0000000075942]" type="box">100</container><container id="897aac9a11316d4b2b956e59003cd693" parent="630423dbe9622a9df97d70b718041c1f" type="folder">1-3</container></did><accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="1db0c21858cc9e616d5906c203e6860d" level="file"><did><unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle><unitdate type="inclusive">2004 March 15</unitdate><container altrender="Record Storage Box (Paige)" id="45a839d1e0b79d1704792ab760fb660a" label="mixed materials [A0000000075942]" type="box">100</container><container id="8c8f876609e95a7b05dfd49cde7dd72a" parent="45a839d1e0b79d1704792ab760fb660a" type="folder">4-5</container></did><accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file"><did><unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="1e5ab0caae72c4a49f54c3dd4b48a9e4" label="mixed materials [A0000000075942]" type="box">100</container><container id="65bb7ce438b4822ccf0467403a0de968" parent="1e5ab0caae72c4a49f54c3dd4b48a9e4" type="folder">6-8</container></did><accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file"><did><unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle><unitdate type="inclusive">2004 February 2</unitdate><container altrender="Record Storage Box (Paige)" id="04499b5bd7f041076266c64e13474773" label="mixed materials [A0000000075942]" type="box">100</container><container id="1febdbd64bb83ae3dffb48f17d5b6d0a" parent="04499b5bd7f041076266c64e13474773" type="folder">9-10</container></did><accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="9ea3892837eec8429d01fe1dc14e6b41" level="file"><did><unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle><unitdate type="inclusive">2004 January 19</unitdate><container altrender="Record Storage Box (Paige)" id="5ca49e3a2da117fb6bf8e783cf0b31d4" label="mixed materials [A0000000075942]" type="box">100</container><container id="cc9c3147db7d68ad4bbedc6660d6a72a" parent="5ca49e3a2da117fb6bf8e783cf0b31d4" type="folder">11-14</container></did><accessrestrict id="7815c3c9e1b402b4a02ed5022e168609"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1703fc66140060139d86d70ac0c3846" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="d21408de58807df94abc12fe5174049c" label="mixed materials [A0000000075942]" type="box">100</container><container id="1e8a6d4aba56222d9a9d67c395c830aa" parent="d21408de58807df94abc12fe5174049c" type="folder">15-18</container></did><accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e8f33c13c32daa15598a2e144e9f900f" level="file"><did><unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle><unitdate type="inclusive">2004 February 16</unitdate><container altrender="Record Storage Box (Paige)" id="704bbb739a17a02810549824380b44bb" label="mixed materials [A0000000075943]" type="box">101</container><container id="77451b8341473d5efbc8250c1fa48ae3" parent="704bbb739a17a02810549824380b44bb" type="folder">1</container></did><accessrestrict id="81a1621d7a2a2452c30a530869fc9bea"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="f1258ee39d7e2cce0fa124be57ed0634" level="file"><did><unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 March</unitdate><container altrender="Record Storage Box (Paige)" id="0d800b6ae2da5c6f394154fecb2504c9" label="mixed materials [A0000000075943]" type="box">101</container><container id="e055677ef0e453b2dba6d668166f7b54" parent="0d800b6ae2da5c6f394154fecb2504c9" type="folder">2-8</container></did><accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="dcf6c003359f1d37afb6b89504a47763" level="file"><did><unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 February</unitdate><container altrender="Record Storage Box (Paige)" id="a4a7e54349cf0da85f42f68ba12eb8fc" label="mixed materials [A0000000075943]" type="box">101</container><container id="6040c1506b376d57fa14e8b1908be341" parent="a4a7e54349cf0da85f42f68ba12eb8fc" type="folder">9-17</container></did><accessrestrict id="ee022307e7bb1d19942f259293477255"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="6fbfdca263989f40ad70c131c6355dee" label="mixed materials [A0000000075943]" type="box">101</container><container id="7017a829002d22245634c0106854ef6b" parent="6fbfdca263989f40ad70c131c6355dee" type="folder">18-19</container></did><accessrestrict id="cae76792326d54b966f74999980f0522"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="499346d5020cece037a74d774986c858" level="file"><did><unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 January</unitdate><container altrender="Record Storage Box (Paige)" id="1335a40b48797b61b53d036b0d72f82e" label="mixed materials [A0000000075944]" type="box">102</container><container id="2cdce58a6565a5947c2991ef5156f066" parent="1335a40b48797b61b53d036b0d72f82e" type="folder">1-4</container></did><accessrestrict id="78b76f282a6087796d952eea7ca3851b"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c><c id="e2ff3268992aa759f09a842e60822ffb" level="file"><did><unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle><unitdate type="inclusive">2004 July</unitdate><container altrender="Record Storage Box (Paige)" id="daef262530b7c3b5f2870a5b06cb3ed1" label="mixed materials [A0000000075944]" type="box">102</container><container id="39de21cbfff8122e88d28c912e015a0d" parent="daef262530b7c3b5f2870a5b06cb3ed1" type="folder">5-14</container></did><accessrestrict id="04e11af6b467a1e7c10d7574675c44fb"><head>Conditions Governing Access</head><p>Restricted material - Open in 2030</p></accessrestrict></c></dsc>
</archdesc>
</ead>
